
<html lang="en"     class="pb-page"  data-request-id="fd4b5158-679e-4ff4-8be0-f74b72ac4f0f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-10;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm1000908;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT1A Antagonists" /></meta><meta name="dc.Creator" content="Wayne E.  Childers, Jr." /></meta><meta name="dc.Creator" content="Lisa M.  Havran" /></meta><meta name="dc.Creator" content="Magda  Asselin" /></meta><meta name="dc.Creator" content="James J.  Bicksler" /></meta><meta name="dc.Creator" content="Dan C.  Chong" /></meta><meta name="dc.Creator" content="George T.  Grosu" /></meta><meta name="dc.Creator" content="Zhongqi  Shen" /></meta><meta name="dc.Creator" content="Magid, A.  Abou-Gharbia" /></meta><meta name="dc.Creator" content="Alvin C.  Bach, III" /></meta><meta name="dc.Creator" content="Boyd L.  Harrison" /></meta><meta name="dc.Creator" content="Natasha  Kagan" /></meta><meta name="dc.Creator" content="Teresa  Kleintop" /></meta><meta name="dc.Creator" content="Ronald  Magolda" /></meta><meta name="dc.Creator" content="Vasilios  Marathias" /></meta><meta name="dc.Creator" content="Albert J.  Robichaud" /></meta><meta name="dc.Creator" content="Annmarie L.  Sabb" /></meta><meta name="dc.Creator" content="Mei-Yi  Zhang" /></meta><meta name="dc.Creator" content="Terrance H.  Andree" /></meta><meta name="dc.Creator" content="Susan H.  Aschmies" /></meta><meta name="dc.Creator" content="Chad  Beyer" /></meta><meta name="dc.Creator" content="Thomas A.  Comery" /></meta><meta name="dc.Creator" content="Mark  Day" /></meta><meta name="dc.Creator" content="Steven M.  Grauer" /></meta><meta name="dc.Creator" content="Zoe A.  Hughes" /></meta><meta name="dc.Creator" content="Sharon  Rosenzweig-Lipson" /></meta><meta name="dc.Creator" content="Brian  Platt" /></meta><meta name="dc.Creator" content="Claudine  Pulicicchio" /></meta><meta name="dc.Creator" content="Deborah E.  Smith" /></meta><meta name="dc.Creator" content="Stacy J.  Sukoff-Rizzo" /></meta><meta name="dc.Creator" content="Kelly M.  Sullivan" /></meta><meta name="dc.Creator" content="Adedayo  Adedoyin" /></meta><meta name="dc.Creator" content="Christine  Huselton" /></meta><meta name="dc.Creator" content="Warren D.  Hirst" /></meta><meta name="dc.Description" content="As part of an effort to identify 5-HT1A antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound 10a was identified from earlier wor..." /></meta><meta name="Description" content="As part of an effort to identify 5-HT1A antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound 10a was identified from earlier wor..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 5, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1000908" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1000908" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1000908" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1000908" /></link>
        
    
    

<title>The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT1A Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1000908" /></meta><meta property="og:title" content="The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT1A Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0024.jpeg" /></meta><meta property="og:description" content="As part of an effort to identify 5-HT1A antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound 10a was identified from earlier work in a combined 5-HT1A antagonist/SSRI program. This quinolyl-piperazinyl piperidine analogue displayed potent, selective 5-HT1A antagonism but suffered from poor oxidative metabolic stability, resulting in low exposure following oral administration. SAR studies, driven primarily by in vitro liver microsomal stability assessment, identified compound 10b, which displayed improved oral bioavailability and lower intrinsic clearance. Further changes to the scaffold (e.g., 10r) resulted in a loss in potency. Compound 10b displayed cognitive enhancing effects in a number of animal models of learning and memory, enhanced the antidepressant-like effects of the SSRI fluoxetine, and reversed the sexual dysfunction induced by chronic fluoxetine treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1000908"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1000908">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1000908&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1000908&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1000908&amp;href=/doi/10.1021/jm1000908" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4066-4084</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100055b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100100q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT<sub>1A</sub> Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne+E.++Childers%2C++Jr.">Wayne E. Childers, Jr.</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+M.++Havran">Lisa M. Havran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Magda++Asselin">Magda Asselin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+J.++Bicksler">James J. Bicksler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan+C.++Chong">Dan C. Chong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George+T.++Grosu">George T. Grosu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhongqi++Shen">Zhongqi Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Magid%2C+A.++Abou-Gharbia">Magid, A. Abou-Gharbia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alvin+C.++Bach%2C++III">Alvin C. Bach, III</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boyd+L.++Harrison">Boyd L. Harrison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natasha++Kagan">Natasha Kagan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Teresa++Kleintop">Teresa Kleintop</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronald++Magolda">Ronald Magolda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vasilios++Marathias">Vasilios Marathias</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albert+J.++Robichaud">Albert J. Robichaud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Annmarie+L.++Sabb">Annmarie L. Sabb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mei-Yi++Zhang">Mei-Yi Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terrance+H.++Andree">Terrance H. Andree</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+H.++Aschmies">Susan H. Aschmies</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chad++Beyer">Chad Beyer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+A.++Comery">Thomas A. Comery</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Day">Mark Day</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+M.++Grauer">Steven M. Grauer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zoe+A.++Hughes">Zoe A. Hughes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sharon++Rosenzweig-Lipson">Sharon Rosenzweig-Lipson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Platt">Brian Platt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudine++Pulicicchio">Claudine Pulicicchio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deborah+E.++Smith">Deborah E. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacy+J.++Sukoff-Rizzo">Stacy J. Sukoff-Rizzo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly+M.++Sullivan">Kelly M. Sullivan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adedayo++Adedoyin">Adedayo Adedoyin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Huselton">Christine Huselton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Warren+D.++Hirst">Warren D. Hirst</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Chemical Sciences</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Neuroscience</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Drug Safety and Metabolism</span></div><div class="aff-info" id="aff4"><span class="aff-text">Pfizer Global Research and Development, CN-8000, Princeton, New Jersey 08543-8000</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: (215)-862-0580. Fax: (732)-274-4505. E-mail: <a href="/cdn-cgi/l/email-protection#a1d6c2c9c8cdc5c4d3d2e1d8c0c9cece8fc2cecc"><span class="__cf_email__" data-cfemail="f384909b9a9f97968180b38a929b9c9cdd909c9e">[email protected]</span></a></div><div class="corresp-fn" id="fn1">∥Current Address: Molder Center for Drug Discovery Research, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140</div><div class="corresp-fn" id="fn2">⊥Deceased.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1000908&amp;href=/doi/10.1021%2Fjm1000908" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4066–4084</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 5, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 January 2010</li><li><span class="item_label"><b>Published</b> online</span>5 May 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 May 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1000908" title="DOI URL">https://doi.org/10.1021/jm1000908</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4066%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWayne%2BE.%2BChilders%252C%2BLisa%2BM.%2BHavran%252C%2BMagda%2BAsselin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D10%26contentID%3Djm1000908%26title%3DThe%2BSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2BQuinolyl-piperazinyl%2BPiperidines%2Bas%2BPotent%2BSerotonin%2B5-HT1A%2BAntagonists%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4084%26publicationDate%3DMay%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1000908"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3059</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1000908" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Synthesis and Biological Evaluation of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT1A Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;E. Childers&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;M. Havran&quot;},{&quot;first_name&quot;:&quot;Magda&quot;,&quot;last_name&quot;:&quot;Asselin&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;J. Bicksler&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;C. Chong&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;T. Grosu&quot;},{&quot;first_name&quot;:&quot;Zhongqi&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Magid,&quot;,&quot;last_name&quot;:&quot;A. Abou-Gharbia&quot;},{&quot;first_name&quot;:&quot;Alvin&quot;,&quot;last_name&quot;:&quot;C. Bach&quot;},{&quot;first_name&quot;:&quot;Boyd&quot;,&quot;last_name&quot;:&quot;L. Harrison&quot;},{&quot;first_name&quot;:&quot;Natasha&quot;,&quot;last_name&quot;:&quot;Kagan&quot;},{&quot;first_name&quot;:&quot;Teresa&quot;,&quot;last_name&quot;:&quot;Kleintop&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;Magolda&quot;},{&quot;first_name&quot;:&quot;Vasilios&quot;,&quot;last_name&quot;:&quot;Marathias&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;J. Robichaud&quot;},{&quot;first_name&quot;:&quot;Annmarie&quot;,&quot;last_name&quot;:&quot;L. Sabb&quot;},{&quot;first_name&quot;:&quot;Mei-Yi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Terrance&quot;,&quot;last_name&quot;:&quot;H. Andree&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;H. Aschmies&quot;},{&quot;first_name&quot;:&quot;Chad&quot;,&quot;last_name&quot;:&quot;Beyer&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;A. Comery&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Day&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;M. Grauer&quot;},{&quot;first_name&quot;:&quot;Zoe&quot;,&quot;last_name&quot;:&quot;A. Hughes&quot;},{&quot;first_name&quot;:&quot;Sharon&quot;,&quot;last_name&quot;:&quot;Rosenzweig-Lipson&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Platt&quot;},{&quot;first_name&quot;:&quot;Claudine&quot;,&quot;last_name&quot;:&quot;Pulicicchio&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;E. Smith&quot;},{&quot;first_name&quot;:&quot;Stacy&quot;,&quot;last_name&quot;:&quot;J. Sukoff-Rizzo&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;M. Sullivan&quot;},{&quot;first_name&quot;:&quot;Adedayo&quot;,&quot;last_name&quot;:&quot;Adedoyin&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Huselton&quot;},{&quot;first_name&quot;:&quot;Warren&quot;,&quot;last_name&quot;:&quot;D. Hirst&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;4066-4084&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1000908&quot;},&quot;abstract&quot;:&quot;As part of an effort to identify 5-HT1A antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound 10a was identified from earlier work in a combined 5-HT1A antagonist/SSRI program. This quinolyl-piperazinyl piperidine analogue displayed potent, selective 5-HT1A antagonism but suffered from poor oxidative metabolic stability, resulting in low exposure following oral administration. SAR studies, driven primarily by in vitro liver microsomal stability assessment, identified compound 10b, which displayed improved oral bioavailability and lower intrinsic clearance. Further changes to the scaffold (e.g., 10r) resulted in a loss in potency. Compound 10b displayed cognitive enhancing effects in a number of animal models of learning and memory, enhanced the antidepressant-like effects of the SSRI fluoxetine, and reversed the sexual dysfunction induced by chronic fluoxetine treatment.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1000908&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1000908" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1000908&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1000908" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1000908&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1000908" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1000908&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1000908&amp;href=/doi/10.1021/jm1000908" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1000908" /></input><a href="/doi/pdf/10.1021/jm1000908" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1000908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1000908%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DChilders%26date%3D2010%26atitle%3DThe%2BSynthesis%2Band%2BBiological%2BEvaluation%2Bof%2BQuinolyl-piperazinyl%2BPiperidines%2Bas%2BPotent%2BSerotonin%2B5-HT1A%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D10%26spage%3D4066%26epage%3D4084%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">As part of an effort to identify 5-HT<sub>1A</sub> antagonists that did not possess typical arylalkylamine or keto/amido-alkyl aryl piperazine scaffolds, prototype compound <b>10a</b> was identified from earlier work in a combined 5-HT<sub>1A</sub> antagonist/SSRI program. This quinolyl-piperazinyl piperidine analogue displayed potent, selective 5-HT<sub>1A</sub> antagonism but suffered from poor oxidative metabolic stability, resulting in low exposure following oral administration. SAR studies, driven primarily by in vitro liver microsomal stability assessment, identified compound <b>10b</b>, which displayed improved oral bioavailability and lower intrinsic clearance. Further changes to the scaffold (e.g., <b>10r</b>) resulted in a loss in potency. Compound <b>10b</b> displayed cognitive enhancing effects in a number of animal models of learning and memory, enhanced the antidepressant-like effects of the SSRI fluoxetine, and reversed the sexual dysfunction induced by chronic fluoxetine treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The 5-HT<sub>1A</sub><a class="ref internalNav" href="#fn3" aria-label="a">a</a><div class="NLM_fn" id="fn3">a<p class="last">Abbreviations: 5-HT, 5-hydroxytryptamine; 8-OH-DPAT, 8-hydroxy-2-(di-<i>n</i>-propylamino)-tetralin; Aβ, beta-amyloid; AMP, adeonosine monophosphate; APP, amyloid precursor protrein; BINAP, tetrakis(triphenylphosphino)-1,1-binapthyl; B/P, brain to plasma; CHO, Chinese hamster ovary; CYMAP, dicyclohexylphosphine-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl; <i>E</i><sub>max</sub>, maximum enhancing effect level; GPCR, G-protein coupled receptor; GTPγS, guanosine 5′-<i>O</i>-[γ-thio]triphosphate; HPLC, high pressure liquid chromatography; <i>I</i><sub>max</sub>, maximum inhibitory effect level; MED, minimal effective dose; NADPH, nicotinamide adenine dinucleotide phosphate; OB, olfactory bulbectomy; PK, pharmacokinetic; SAR, structure−activity relationship; SSRI, selective serotonin reuptake inhibitor.</p></div> receptor is arguably the most thoroughly studied of all the serotonin receptor subtypes. A plethora of information on this receptor has been generated since its discovery in 1981<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and subsequent cloning in 1988.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The receptor possesses a tertiary structure typical of 7-transmembrane G-protein coupled receptors (GPCRs), with multiple sites for glycosylation and phosphorylation. It is located both presynaptically, where it functions as an inhibitory somatodendritic autoreceptor and postsynaptically, where it also functions as an inhibitory receptor. The rat 5-HT<sub>1A</sub> receptor is 89% homologous to the human protein and resembles its human counterpart both pharmacologically and in terms of anatomical localization. The 5-HT<sub>1A</sub> receptor has been an important drug discovery target in the brain for nearly two decades and continues to attract attention.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Several lines of evidence suggest that 5-HT<sub>1A</sub> receptors are involved in learning and memory.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The 5-HT<sub>1A</sub> receptor is expressed in abundance in several brain regions thought to be associated with learning and memory, such as the hippocampus, frontal cortex, and septum.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These receptors are poised to modulate cholinergic neurotransmission via both direct and indirect signaling. Postsynaptic 5-HT<sub>1A</sub> receptors provide inhibitory tone to the cholinergic projections from the nucleus basalis of Maynert to the frontal cortex and hippocampus. Presynaptic 5-HT<sub>1A</sub> receptors in the dorsal raphe modulate serotonergic neurotransmission to the prefrontal cortex (where they control excitatory glutamatergic signals) and the locus cerruleus (where they control adrenergic signaling). A 5-HT<sub>1A</sub> antagonist would be expected to directly block inhibitory tone in the nucleus basalis while, at the same time, indirectly stimulate excitatory tone from the prefrontal cortex and locus ceruleus via blockade of autoreceptors in the dorsal raphe. The net result would be an increase in cholinergic signaling from the nucleus basalis to the frontal cortex. Consistent with this hypothesis, administration of 5-HT<sub>1A</sub> antagonists enhanced glutamate and acetylcholine release.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> This enhancement on cholinergic neurotransmission correlated with improvement in animal models of cognition.</div><div class="NLM_p">5-HT<sub>1A</sub> antagonists have also been explored as potential adjunctive therapies for selective serotonin reuptake inhibitor (SSRI) antidepressants. SSRIs are extensively used to treat depression. However, as a class, they suffer from a delayed onset of antidepressant action<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and a number of side effects, including sexual dysfunction.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The delay in onset of clinical efficacy is thought to occur because the high density of inhibitory 5-HT<sub>1A</sub> autoreceptors in the target forebrain regions compensates for the elevations in synaptic 5-HT induced by acute SSRI treatment.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Chronic SSRI treatment is required to see positive effects and the 2−4 week delay in onset of action is thought to represent the time needed for desensitization of the autoreceptors to occur. Clinical evidence with pindolol suggests that coadministration of a 5-HT<sub>1A</sub> antagonist may shorten this delay,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> although the data with pindolol may be confounded by the compound’s β-adrenergic antagonist activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> There is conflicting clinical evidence regarding whether 5-HT<sub>1A</sub> antagonists may be useful adjuctive therapies for ameliorating SSRI-induced sexual dysfunction, but encouraging data from animal models is beginning to emerge.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">Selective 5-HT<sub>1A</sub> antagonists reported to date generally fall into two structural classes. The first class (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is the aryl alkyl amines, exemplified by compounds like (S)-U-301 (<b>1</b>) and robalzotan (<b>2</b>). The second structural class is the aryl piperazines (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), represented by compounds like LY-426965 (<b>3</b>) and WAY-100635 (<b>4</b>). We recently reported on two potent, selective orally active 5-HT<sub>1A</sub> antagonists possessing this moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), lecozotan (<b>5</b>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and WAY-101405 (<b>6</b>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Similar aryl piperazine analogues (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), such as adatanserin (<b>7</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and BMY 7378 (<b>8</b>),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> display partial agonist activity, especially in the dorsal raphe where the high degree of receptor reserve seen for presynaptic 5-HT<sub>1A</sub> autoreceptors amplifies small levels of intrinsic activity. One of the structural features that may promote potent, full antagonist activity in compounds <b>3</b>−<b>6</b> is the presence of a pendent aryl or heteroaryl group located in proximity to the carbonyl moiety. The carboxamide grouping of compounds like <b>5</b>−<b>8</b> represents a potential site for metabolic hydrolysis and/or chemical instability. In our continuing search for 5-HT<sub>1A</sub> antagonists, we explored structural scaffolds that did not possess a carboxamide moiety.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative 5-HT<sub>1A</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Aryl-piperazine 5-HT<sub>1A</sub> antagonists and partial agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More recently, compounds prepared as dual-acting 5-HT<sub>1A</sub> antagonists/SSRIs have been reported.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> These compounds, which often consist of combinations of 5-HT<sub>1A</sub> pharmacophores and SSRI pharmacophores (see, for example, Hatzenbuhler et al.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a>), do not possess all three structural features inherent in selective 5-HT<sub>1A</sub> antagonists like <b>3</b>−<b>6</b> (i.e., the aryl piperazine, the substituted amide/ketone, and the pendent aryl/heteroaryl grouping). We recently disclosed our work on a series of quinolylpiperazines as mixed SSRI-5-HT<sub>1A</sub> antagonists.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> These compounds, exemplified by <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), displayed potent affinity for both the human serotonin transporter (measured as displacement of [<sup>3</sup>H]-paroxetine) and the human 5-HT<sub>1A</sub> receptor and a variety of intrinsic activities in an in vitro functional model (inhibition of GTPγS binding to the human 5-HT<sub>1A</sub>/G-protein complex). In the course of prosecuting this series, we synthesized the previously undisclosed quinolyl-piperazinyl piperidine analogue <b>10a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Compound <b>10a</b> was surprisingly devoid of serotonin transporter affinity yet maintained potent affinity and full antagonist activity at the 5-HT<sub>1A</sub> receptor. To our knowledge, this compound represents one of the first potent, selective aryl piperazine-based 5-HT<sub>1A</sub> antagonists that does not possess an amide/ketone moiety. Previous work<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> had shown that substitution in the 6-position of the quinolylpiperazinyl ring system was particularly favorable for producing compounds that profiled in vitro as potent, full 5-HT<sub>1A</sub> antagonists, so we kept the 6-methoxy group constant for the purposes of the SAR studies that are the subject of this manuscript.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Recently identified 5-HT<sub>1A</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Target compounds <b>10a</b>−<b>r</b> were prepared by condensation of 5-methoxy-7-(1-piperazinyl)quinoline <b>15</b> and appropriate quinolinylpiperidinones <b>18a</b>−<b>r</b> under reductive amination conditions (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaBH<sub>3</sub>CN, room temperature, overnight.</p></p></figure><div class="NLM_p">Compound <b>15</b> was synthesized in four steps (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) from 3-chloro-4-aminophenol (<b>11</b>) in a sequence that involved a Skraup reaction<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> to give <b>12</b>, followed by methylation of the phenol to provide <b>13</b>. Treatment of <b>13</b> with a monoprotected piperazine derivative under modified Buchwald−Hartwig conditions<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> afforded <b>14</b>, which was deprotected to give 1<b>5</b>. Required quinolinylpiperidones <b>18a</b>−<b>r</b> were prepared by deprotecting ketals <b>17a</b>−<b>r</b>. Intermediates <b>17a</b>−<b>d</b> and <b>17f</b>−<b>r</b> were obtained from 8-haloquinolines <b>16a</b>−<b>d</b> and <b>16f</b>−<b>r</b>, respectively, by treatment with 1,4-dioxa-8-azaspiro[4,5]decane under modified Buchwald−Hartwig conditions (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). When the halogen leaving group was bromine, tetrakis(triphenylphosphino)-1,1-binapthyl (BINAP) was used as a catalyst, whereas dicyclohexylphosphine-2′-(<i>N</i>,<i>N</i>-dimethylamino)-biphenyl (CYMAP) was preferred when the leaving group was chlorine. Compound <b>17e</b> was obtained by condensation of 7,8-difluoroquinoline <b>16e</b> with 1,4-dioxa-8-azaspiro[4,5]decane to give a mixture of protected piperidinones which was separated by chromatography to yield the desired 7-fluoro isomer (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The required haloquinolines <b>16a</b>−<b>r</b> were obtained from commercial sources or were prepared via a variety of published methods from appropriately substituted commercially available haloanilines.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Fe<sub>2</sub>(SO<sub>4</sub>)<sub>3</sub>, glycerol, H<sub>3</sub>BO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 150 °C; (ii) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>; (iii) <i>tert</i>-butoxycarbonylpiperazine, sodium <i>tert</i>-butoxide, CYMAP, Pd<sub>2</sub>(dba)<sub>3</sub>; (iv) 4N HCl/dioxane.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for X = Cl, 1,4-dioxa-8-azaspiro-4,5-decane, <i>tert</i>-butoxide, CYMAP, Pd<sub>2</sub>(dba)<sub>3</sub>; For X = Br, 1,4-dioxo-8-azaspiro-4,5-decane, <i>tert</i>-butoxide, BINAP, Pd<sub>2</sub>(dba)<sub>3</sub>; (ii) 2N NCl/diethyl ether.</p></p></figure><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1,4-dioxa-8-azaspiro-4,5-decane, 120 °C; (ii) separation of 7- and 8-fluororegioisomers by flash chromatography; (iii) 2N HCl/diethyl ether.</p></p></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> In Vitro Metabolism/Metabolite ID</h3><div class="NLM_p last">Microsomal stability was determined by incubating test compounds with rat or human liver microsomes at 37 °C for 20 min in the presence of NADPH or a NADPH regenerating system. Structural identification of microsomal metabolites was accomplished by incubating test compounds with rat or human liver microsomes at 37 °C for 15 min in the presence of NADPH. Concentrated supernatants were subjected to LC/MS/MS analysis. Major components were isolated by HPLC, and their structures were confirmed by NMR analysis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Receptor Occupancy</h3><div class="NLM_p last">In vivo receptor occupancy was determined by measuring the displacement of [<sup>3</sup>H]-WAY-100635 from rat hippocampus and cortex by test compounds.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The cerebellum was used as a reference tissue for nonspecific binding of [<sup>3</sup>H]-WAY-100635 which, under the present conditions, accounted for 15% to 18% of the total binding.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Pharmacokinetics</h3><div class="NLM_p last">The pharmacokinetic profile of test compounds was asssessed in rats following a 1 mg/kg iv or 3 mg/kg po dose. Plasma or brain homogenate concentrations were determined following protein precipitation with acetonitrile by LC/MS/MS using an internal standard.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vitro</h3><div class="NLM_p last">5-HT<sub>1A</sub> data were generated using membranes from CHO cells stably transfected with the human 5-HT<sub>1A</sub> receptor as previously described.<a onclick="showRef(event, 'ref7 ref27'); return false;" href="javascript:void(0);" class="ref ref7 ref27">(7, 27)</a> Affinity for the human 5-HT<sub>1A</sub> receptor was assessed as the test compound’s ability to inhibit binding of [<sup>3</sup>H]-8-OH DPAT. In vitro 5-HT<sub>1A</sub> intrinsic activity was measured as the test compound’s ability to block 8-OH DPAT-induced inhibition of forskolin-stimulated increases in cyclic AMP. Data are expressed in nM as IC<sub>50</sub> values, with the maximum percent inhibition of the 8-OH DPAT effect expressed as an <i>I</i><sub>max</sub> value. Compounds with <i>I</i><sub>max</sub> values of 95−100 are considered to be full antagonists, while compounds with <i>I</i><sub>max</sub> values significantly less than 100 are considered to be partial agonists.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> In Vivo</h3><div class="NLM_p">In vivo microdialysis was used to confirm the 5-HT<sub>1A</sub> antagonist activity of test compounds by measuring their effect on 5-HT release in the frontal cortex. The technique was also used to assess the effect of test compounds on acetylcholine release in the hippocampus. The pro-cognitive effects of test compounds were examined in a number of animal models of learning and memory. The ability of test compounds to enhance recognition memory was assessed using a novel object recognition model. The Atlantis water maze model was used to examine compound effects on hippocampal-based spatial memory. Test compounds were also evaluated for their ability to enhance contextual memory in transgenic Tg2576 mice overexpressing a mutated form of human amyloid precursor protein (APP) using a contextual fear conditioning model.</div><div class="NLM_p last">In addition to assessment in a battery of cognitive tests, compounds were examined for their ability to enhance the antidepressant-like effects or inhibit the sexual dysfunction side effects of the SSRI fluoxetine. In vivo microdialysis was used to examine the effect of test compounds on fluoxetine-induced 5-HT release in the rat frontal cortex. The ability of compounds were evaluated for their ability to enhance antidepressant-like behavioral effects induced by fluoxetine was assessed using a rat olfactory bulbectomy model and schedule-induced polydipsia, a model of obsessive/compulsive behavior. Finally, test compounds were examined for their ability to inhibit the decrease in rat penile erections caused by fluoxetine.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>10a</b> displayed a desirable in vitro pharmacological profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The compound displayed similar potency for the 5-HT<sub>1A</sub> receptor as that seen with the standard 5-HT<sub>1A</sub> antagonist <b>4</b> and showed no intrinsic activity in the functional cyclic AMP-based assay. However, stability data from rat and human microsomal preparations predicted that the compound might not possess optimal pharmacokinetic parameters. A rat PK study (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) confirmed this assessment. Administration of <b>10a</b> was characterized by high clearance and a short half-life. The peak plasma concentration following a 3 mg/kg oral dose was moderate (in the range of 200−300 nM), although significant brain penetration was seen following a 3 mg/kg intravenous dose (B/P = 2.8). A study was undertaken to identify the potential sites of oxidative metabolism. Compound <b>10a</b> was incubated with rat and human liver microsomes, and the major metabolites were identified by LC/MS/MS and NMR. The results are summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Minor metabolites in both species included the des-methyl metabolite <b>19</b> and metabolites <b>20</b> and <b>21</b>, where hydroxylation had occurred on the piperidinyl group. The major metabolite in both species was the 5-hydroxyquinolyl derivative <b>22</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of the Quinoline “B”-Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0008.gif" alt="" id="_i10" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">5-HT<sub>1A</sub></th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">cAMP</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">microsomal <i>t</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>I</i><sub>max</sub> (%)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">RLM<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">HLM<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="left">6-F</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">46.5</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">6-Br</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="char" char=".">276</td><td class="colsep0 rowsep0" align="char" char=".">331</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data are the results of at least three repetitions.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">RLM = rat liver microsomes.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">HLM = human liver microsomes.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Data taken from Childers, W. E., et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. PK Parameters of Compounds <b>10a</b>, <b>10b</b>, and <b>10r</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">1 mg/kg (iv)</th><th class="colsep0 rowsep0" colspan="6" align="center" char=".">3 mg/kg (po)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">B/P</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="char" char=".">38.7</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">360</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="char" char=".">15.0</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">247</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">472</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10r</b></td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">417</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">3758</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">CL = intrinsic clearance; <i>V</i><sub>ss</sub> = volume of distribution. AUC = calculated area under the curve from <i>t</i> = 0 to <i>t</i> = ∞; <i>F</i>(%) = percent bioavailability following oral administration. B/P = brain to plasma ratio.</p></div></div></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Microsomal metabolism of compound <b>10a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SAR studies were initiated to block metabolism on the 5-position of the quinoline appended to the piperidine group (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Substituting the 5-position with a fluorine group (to give compound <b>10b</b>) retained potent 5-HT<sub>1A</sub> full antagonist activity but resulted in only a marginal increase in stability in the human microsomal assay. Substitutions in the 6- and 7-positions of the quinoline ring induced some degree of intrinsic activity in the in vitro cAMP assay, suggesting that these compounds were partial agonists. Surprisingly, even a fluoro substituent in the 7-position resulted in a significant loss in 5-HT<sub>1A</sub> affinity, suggesting the possibility of electronic or torsional requirements for that region of the scaffold. As with compound <b>10a</b>, none of the analogues showed significant 5-HT uptake inhibitory activity.</div><div class="NLM_p">Another metabolite identification study was performed to determine the sites of metabolism for <b>10b</b>. The results are summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. Once again, des-methylation of the methoxy group to give the metabolite <b>23</b> was a minor pathway in rat and human microsomes. The major pathway involved the formation of the 3-hydroxy derivative <b>26</b> via the 2,3-dihydroxy metabolite <b>25</b>. The formation of <b>25</b> was hypothesized to occur through a proposed 2,3-epoxy intermediate <b>24</b>. The structure of <b>24</b> was tentatively assigned by LC/MS/MS, but the metabolite was too unstable to be fully characterized by NMR.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Microsomal metabolism of compound <b>10b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An effort was then undertaken to block this alternate metabolic pathway. An initial SAR study examining the effects of substitution on the “A”-ring of the quinoline in the absence of the 5-fluoro substitutient was performed. The results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Compounds containing typical leaving groups in the 2- and 4-position of the quinoline ring were excluded to avoid potential side reactions. Substitution in the 2-position (e.g., compounds <b>10f</b> and <b>10g</b>) maintained good 5-HT<sub>1A</sub> potency and antagonist activity, although the potency in the functional assay was around 10-fold lower that that seen with the unsubstituted analogue <b>10a</b>. Substitution of fluorine in the 3-position of the “A”-ring retained antagonist activity, but larger groups in the 3- and 4- positions of the “A”-ring (compounds <b>10i</b>−<b>k</b>) imparted partial agonist activity. Results with 2,4-bis substitution were variable, with the dimethyl analogue <b>10l</b> profiling as a full antagonist and the 2-trifluoromethyl-4-methoxy derivative <b>10m</b> showing partial agonist activity. It was not expected that “A”-ring substitution would dramatically increase metabolic stability, given likelihood of hydroxylation on the 5-position. Nevertheless, some encouraging results were obtained with 3- and 2,4-bis substitution (compounds <b>10j</b> and <b>10m</b>, respectively) where increases in stability were seen in human microsomal preparations.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of the Quinoline “A”-Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0011.gif" alt="" id="_i13" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">5-HT<sub>1A</sub></th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">cAMP</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">microsomal <i>t</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>I</i><sub>max</sub> (%)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">RLM<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">HLM<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="left">2-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10i</b></td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10j</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10k</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10l</b></td><td class="colsep0 rowsep0" align="left">2,4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10m</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub> 4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data are the results of at least three repetitions.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">RLM = rat liver microsomes.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">HLM = human liver microsomes.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Data taken from Childers, W. E. et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></p></div></div></div><div class="NLM_p">Finally, the effects of “A”-ring substitution in the presence of the 5-fluoro group were examined (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Substitution in the 2-position did little to improve metabolic stability. Substitution in the 3-position could enhance stability in both rat and human microsomes, although the size of the substituent influenced its impact. The 3-trifluoromethyl derivative <b>10o</b> showed an increase in stability while the 3-fluoro analogue <b>10p</b> was not particularly stable. Unfortunately, as with the des-fluoro compounds <b>10i</b> and <b>10j</b>, the 3-substituted 5-fluoro analogues profiled as partial agonists. Compounds with substituents in the 2- and 4-positions profiled as antagonists, and an appropriate choice of metabolically stable substituents (such as those seen in <b>10r</b>) led to a compound with enhanced stability in both rat and human microsomal preparations. As with the B-ring substituted analogues, A-ring substituted derivatives showed no inhibitory activity on 5-HT uptake.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of 5-Fluoroquinolylpiperazine Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0012.gif" alt="" id="_i15" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">5-HT<sub>1A</sub></th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">cAMP</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">microsomal <i>t</i><sub>1/2</sub> (min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>I</i><sub>max</sub> (%)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">RLM<a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">HLM<a class="ref internalNav" href="#tbl4-fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a class="ref internalNav" href="#t4fn1" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">>1</td><td class="colsep0 rowsep0" align="char" char=".">>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10n</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10o</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10p</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10q</b></td><td class="colsep0 rowsep0" align="left">2,4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">177</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10r</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub> 4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Data are the results of at least three repetitions.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">RLM = rat liver microsomes.</p></div><div class="footnote" id="tbl4-fn3"><sup>c</sup><p class="last">HLM = human liver microsomes.</p></div><div class="footnote" id="t4fn1"><sup>d</sup><p class="last">Data taken from Childers, W. E., et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></p></div></div></div><div class="NLM_p">To assess intrinsic activity in vivo, compounds <b>10b</b> and <b>10r</b> were examined for their effects on rat cortical serotonin release in a series of microdialysis studies (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Previous studies have shown that this assay is sensitive to small degrees of 5-HT<sub>1A</sub> intrinsic activity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In this assay, the full 5-HT<sub>1A</sub> agonist 8-OH-DPAT induced a significant decrease in extracellular 5-HT levels through its action on presynaptic 5-HT<sub>1A</sub> autoreceptors. When doses were at 10 mg/kg po, compounds <b>10b</b> and <b>10r</b> had no effect on extracellular 5-HT levels on their own. However, pretreatment with <b>10b</b> (<i>P</i> = 0.049) or <b>10r</b> (<i>P</i> = 0.048) completely blocked the effect of 8-OH-DPAT. These data are indicative of full antagonist activity, and the results are similar to those obtained with other 5-HT<sub>1A</sub> antagonists.<a onclick="showRef(event, 'ref7 ref16'); return false;" href="javascript:void(0);" class="ref ref7 ref16">(7, 16)</a></div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compounds <b>10b</b> and <b>10r</b> (10 mg/kg po) on rat cortical 5-HT levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Animal Models of Cognition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A 5-HT<sub>1A</sub> antagonist would be expected to enhance learning and memory by enhancing cholinergic (and glutamatergic) neurotransmission.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We have previously shown that systemic administration of 5-HT<sub>1A</sub> antagonists can enhance the release of both glutamate<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and acetylcholine<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a> in brain regions known to degenerate in Alzheimer’s disease. As a representative of the series, compound <b>10b</b> was examined for its effects on modulating acetylcholine levels using in vivo microdialysis. The results are presented in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>. A 10 mg/kg oral dose of <b>10b</b> caused a significant increase in the level of acetylchloine in the rat dorsal hippocampus. The pharmacodynamic effect of <b>10b</b> correlated with its plasma PK profile, achieving maximum effect at around 40 min postadministration and lasting for approximately 2−3 h. These data suggest that the brain PK profile for <b>10b</b> tracks closely with that seen in the plasma.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>10b</b> (10 mg/kg po) on rat hippocampal acetylcholine levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>10b</b> and <b>10r</b> were considered for more detailed profiling. The lower potency of <b>10r</b> relative to <b>10b</b>, coupled with solubility issues and lower CNS penetration (likely due to the compound’s increased lipophilicity, data not shown), led us to deprioritize <b>10r</b>. Compounds <b>10b</b> was therefore profiled for its effect in the novel object recognition test, a memory test based on exploratory activity.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Animals are allowed to explore a pair of identical objects (training) and then returned to their home cages. After a period of time, the animals are presented with one previously explored “familiar” object and an unexplored “novel”object”. The animal will spontaneously explore the novel object more than the familiar one. Memory for the familiar object is recorded as greater time spent exploring the novel object. When the time between training and the trial is increased to 48 h, the animal no longer remembers the familiar object and will spend equal amounts of time exploring both objects during the trial. Compounds <b>10b</b> was able to reverse the time-induced cognitive deficit, with the MED (minimal effective dose) for <b>10b</b> being 0.3 mg/kg po (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Compound <b>10b</b> was effective in this model when receptor occupancy was in the 20−30% range. A selectivity profile (NovaScreen) for compound <b>10b</b> (data not shown) revealed that the compound had no significant affinity for 55 receptors, ion channels transporters, and enzyme binding sites at concentrations up to 1 uM, supporting the assertion that the compound’s pro-cognitive efficacy in this model, even at relatively low receptor occupancy, was due to its 5-HT<sub>1A</sub> antagonist activity.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0015.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a) Effect of <b>10b</b> novel object recognition; (b) receptor occupancy of <b>10b</b> in rat cortex and hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Memory deficits in the novel object recognition model can also be induced by treatment with a glutamatergic antagonist like MK-801 (dizocilpine) or a cholinergic antagonist like scopolamine prior to training. Compound <b>10b</b> was able to reverse both the MK-801-induced deficit (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) and the scopolamine-induced deficit (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), with MED values of 1.0 mg/kg po (<i>P</i> < 0.05) and 0.3 mg/kg po (<i>P</i> < 0.05), respectively. In addition, a subeffective dose of compound <b>10b</b> coadministered with a subeffective dose of the clinically used acetylcholinesterase inhibitor donepazil reversed the 48 h delay-induced deficit (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>), suggesting a possible synergy between the two mechanisms.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0016.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Reversal of MK-801-induced deficit in novel object recognition by <b>10b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0017.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Reversal of scopolamine-induced deficit in novel object recognition by <b>10b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0018.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cognitive-enhancing synergy of <b>10b</b> and donepazil in novel object recognition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The impressive in vivo potency of compound <b>10b</b> in the novel object recognition model encouraged us to test the compound in additional cognition models. <b>10b</b> was evaluated in the Atlantis water maze, a hippocampal-dependent spatial memory task (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In this variation of the classic water maze test, animals do not have ready access to the escape platform but must spend a predetermined amount of “dwell time” in a “trigger zone”, which encompasses the spot in which a pneumatically activated platform rises from the bottom of the water tank. Increasing dwell times over training sessions is a way to nonpharmacologically increase the difficulty of the task, thus providing for an expanded window to see improvements with test compounds. On the first training day, vehicle- and drug-treated rats (3 and 10 mg/kg po) learned the location of the escape platform, using the extra-maze cues, from trial 1 to trial 4, as reflected by the progressive decrease in the mean escape latency (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>b). As the task became progressively more demanding on the subsequent days, when the dwell time over the trigger zone increased to 2 s and then to 3 s, the vehicle and 3 mg/kg groups found it harder to locate the platform. In contrast, the 10 mg/kg po group demonstrated an improvement by trial 4 (<i>P</i>’s = 0.009−0.015), or earlier, demonstrating a positive effect on the encoding of spatial memory. There was not significant effect of drug treatment on swim speed (data not shown). The retention of this memory was assessed in a drug-free probe test conducted 5 days after the conclusion of acquisition training. Animals were placed back in the water maze without the platform. As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>c, the group treated with 10 mg/kg po of compound <b>10b</b> spent significantly greater percentage of time in the previously targeted zone than vehicle- or 3 mg/kg-treated animals (<i>P</i> = 0.0003).</div><figure id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0019.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Cognitive enhancing effects of <b>10b</b> in the Atlantis water maze model: (a) training/dosing schedule; (b) training phase; (c) memory trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our next goal was to assess the potential efficacy of compound <b>10b</b> in a cognition model with at least some of the hallmarks of Alzheimer’s disease present. Tg2576 mice overexpress a mutated form of APP and show increased Aβ<sub>40</sub> and Aβ<sub>42/43</sub> and plaque deposition at 9−12 months of age.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These animals display behavioral deficits that correlate with soluble β-amyloid species, which may be one of the contributing factors to cognitive decline and neurodegeneration in Alzheimer’s patients. Dineley and co-workers reported that Tg2576 mice show hippocampal-dependent conditioning deficits beginning at 20 weeks of age.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> These deficits can be monitored using a contextual fear conditioning (CFC) model in which animals are trained to associate a mild foot shock with an auditory cue (the context) and then later display memory for the context by freezing when presented with the auditory cue in the absence of the shock.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>, compound <b>10b</b>, when administered 1 h prior to training, was able to improve contextual memory in the CFC model, with an MED of 0.3 mg/kg po (<i>P</i> < 0.05).</div><figure id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0020.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Cognitive enhancing effect of <b>10b</b> on contextual memory in Tg2576 mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Animal Models of Depression</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although currently available SSRIs like fluoxetine acutely inhibit the 5-HT transporter and elevate 5-HT levels in midbrain regions, there is little or no elevation of 5-HT in desired target forebrain regions until an adaptive desensitization of the inhibitory 5-HT<sub>1A</sub> autoreceptors has occurred.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This delayed effect on forebrain 5-HT is thought to contribute to the delayed onset of clinical efficacy suffered by SSRIs like fluoxetine.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> It has been hypothesized that cotherapy of a 5-HT<sub>1A</sub> antagonist with an SSRI might maximize serotonergic function by inhibiting feedback inhibition of neuronal firing and immediately increasing synaptic levels of 5-HT in the forebrain regions. In support of this hypothesis, acute treatment with fluoxetine had no significant effect on cortical 5-HT levels.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Chronic fluoxetine treatment was required to increase forebrain 5-HT, and these increases correlated with desensitization of 5-HT1A autoreceptors in the dorsal raphe.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> However, cotreatment with the 5-HT<sub>1A</sub> antagonist <b>4</b> accelerated the fluoxetine-induced increases in cortical 5-HT. These neurochemical effects seem to correlate behaviorally, at least in some models. For example, cotreatment with <b>4</b> accelerated the antidepressant-like effect of the SSRI paroxetine in the rat olfactory bulbectomy model.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">We therefore examined the effects of compound <b>10b</b> on fluoxetine-induced 5-HT release in the rat frontal cortex using in vivo microdialysis (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>). Treatment with <b>10b</b> alone had no effect on cortical 5-HT levels. As expected, acute fluoxetine treatment had no significant effect on cortical 5-HT levels. However, coadministration of <b>10b</b> (10 mg/kg po) together with fluoxetine resulted in an immediate, significant increase in cortical 5-HT, which peaked at around 120% over baseline (<i>P</i> = 0.02).</div><figure id="fig14" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0021.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <b>10b</b> enhances the acute effect of fluoxetine on rat cortical 5-HT levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Schedule-induced polydipsia has been used as a model of obsessive compulsive behavior and is responsive to treatment with SSRIs like fluoxetine.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> When food pellets are delivered to rats on a schedule of one every two minutes for a period of two hours, the animals will develop a repetitive drinking behavior resulting in consumption of water that is 5−10-fold greater than baseline levels. Chronic treatment with fluoxetine prior to the trial inhibits this obsessive drinking behavior, and it has been shown that cotreatment with <b>4</b> can accelerate this activity.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> To examine the potential enhancing effects of <b>10b</b> on fluoxetine in this model, an initial dose−response study was performed with fluoxetine (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>a). A 5.6 mg/kg ip dose of fluoxetine was shown to have no significant effect. A dose−response with compound <b>10b</b> in combination with a 5.6 mg/kg ip dose of fluoxetine was then performed. As can been seen from Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>b, a 10 mg/kg po dose of compound <b>10b</b> had no effect on drinking alone. However, compound <b>10b</b> dose-dependently inhibited adjunctive water intake when coadministered with the subefffective dose of fluoxetine, with an MED value of 3 mg/kg po in this study (<i>P</i> < 0.001).</div><figure id="fig15" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0022.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. <b>10b</b> enhances the effect of fluoxetine on adjuvant drinking in schedule-induced polydipsia: (a) fluoxetine dose−response; (b) effect of <b>10b</b>/fluoxetine combination on SIP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The rat olfactory bulbectomy (OB) model has been widely used to profile potential antidepressant agents.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In this model, bilateral removal of the olfactory bulbs results in a characteristic increase in locomotor activity. Many of the neurochemical, endocrine, and immunological changes induced in this model correspond with those seen in clinical depression. Treatment with many classes of antidepressant agents, including SSRIs, result in a reduction in OB-induced hyperlocomotor activity. However, chronic treatment with the antidepressant agent is required for efficacy, which correlates with the typical delayed onset of action seen in the clinical setting. For example, 14 days of treatment is required to see efficacy in this model with fluoxetine. Co-treatment with <b>4</b> has been shown to accelerate the antihyperlocomotor effect seen with the SSRI paroxetine in the OB model.</div><div class="NLM_p">Compound <b>10b</b> was assessed for its enhancing effects on a subeffective dose of fluoxetine in the OB model (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>). Bulbectomy resulted in an approximately 25% significant increase in locomotor activity compared to sham-surgery control animals when evaluated beginning at 14 days postsurgery. A dose−response curve (data not shown) identified a 5.6 mg/kg ip dose given once daily for 7 days as a subeffective dose of fluoxetine. This dose produced a small, nonsignificant decrease in locomotor activity compared to treatment with vehicle in bulbectomized rats. A 7-day cotreatment with fluoxetine (5.6 mg/kg ip) and <b>10b</b> (10 mg/kg po) provided a significant reduction in locomotor activity, returning the total distance moved back to sham control levels (<i>P</i> < 0.05).</div><figure id="fig16" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0023.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. <b>10b</b> (10 mg/kg po) enhances the antidepressant-like effect of fluoxetine on olfactory bulbectomized rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sexual dysfunction is one of the leading causes of antidepressant discontinuation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The role of 5-HT<sub>1A</sub> receptors in sexual function is still poorly understood, but a small number of clinical trials have demonstrated an improvement in SSRI-induced sexual dysfunction by treatment with the 5-HT<sub>1A</sub> partial agonist buspirone.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> That data, coupled with the recent clinical report of failure of the 5-HT<sub>1A</sub> agonist VML-670 to ameliorate SSRI-induced sexual dysfunction,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> suggest that the 5-HT<sub>1A</sub> antagonist-like properties of buspirone may contribute to the compound’s beneficial effects on SSRI-induced sexual dysfunction.</div><div class="NLM_p last">We recently reported on a rat noncontact penile erection model of sexual dysfunction<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and demonstrated that either chronic or acute cotreatment with 5-HT<sub>1A</sub> antagonists ameliorate the fluoxetine-induced decrease in erections seen in that model.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Compound <b>10b</b> was examined in this model (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Following 14 day treatment, fluoxetine (10 mg/kg ip, once daily) produced a 54% decrease in the number of noncontact penile erections relative to vehicle treated controls. Compound <b>10b</b> (10 mg/kg po), when administered either acutely on day 14 or chronically with fluoxetine on days 1−14, reversed the SSRI-induced decrease in noncontact penile erections, returning them essentially to sham control levels. By itself, compound <b>10b</b> had no effect on noncontact penile erections.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">SAR around prototype compound <b>10a</b> led to the identification of a series of quinolyl-piperazinyl piperidines that displayed potent 5-HT<sub>1A</sub> antagonist activity. Stability in rat and human liver microsomes was used as a predictive screen to help guide the SAR directed at enhancing metabolic stability. Identification of the primary paths of oxidative metabolism was crucial to the success of this effort. Unfortunately, structural changes that significantly improved metabolic stability also decreased in vitro affinity and potency and led to a reduction in CNS penetration. Compound <b>10b</b> displayed potent 5-HT<sub>1A</sub> antagonist activity both in vitro and in vivo and was selected for detailed profiling. The compound stimulated acetylcholine release in the rat frontal cortex and displayed cognitive enhancing activity in a number of animal models of learning and memory, including a contextual fear conditioning model in transgenic Tg2576 mice. In addition, compound <b>10b</b> was able to accelerate the antidepressant-like neurochemical and behavioral effects of fluoxetine and to reverse the sexual dysfunction induced by chronic fluoxetine treatment in a rat noncontact penile erection model. Despite the limited metabolic stability seen for <b>10b</b>, successful development of sustained release formulations<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> has allowed us to advance the compound to phase 1 clinical trials.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Melting points were recorded on a Thomas−Hoover capillary melting point apparatus and are uncorrected. <sup>1</sup>H NMR spectra were recorded on a Varian Unity Plus 400 or a Varian 500 Unity INOVA spectrometer. The chemical shifts (δ) are reported in parts per million (ppm) downfield from zero relative to the residual chloroform signal (7.26 ppm) or DMSO signal (2.49 ppm). Coupling constants are reported in hertz (Hz), and the exchangeable protons from HCl are not reported. Mass spectra were recorded on either a Hewlett−Packard 5995A, a Finnigan Trace MS, or a Micromass LCT spectrometer. Purity of tested compounds was assessed by reversed-phase high pressure liquid chromatography on a C18 column using two separate solvent systems: (1) A, 10 mM ammonium bicarbonate in water (pH 9.5), B, 50:50 acetonitrile:methanol, gradient of 85/15 A/B to 5/95 A/B over 2 min; (2) A, 10 mM ammonium formate in water (pH 3.5), B, 50:50 acetonitrile:methanol, gradient of 85/15 A/B to 5/95 A/B over 2 min. Detection was performed by UV analysis at both 215 and 254 nm. All compounds were shown to be >95% pure. Structures were confirmed by high resolution mass spectrometry on an Agilent TOF instrument. Unless otherwise noted below, reagents were obtained from commercial sources and were used without further purification. Chromatographic purifications were performed by flash chromatography using Baker 40 μm silica gel. Some of the procedures described below were originally presented in the patent literature.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div id="sec8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Chemical Procedures</h3><div class="NLM_p">The synthesis of <b>10a</b> illustrates the general procedure used to prepare compounds <b>10a</b>−<b>r</b>.</div><div id="sec8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 6-Methoxy-8-{4-[1-(8-quinolinyl)-4-piperidinyl]-1-piperazinyl}quinoline Trihydrochloride (<b>10a</b>)</h4><div class="NLM_p">To a solution of <b>15</b> (0.250 g, 1.03 mmol) in methanol (15 mL) was added <b>18a</b> (0.279 g, 1.023 mmol) followed by sodium cyanoborohydride (0.126 g, 2.00 mmol). The resulting reaction mixture was stirred at room temperature overnight. The reaction mixture was concentrated on a rotary evaporator and the residue taken up in ethyl acetate. The organic layer was washed with water, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The resulting residue was purified by flash chromatography on silica gel (5% methanol/ethyl acetate) to give the desired product, which was dissolved in methanol and treated with excess 2N HCl in diethyl ether to afford the trihydrochloride salt (0.229 g, 40% yield) as a yellow solid: mp = 241−243 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.15 (d, <i>J</i> = 4.2 Hz, 1H), 8.95 (d, <i>J</i> = 4.0 Hz, 1H), 8.88 (d, <i>J</i> = 6.6 Hz, 1H), 8.85−8.93 (m, 1H), 7.97 (d, <i>J</i> = 7.8 Hz, 1H), 7.88−7.95 (m, 2H), 7.82−7.93 (m, 2H), 7.78 (d, <i>J</i> = 7.9 Hz, 1H), 7.60 (s, 1H), 3.92 (s, 3H), 3.70−3.98 (m, 2H), 3.39−3.78 (m, 9H), 3.12 (t, <i>J</i> = 13.7 Hz, 2H), 2.40−2.52 (m, 2H), 2.25−2.90 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 454 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">The following compounds were prepared using a similar procedure.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} Quinoline Trihydrochloride (<b>10b</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18b</b> in 56% overall yield and obtained as a yellow solid: mp = 226−230 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.04 (dd, <i>J</i><sub>1</sub> = 4.3 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 8.92 (d, <i>J</i> = 3.7 Hz, 1H), 8.65−8.78 (m, 1H), 8.54 (dd, <i>J</i><sub>1</sub> = 7.5 Hz, <i>J</i><sub>2</sub> = 1.2 Hz, 1H), 7.76−7.88 (m, 1H), 7.66−7.74 (m, 1H), 7.35−7.50 (m, 2H), 7.30−7.43 (m, 1H), 7.16−7.26 (m, 1H), 3.91 (s, 3H), 3.84−3.95 (m, 2H), 3.57−3.88 (m, 6H), 3.43−3.58 (m, 1H), 3.42 (t, <i>J</i> = 12.1 Hz, 2H), 2.96−3.13 (m, 2H), 2.30−2.42 (m, 2H), 2.18−2.32 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 472 ([M + H]<sup>+</sup>).</div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 6-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} Quinoline Trihydrochloride (<b>10c</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18c</b> in 41% overall yield and obtained as a yellow solid: mp = 222−225 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.85−8.98 (m, 2H), 8.60−8.73 (m, 1H), 8.38 (d, <i>J</i> = 8.3 Hz, 1H), 7.74−7.85 (m, 1H), 7.59 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 4.4 Hz, 1H), 7.25−7.42 (m, 2H), 7.06−7.24 (m, 2H), 4.09 (d, <i>J</i> = 11.3 Hz, 2H), 3.91 (s, 3H), 3.54−3.80 (m, 5H), 3.28−3.52 (m, 4H), 2.84 (t, <i>J</i> = 11.6 Hz, 2H), 2.25−2.37 (m, 2H), 2.07−2.21 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 472 ([M + H]<sup>+</sup>).</div></div><div id="sec8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-Bromo-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} Quinoline Trihydrochloride (<b>10d</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18d</b> in 47% overall yield and obtained as a yellow solid: mp = 230−234 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.83−8.94 (m, 2H), 8.62−8.74 (m, 1H), 8.35 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1.3 Hz, 1H), 7.84 (d, <i>J</i> = 1.8 Hz, 1H), 7.73−7.84 (m, 1H), 7.58 (dd, <i>J</i><sub>1</sub> = 8.3 Hz, <i>J</i><sub>2</sub> = 4.3 Hz, 1H), 7.25−7.37 (m, 1H), 7.27 (m, 1H), 7.03−7.12 (m, 1H), 4.07 (d, <i>J</i> = 11.1 Hz, 2H), 3.90 (s, 3H), 3.58−3.82 (m, 6H), 3.39−3.53 (m, 1H), 3.30−3.42 (m, 2H), 2.85 (t, <i>J</i> = 11.6 Hz, 2H), 2.25−2.35 (m, 2H), 2.05−2.19 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 533 ([M + H]<sup>+</sup>).</div></div><div id="sec8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 7-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} Quinoline Trihydrochloride (<b>10e</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18e</b> in 50% overall yield and obtained as a yellow solid: mp = 214−217 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.03−9.12 (m, 1H), 8.87−8.96 (m, 1H), 8.42−8.54 (m, 1H), 7.90−8.02 (m, 1H), 7.65−7.80 (m, 1H), 7.54−7.72 (m, 3H), 7.12−7.23 (m, 1H), 6.95−7.045 (m, 1H), 3.88 (s, 3H), 3.40−4.03 (m, 10H), 3.36−3.52 (m, 1H), 3.26−3.41 (m, 2H), 2.40−2.57 (m, 2H), 2.15−2.25 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 472 ([M + H]<sup>+</sup>).</div></div><div id="sec8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 8-{4-[4-(6-Methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-2-methylquinoline Trihydrochloride (<b>10f</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18f</b> in 58% overall yield and obtained as a yellow solid: mp = 235−237 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.87 (d, <i>J</i> = 2.2 Hz, 1H), 8.61−8.75 (m, 2H), 7.90 (d, <i>J</i> = 8.3 Hz, 1H), 7.65−7.83 (m, 4H), 7.37 (D, <i>J</i> = 2.0 Hz, 1H), 7.22 (d, <i>J</i> = 1.9 Hz, 1H), 3.92 (s, 3H), 3.72−3.83 (m, 2H), 3.42−3.76 (m, 7H), 3.33 (t, <i>J</i> = 10.9 Hz, 2H), 3.07−3.19 (m, 2H), 2.58−2.79 (m, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 468 ([M + H]<sup>+</sup>).</div></div><div id="sec8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 8-{4-[4-(6-Methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-2-(trifluoromethyl) Quinoline Trihydrochloride (<b>10g</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18g</b> in 39% overall yield and obtained as a yellow solid: mp = 245−248 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.81−8.85 (m, 1H), 8.53−8.63 (m, 2H), 7.92 (d, <i>J</i> = 8.5 Hz, 1H), 7.67−7.74 (m, 1H), 7.60−7.66 (m, 2H), 7.30 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 4.1 Hz, 1H), 7.25−7.29 (m, 1H), 7.07−7.11 (m, 1H), 4.12 (d, <i>J</i> = 11.2 Hz, 2H), 3.89 (s, 3H), 3.70−3.81 (m 2H), 3.41−3.79 (m, 5H), 3.25−3.38 (m, 2H), 2.35 (t, <i>J</i> = 1.2 Hz, 2H), 2.30−2.39 (m, 2H), 2.04−2.10 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 522 ([M + H]<sup>+</sup>).</div></div><div id="sec8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} Quinoline Trihydrochloride (<b>10h</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18h</b> in 20% overall yield and obtained as a yellow solid: mp = 234−236 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.87−8.94 (m, 2H), 8.63−8.73 (M, 1H), 8.20 (dd, <i>J</i><sub>1</sub> = 9.6 Hz, <i>J</i><sub>2</sub> = 2.9 Hz, 1H), 7.74−7.86 (m, 1H), 7.53−7.62 (m, 2H), 7.25−7.40 (m, 2H), 7.15−7.23 (m, 1H), 4.03 (d, <i>J</i> = 12.2 Hz, 2H), 3.90 (s, 3H), 3.58−3.79 (m, 6H), 3.45−3.57 (m, 1H), 3.33−3.44 (m, 2H), 3.39 (t, <i>J</i> = 12.4 Hz, 2H), 2.30−2.40 (m, 2H), 2.06−2.22 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 472 ([M + H]<sup>+</sup>).</div></div><div id="sec8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 8-{4-[4-(6-Methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-3-methylquinoline Trihydrochloride (<b>10i</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18i</b> in 44% overall yield and obtained as a yellow solid: mp = 232−235 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.93 (s, 1H), 8.81−8.87 (m, 1H), 8.45−8.57 (m, 2H), 7.60−7.72 (m, 2H), 7.60−7.68 (m, 1H), 7.52−7.63 (m, 1H), 7.19−7.27 (m, 1H), 7.02−7.13 (m, 1H), 3.89 (s, 3H), 3.80−3.95 (m, 2H), 3.69−3.81 (m, 2H), 3.53−3.72 (m, 4H), 3.45−3.58 (m, 1H), 3.30−3.44 (m, 2H), 2.53 (s, 3H), 2.93−3.06 (m, 2H), 2.25−2.40 (m, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 468 ([M + H]<sup>+</sup>).</div></div><div id="sec8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 8-{4-[4-(6-Methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-3-(trifluoromethyl) Quinoline Trihydrochloride (<b>10j</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18j</b> in 33% overall yield and obtained as a yellow solid: mp = 244−247 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.16 (d, <i>J</i> = 2.3 Hz, 1H), 8.83−8.95 (m, 2H), 8.53−8.67 (m, 1H), 7.70−7.83 (m, 2H), 7.65 (t, <i>J</i> = 7.8 Hz, 1H), 7.41 (d, <i>J</i> = 7.4 Hz, 1H), 7,23−7,32 (m, 1H), 7.06−7.16 (m, 1H), 4.10 (d, <i>J</i> = 1.5 Hz, 2H), 3.91 (s, 3H), 3.79−4.05 (m, 2H), 3.64−3.75 (m, 3H), 3.45−3.73 (m, 2H), 3.30−3,42 (m, 2H), 2.87 (t, <i>J</i> = 11.3 Hz, 2H), 2.30−2.42 (m, 2H), 2.05−2.18 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 522 ([M + H]<sup>+</sup>).</div></div><div id="sec8_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 8-{4-[4-(6-Methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-4-methylquinoline Trihydrochloride (<b>10k</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18k</b> in 37% overall yield and obtained as a yellow solid: mp = 230−234 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.69−8.80 (m, 2H), 8.00 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.46 (t, <i>J</i> = 8.0 Hz, 1H), 7.25−7.38 (m, 1H), 7.1−7.24 (m, 2H), 6.82 (s, 1H), 6.70−6.78 (m, 1H), 4.09 (d, <i>J</i> = 11.7 Hz, 2H), 3.90 (s, 3H), 3.40−3.61 (m, 5H), 3.08−3.20 (m, 4H), 2.82 (t, <i>J</i> = 11.5 Hz, 2H), 2.68 (s, 3H), 2.02−2.19 (m, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 468 ([M + H]<sup>+</sup>).</div></div><div id="sec8_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 8-{4-[4-(6-Methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-2,4-dimethylquinoline Trihydrochloride (<b>10l</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18l</b> in 52% overall yield and obtained as a yellow solid: mp = 240−244 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.83 (d, <i>J</i> = 4.4 Hz, 1H), 8.58 (d, <i>J</i> = 8.2 Hz, 1H), 8.07 (d, <i>J</i> = 7.8 Hz, 1H), 7.81−7.90 (m, 2H), 7.78 (s, 1H), 7.70−7.77 (m, 1H), 7.26 (d, <i>J</i> = 1.7 Hz, 1H), 7.15 (d, <i>J</i> = 2.1 Hz, 1H), 3.89 (s, 3H), 3.85 (d, <i>J</i> = 11.5 Hz, 2H), 3.55−3.78 (m, 6H), 3.40−3.50 (m, 2H), 3.28−3.37 (m, 1H), 3.04 (t, <i>J</i> = 11.6 Hz, 2H), 2.95 (s, 3H), 2.84 (s, 3H), 2.20−2.43 (m, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 482 ([M + H]<sup>+</sup>).</div></div><div id="sec8_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Methoxy-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-2-(trifluoromethyl)-quinoline Trihydrochloride (<b>10m</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18m</b> in 37% overall yield and obtained as a yellow solid: mp = 244−248 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.81−8.86 (m, 1H), 8.50−8.62 (m, 1H), 7.75 (d, <i>J</i> = 7.5 Hz, 1H), 7.56 (t, <i>J</i> = 7.9, 1H), 7.36 (s, 1H), 7.28 (d, <i>J</i> = 7.6 Hz, 1H), 7.20−7.29 (m, 1H), 7.06−7.13 (m, 1H), 4.10 (s, 3H), 3.75−4.15 (m, 5H), 3.89 (s, 3H), 3.70 (d, <i>J</i> = 11.2 Hz, 2H), 3.42−3.62 (m, 2H), 3.24−3.38 (m, 2H), 2.82 (t, <i>J</i> = 11.8 Hz, 2H), 2.27−2.38 (m, 2H), 1.98−2.12 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 552 ([M + H]<sup>+</sup>).</div></div><div id="sec8_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-2-(trifluoromethyl)-quinoline Trihydrochloride (<b>10n</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18n</b> in 46% overall yield and obtained as a yellow solid: mp = 239−241 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.92 (d, <i>J</i> = 4.5 Hz, 1H), 8.67−8.80 (m, 1H), 8.71 (d, <i>J</i> = 7.9 Hz, 1H), 8.02 (d, <i>J</i> = 8.7 Hz, 1H), 7.80−7.91 (m, 1H), 7.50 (t, <i>J</i> = 8.8 Hz, 1H), 7.37 (s, 1H), 7.16−7.30 (m, H), 4.00 (d, <i>J</i> = 12.1 Hz, 2H), 3.91 (s, 3H), 3.57−3.73 (m, 6H), 3.40−3.55 (m, 1H), 3.33−3.43 (m, 2H), 2.84 (t, <i>J</i> = 11.5 Hz, 2H), 2.30−2.40 (m, 2H), 2.00−2.14 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 540 ([M + H]<sup>+</sup>).</div></div><div id="sec8_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-3-(trifluoromethyl)-quinoline Trihydrochloride (<b>10o</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18o</b> in 40% overall yield and obtained as a yellow solid: mp = 239−243 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.26 (d, <i>J</i> = 2.1 Hz, 1H), 8.85−8.93 (m, 1H), 8.79 (s, 1H), 8.86−8.71 (m, 1H), 7.70−7.85 (m, 1H), 7.50 (t, <i>J</i> = 8.9 Hz, 1H), 7.36 (dd, <i>J</i><sub>1</sub> = 8.5 Hz, <i>J</i><sub>2</sub> = 5.3 Hz, 1H), 7.25−7.33 (m, 1H), 7.10−7.20 (m, 1H), 3.93 (d, <i>J</i> = 11.8 Hz, 2H), 3.90 (s, 3H), 3.52−3.88 (m, 6H), 3.38−3.54 (m, 1H), 3.30−3.42 (m, 2H), 2.83 (t, <i>J</i> = 11.7 Hz, 2H), 2.25−2.41 (m, 2H), 2.04−2.18 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 540 ([M + H]<sup>+</sup>).</div></div><div id="sec8_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3,5-Difluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}quinoline Trihydrochloride (<b>10p</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18p</b> in 51% overall yield and obtained as a yellow solid: mp = 232−234 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.99 (d, <i>J</i> = 2.9 Hz, 1H), 8.80−8.86 (m, 1H), 8.49−8.61 (m, 1H), 8.23 (dd, <i>J</i><sub>1</sub> = 9.2 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 7.64−7.74 (m, 1H), 7.40 (t, <i>J</i> = 8.9 Hz, 1H), 7.19−7.27 (m, 1H), 7.15 (dd, <i>J</i><sub>1</sub> = 8.7 Hz, <i>J</i><sub>2</sub> = 5.4 Hz, 1H), 7.03−7.13 (m, 1H), 3.94 (d, <i>J</i> = 11.7 Hz, 2H), 3.89 (s, 3H), 3.39−3.89 (m, 6H), 3.25−3.38 (m, 2H), 3.20−3.34 (m, 1H), 2.81 (t, <i>J</i> = 11.5 Hz, 2H), 2.25−2.39 (m, 2H), 2.04−2.15 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 490 ([M + H]<sup>+</sup>).</div></div><div id="sec8_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-Fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-2,4-dimethylquinoline Trihydrochloride (<b>10q</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18q</b> in 36% overall yield and obtained as a yellow solid: mp = 236−240 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.82−8.90 (m, 1H), 8.53−8.65 (m, 1H), 7.64−7.78 (m, 1H), 7.42−7.60 (m, 2H), 7.29−7.41 (m, 1H), 7.20−7.31 (m, 1H), 7.06−7.16 (m, 1H), 3.89 (s, 3H), 3.70−3.94 (m, 4H), 3.48−3.74 (m, 5H), 3.30−3.45 (m, 2H), 2.77 (s, 3H), 2.73−2.82 (m, 2H), 2.72 (s, 3H), 2.23−2.45 (m, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 500 ([M + H]<sup>+</sup>).</div></div><div id="sec8_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-Fluoro-4-methoxy-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl}-2-(trifluoromethyl)quinoline Trihydrochloride (<b>10r</b>)</h4><div class="NLM_p last">Prepared from <b>15</b> and <b>18r</b> in 22% overall yield and obtained as a yellow solid: mp = 251−254 °C. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.77−8.85 (m, 1H), 8.42−8.58 (m, 1H), 7.63−7.712 (m, 1H), 7.42 (s, 1H), 7.30−7.46 (m, 1H), 7.15−7.29 (m, 2H), 7.0−7.09 (m, 1H), 4.08 (s, 3H), 3.90−3.96 (m, 2H), 3.90 (s, 3H), 3.53−3.81 (m, 6H), 3.40−3.53 (m, 1H), 3.25−3.29 (m, 2H), 2.79 (t, <i>J</i> = 11.7, 2H), 2.24−2.38 (m, 2H), 1.95−2.11 (m, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 560 ([M + H]<sup>+</sup>).</div></div></div><div id="sec8_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Synthesis of 6-Methoxy-8-piperazinoquinoline (<b>15</b>)</h3><div id="sec8_19_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 8-Chloro-6-hydroxyquinoline (<b>12</b>)</h4><div class="NLM_p last">To a 500 mL 3-neck round-bottom flask was added, in order, iron(II) sulfate (2.0 g, 13.2 mmol), 4-amino-3-chlorophenol hydrochloride (6.4 g, 35.5 mmol), nitrobenzene (2.9 mL), and a solution of boric acid (3.0 g, 48.5 mmol) in glycerol (16 mL). The stirred mixture was cooled in an ice bath, and concentrated sulfuric acid (9.0 mL) was added dropwise. The ice bath was then removed and the stirred mixture cautiously heated to 120 °C for 2 h, then at 150 °C for 20 h. The reaction mixture was cooled to room temperature and then poured onto ice. The resulting aqueous mixture was neutralized with solid potassium carbonate, and the desired product precipitated as a light-brown solid. The solid was collected by vacuum filtration, washed with water and hexane, and dried in vacuo to provide the desired product as a tan solid (7.0 g, 77% yield). <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 10.37 (s, 1H), 8.77 (d, <i>J</i> = 4.3 Hz, 1H), 8.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.35−7.52 (m, 2H), 7.17 (s, 1H). MS (ESI−) (<i>m</i>/<i>z</i>) 178 ([M − H]<sup>−</sup>).</div></div><div id="sec8_19_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 8-Chloro-6-methoxyquinoline (<b>13</b>)</h4><div class="NLM_p last">To a solution of <b>12</b> (3.3 g, 18.4 mmol) in dimethylformamide (30 mL) was added anhydrous potassium carbonate (3.8 g, 27.5 mmol), followed by iodomethane (5.2 g, 36.6 mmol). The mixture was stirred at room temperature overnight. Water 200 mL) was added, and the resulting mixture was extracted three times with dichloromethane (75 mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The resulting residue was purified by flash chromatography on silica gel (100% dichloromethane) to afford the desired product (2.2 g, 62% yield) as a beige solid: mp = 74−75 °C. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.89 (dd, <i>J</i><sub>1</sub> = 4.3 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 8.07 (dd, <i>J</i><sub>1</sub> = 8.3 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 7.54 (d, <i>J</i> = 2.8 Hz, 1H), 7.36−7.49 (m, 1H), 7.02 (d, <i>J</i> = 2.8 Hz, 1H), 3.93 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 180 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-Methoxy-8-[1-(<i>tert</i>-butoxycarbonyl)-4-piperazino]quinoline (<b>14</b>)</h4><div class="NLM_p last">To a mixture of <b>13</b> (2.7 g, 14.0 mmol) in anhydrous tetrahydrofuran (50 mL) under a nitrogen atmosphere was added tris(dibenzylideneacetone)dipalladium (0) (Pd<sub>2</sub>(dba)<sub>3</sub>, 0.064 g, 0.07 mmol), sodium <i>tert</i>-butoxide (1.9 g, 5.21 mmol), 2-dicylcohexylphosphine-2′-(<i>N</i>,<i>N</i>-dimethylamino)biphenyl (CYMAP, 0.08 g, 0.20 mmol), and <i>tert</i>-butoxycarbonylpiperazine (3.4 g, 15.3 mmol). The resulting mixture was stirred at reflux for 5 h and then cooled to room temperature. The reaction mixture was diluted with diethyl ether, filtered through a pad of celite, and concentrated on a rotary evaporator. The resulting residue was purified by flash chromatography on silica gel (100% dichloromethane) to afford the desired product (4.4 g, % yield) as a beige solid: mp = 92−93 °C. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.72 (dd, <i>J</i><sub>1</sub> = 4.2 Hz, <i>J</i><sub>2</sub> = 1.9 Hz, 1H), 8.00 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 7.33 (dd, <i>J</i><sub>1</sub> = 8.2 Hz, <i>J</i><sub>2</sub> = 4.2 Hz, 1H), 6.78 (d, <i>J</i> = 2.7 Hz, 1H), 6.72 (d, <i>J</i> = 2.5 Hz, 1H), 3.91 (s, 3H), 3.73−3.84 (m, 4H), 3.28−3.40 (M, 4H), 1.50 (s, 9H). MS (ESI+) (<i>m</i>/<i>z</i>) 344 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 6-Methoxy-8-piperazinoquinoline (<b>15</b>)</h4><div class="NLM_p last">To a solution of <b>14</b> (4.0 g, 11.7 mmol) in 1,4-dioxane (20 mL) was added 4N HCl/dioxane (10 mL). The resulting mixture was stirred at room temperature overnight, during which time a white precipitate formed. The precipitate was collected by vacuum filtration, dissolved in water, and neutralized with 2.5 N aqueous sodium hydroxide. The resulting aqueous mixture was extracted three times with dichloromethane (50 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator to give the desired product (2.8 g, 98% yield) as a tan solid which was used without further purification: mp = 105−107 °C. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.71 (dd, <i>J</i><sub>1</sub> = 4.2 Hz, <i>J</i><sub>2</sub> = 2.4 Hz, 1H), 7.98 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 7.25−7.35 (m, 1H), 6.78 (d, <i>J</i> = 2.7 Hz, 1H), 6.69 (d, <i>J</i> = 2.7 Hz, 1H), 3.90 (s, 3H), 3.35−3.48 (m, 4H), 3.15−3.24 (m, 4H), (2.05 (br s, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 224 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 8-Chloro-5-fluoroquinoline (<b>16b</b>)</h4><div class="NLM_p last">To a stirred mixture of 2-chloro-5-fluoroaniline (5.0 g, 34.3 mmol) and <i>m</i>-nitrobenzene sulfonic acid sodium salt (11.0 g, 48.9 mmol) and glycerol (6.0 g, 65.2 mmol) was added dropwise 70% sulfuric acid (20 mL). The reaction temperature was then raised to 140 °C and stirred at that temperature for 2 h. The reaction mixture was cooled to room temperature, poured into water, filtered through a bed of celite, made slightly basic (pH = 8−9) with 50% aqueous sodium hydroxide, and extracted three times with dichloromethane (75 mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (100% dichloromethane) to afford the desired product (3.70 g, 59% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.04 (dd, <i>J</i><sub>1</sub> = 4.3 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 8.47 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 7.84−7.934 (m, 1H), 7.65−7.71 (m, 1H), 7.40 (t, <i>J</i> = 8.5 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 182 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 8-Bromo-6-fluoroquinoline (<b>16c</b>)</h4><div class="NLM_p last">To a mixture of 2-bromo-4-fluoroaniline (6.8 g, 35.8 mmol), glycerol (6.8 g, 73.8 mmol), and <i>m</i>-nitrobenzene sulfonic acid sodium salt (12.8 g, 56.8 mmol) was added 70% sulfuric acid (30 mL) dropwise. The reaction temperature was raised to 150 °C for 4 h. The mixture then was cooled to room temperature, poured into ice water, and was neutralized with 50% aqueous sodium hydroxide solution. The mixture was then extracted three times with dichloromethane (100 mL). The combined organics were washed with brine and dried over anhydrous magnesium sulfate to yield 3.1 g (37%) of the desired product as an off-white solid, which was used without further purification: <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.99 (dd, <i>J</i><sub>1</sub> = 4.2 Hz, <i>J</i><sub>2</sub> = 1.2 Hz, 1H), 8.43 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 8.20 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 7.90 (dd, <i>J</i><sub>1</sub> = 9.1 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 7.67 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 4.2 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 226, 228 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 8-Fluoro-6-Bromoquinoline (<b>16d</b>)</h4><div class="NLM_p last">To a mixture of 4-bromo-2-fluoroaniline (6.8 g, 35.8 mmol), glycerol (6.8 g, 73.8 mmol), and <i>m</i>-nitrobenzene sulfonic acid sodium salt (12.8 g, 56.8 mmol) was added 70% sulfuric acid (30 mL) dropwise. The reaction temperature was raised to 150 °C for 4 h. The mixture then was cooled to room temperature, poured into ice water, and was neutralized with 50% aqueous sodium hydroxide solution. The mixture was then extracted three times with dichloromethane (100 mL). The combined organics were washed with brine and dried over anhydrous magnesium sulfate to yield 4.1 g (50%) of the desired product as a tan solid, which was used without further purification. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.98 (dd, <i>J</i><sub>1</sub> = 4.3 Hz, <i>J</i><sub>2</sub> = 1.5 Hz, 1H), 8.38−8.43 (m, 1H), 8.15 (d, <i>J</i> = 1.8 Hz, 1H), 7.87 (dd, <i>J</i><sub>1</sub> = 10.4 Hz, <i>J</i><sub>2</sub> = 2.1 Hz, 1H), 7.68 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 4.1 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 226, 228 ([M + H]<sup>+</sup>)</div></div><div id="sec8_19_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 7,8-Difluoroqinoline (<b>16e</b>)</h4><div class="NLM_p last">To a stirred mixture of 2,3-difluoroaniline (3.57 g, 27.7 mmol), glycerol (5.55 g, 60.3 mmol), and <i>m</i>-nitrobenzene sulfonic acid sodium salt (10.12 g, 45.0 mmol) was added dropwise 70% sulfuric acid (20 mL). The resulting mixture was heated to 135 °C and then stirred at that temperature for 3.5 h. The reaction was cooled to room temperature, poured onto ice, and made slightly basic (pH = 8−9) with 50% aqueous sodium hydroxide. The aqueous mixture was extracted three times with diethyl ether (75 mL). The combined organic layers were washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The desired compound (4.13 g, 90% yield) was obtained as a light-brown solid and was pure enough to use in subsequent reactions without further purification. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.00 (dd, <i>J</i><sub>1</sub> = 4.3 Hz, <i>J</i><sub>2</sub> = 1.5 Hz, 1H), 8.49 (dd, <i>J</i><sub>1</sub> = 8.5 Hz, <i>J</i><sub>2</sub> = 1.4 Hz, 1H), 7.85−7.95 (m, 1H), 7.71−7.79 (m, 1H), 7.60−7.71 (m, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 166 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 8-Bromo-2-methylquinoline (<b>16f</b>)</h4><div class="NLM_p last">A mixture of 2-bromoaniline (4.27 g, 24.8 mmol) and crotonaldehyde (2.20 g, 25.0 mmol) in 6N aqueous HCl (12.4 mL) was stirred at reflux overnight. The reaction mixture was cooled to room temperature, made basic (pH = 10) by addition of 2.5 N aqueous sodium hydroxide, and extracted four times with dichloromethane (50 mL). The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (30% ethyl acetate/hexane) to afford the desired product 2.10 g, 39% yield) as a yellow oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 7.98−8.06 (m, 2H), 7.73 (dd, <i>J</i><sub>1</sub> = 8.1 Hz, <i>J</i><sub>2</sub> = 1.5 Hz, 1H), 7.28−7.37 (m, 2H), 2.81 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 222, 224 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 8-Bromo-2-(trifluoromethyl)quinoline (<b>16g</b>)</h4><div class="NLM_p last">Compound <b>16g</b> was prepared using the sequence described by Cottet, et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The compound was isolated as a white solid by recrystallization from hexane. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.42 (d, <i>J</i> = 8.4 Hz, 1H), 8.22 (dd, <i>J</i><sub>1</sub> = 7.6 Hz, <i>J</i><sub>2</sub> = 1.4 Hz, 1H), 7.92 (d, <i>J</i> = 8.1 Hz, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 1H),7.55−7.63 (m, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 276, 278 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 8-Bromo-3-fluoroquinoline (<b>16h</b>)</h4><div class="NLM_p">To a solution of 3-aminoquinoline (1.00 g, 6.94 mmol) in 48% fluoroboric acid (10 mL) at 0 °C was added sodium nitrate (0.60 g, 14.49 mmol) dissolved in water (2 mL). The reaction was stirred at 0 °C for 1 h. The reaction was cooled to room temperature, and the resulting yellow precipitate was collected by vacuum filtration, washed with cold ethanol and cold diethylethyl ether, and dried in vacuo. The dried yellow precipitate was suspended in toluene (10 mL) and heated at 110 °C for 1 h. The cooled reaction mixture was poured into ice water. The mixture was treated with diethyl ether to dissolve the resulting brown precipitate, and the layers were separated. The aqueous was made basic with 2.5 N aqueous sodium hydroxide solution and extracted three times with ethyl acetate (50 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (5% ethyl acetate/hexane) to give 0.64 g (63%) of 3-fluoroquinoline as clear oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.90 (d, <i>J</i> = 2.9 Hz, 1H), 8.22 (dd, <i>J</i><sub>1</sub> = 9.6 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 8.03 (d, <i>J</i> = 8.7 Hz, 1H), 7.96 (dd, <i>J</i><sub>1</sub> = 8.1 Hz, <i>J</i><sub>2</sub> = 1.4 Hz, 1H), 7.72 (t, <i>J</i> = 7.7 Hz, 1H), 7.65 (t, <i>J</i> = 8.0 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 148 ([M + H]<sup>+</sup>).</div><div class="NLM_p">A solution of 3-fluoroquinoline (0.64 g, 4.35 mmol) in concentrated sulfuric acid (3.75 mL) was cooled to 0 °C. Fuming nitric acid was added dropwise. The reaction was warmed to room temperature and stirred for 1 h, then poured onto ice. The resulting mixture was made basic with 50% aqueous sodium hydroxide solution and extracted three times with ethyl acetate (50 mL). The combined organic layers were washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator to give 0.81 g (97% yield) of a 1:3 mixture of 3-fluoro-8-nitroquinoline and 3-fluoro-5-nitroquinoline as a clear oil, which was used in the next step without further purification: MS (ESI+) (<i>m</i>/<i>z</i>) 193 ([M + H]<sup>+</sup>).</div><div class="NLM_p">To the mixture of 3-fluoro-8-nitroquinoline and 3-fluoro-5-nitroquinoline (0.81 g, 4.23 mmol) in ethyl acetate (20 mL) was added 10% Pd/C (0.3 g). The mixture was hydrogenated at 55 psi in a Parr reactor for 1 h. The suspension was filtered through celite to remove the catalyst, concentrated on a rotary evaporator, and purified by flash chromatography on silica gel (30% EtOAc/hexane) to give 8-amino-3-fluoroquinoline (0.12 g, 17% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.70 (d, <i>J</i> = 2.9 Hz, 1H), 8.00 (dd, <i>J</i><sub>1</sub> = 10.1 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 7.31 (t, <i>J</i> = 7.9 Hz, 1H), 7.02 (d, <i>J</i> = 8.1 Hz, 1H), 6.79 (d, <i>J</i> = 7.7 Hz, 1H), 5.98 (br s, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 163 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">A mixture of copper(II) bromide (0.123 g, 0.57 mmol) and <i>tert</i>-butyl nitrite (0.09 g, 0.86 mmol) in dry acetonitrile (5 mL) was stirred and heated to 65 °C. To that mixture was added a solution of 3-fluoroquinolin-8-amine (0.09 g, 0.57 mmol) in dry acetonitrile (3 mL) dropwise over 5 min. The resulting reaction mixture was stirred at 65 °C for 15 min and then cooled to room temperature. The reaction was poured into cold 20% aqueous sodium hydroxide solution and extracted three times with diethyl ether (30 mL). The organic layer was concentrated on a rotary evaporator and purified by flash chromatography on silica (5% EtOAc/hexane) to give 0.027 g (17%) of the desired 8-bromo-5-fluoroquinoline as a light-yellow solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.05 (d, <i>J</i> = 3.4 Hz, 1H), 8.37 (dd, <i>J</i><sub>1</sub> = 5.5 Hz, <i>J</i><sub>2</sub> = 2.6 Hz, 1H), 8.13 (d, <i>J</i> = 7.5 Hz, 1H), 8.02 (d, <i>J</i> = 8.2 Hz, 1H), 7.56 (t, <i>J</i> = 7.5 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 226, 228 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 8-Bromo-3-methylquinoline (<b>16i</b>)</h4><div class="NLM_p last">A mixture of 2-bromoaniline (4.56 g, 26.5 mmol) and methacrolein (3.10 g, 39.8 mmol) in 6N aqueous HCl (13 mL) was stirred at reflux overnight. The reaction mixture was cooled to room temperature, made basic (pH = 10) by addition of 50% aqueous sodium hydroxide, and extracted three times with dichloromethane (50 mL). The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (15% ethyl acetate/hexane) to afford the desired product 2.15 g, 46% yield) as a yellow oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.76 (s, 1H), 7.85 (d, <i>J</i> = 7.4 Hz, 1H), 7.76 (s, 1H), 7.57 (d, <i>J</i> = 8.2 Hz, 1H), 7.23 (t, <i>J</i> = 7.5 Hz, 1H), 2.41 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 222, 224 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 8-Bromo-3-(trifluoromethyl)quinoline (<b>16j</b>)</h4><div class="NLM_p">To a solution of 8-bromoquinoline (1.0 g, 4.81 mmol) in glacial acetic acid (6 mL) was added, portionwise, <i>N</i>-iodosuccinimide (1.08 g, 4.81 mmol). The resulting mixture was stirred at 70 °C overnight, cooled to room temperature, and concentrated on a rotary evaporator. The residue was taken up in dichloromethane and washed with saturated aqueous sodium bicarbonate and brine. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (5% ethyl acetate/hexane) to afford the intermediate 8-bromo-3-iodoquinoline (0.79 g, 49% yield) as a white solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.12 (d, <i>J</i> = 2.0 Hz, 1H), 8.52 (d, <i>J</i> = 2.1 Hz, 1H), 8.03 (dd, <i>J</i><sub>1</sub> = 7.5 Hz, <i>J</i><sub>2</sub> = 1.3 Hz, 1H), 7.66 (dd, <i>J</i><sub>1</sub> = −8.1 Hz, <i>J</i><sub>2</sub> = 2.1 Hz, 1H), 7.39 (t, <i>J</i> = 7.7 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 334, 336 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">A mixture of copper(I) iodide (0.25 g, 1.32 mmol) and potassium fluoride (0.077 g, 1.32 mmol) was placed under a high vacuum and heated until the solid assumed a slightly green color. The cooled solid mass was suspended in anhydrous <i>N</i>-methylpyrrolidinone (5 mL) and then treated with the previously described 8-bromo-3-iodoquinoline (0.40 g, 1.20 mmol), followed by trifluoromethyltrimethylsilane (0.17 g, 1.20 mmol). The resulting mixture was stirred under a nitrogen atmosphere at 50 °C overnight. The mixture was then cooled to room temperature and poured into 15% aqueous ammonium hydroxide. The aqueous mixture was extracted four times with diethyl ether (25 mL). The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (4:1 hexane/ethyl acetate) to afford the desired product <b>16j</b> (0.27 g, 33% yield) as a brown oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.18 (d, <i>J</i> = 2.0 Hz, 1H), 8.43 (s, 1H), 8.17 (dd, <i>J</i><sub>1</sub> = 7.5 Hz, <i>J</i><sub>2</sub> = 1.1 Hz, 1H), 7.88 (d, <i>J</i> = 8.1 Hz, 1H), 7.50 (t, <i>J</i> = 7.9 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 276, 278 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 8-Bromo-4-methylquinoline (<b>16k</b>)</h4><div class="NLM_p last">To a mixture of 2-bromoaniline (7.00 g, 40.7 mmol) and methyl vinyl ketone (4.00 mL g, 48.8 mmol) in ethanol/water (37 mL/7 mL) was added zinc chloride (1.35 g, 10.1 mmol) and iron(III) chloride (1.10 g, 6.5 mmol). The resulting mixture was stirred at reflux overnight. The reaction mixture was cooled and treated with ethanol (50 mL), followed by 12% aqueous sodium hydroxide (50 mL). The resulting inorganic white precipitate was removed by vacuum filtration, and the filtrate was extracted twice with dichloromethane (100 mL). The combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (15% ethyl acetate/hexane) to afford the desired product (3.45 g, 38% yield) as an off-white solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.87 (d, <i>J</i> = 4.3 Hz, 1H), 8.03 (d, <i>J</i> = 7.4 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 1H), 7.39 (t, <i>J</i> = 7.9 Hz, 1 H), 7.27 (d, <i>J</i> = 4.4 Hz, 1H), 2.70 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 222, 224 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 8-Bromo-2,4-dimethylquinoline (<b>16l</b>)</h4><div class="NLM_p last">A mixture of 2-bromoaniline (4.00 g, 23.3 mmol) and 3-penten-2-one (65%, 4.18 mL, 27.9 mmol) in concentrated HCl (50 mL) was stirred at reflux for 12 h. The reaction mixture was cooled to room temperature and then cooled in an ice bath and made basic (pH = 10) by addition of 5 N aqueous sodium hydroxide. The resulting aqueous mixture was extracted three times with dichloromethane (75 mL). The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (10% ethyl acetate/hexane) to afford the desired product 2.15 g, 46% yield) as a white solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 7.97 (d, <i>J</i> = 7.3 Hz, 1H), 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 7.29(t, <i>J</i> = 7.8 Hz, 1H), 7.15 (s, 1H), 2.73 (s, 3H), 2.63 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 236, 238 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 8-Bromo-4-methoxy-2-(trifluoromethyl)quinoline (<b>16m</b>)</h4><div class="NLM_p">A solution of ethyl 4,4,4-trifluoroacetoacetate (4.0 mL, 27.3 mmol) in polyphosphoric acid (22) was heated to 100 °C. 2-Bromoaniline (4.47 g, 26.0 mmol) was added slowly to the stirred reaction. The resulting mixture was heated to 150 °C and then stirred at that temperature overnight. The reaction was then cooled to room temperature, and water was added carefully. The resulting tan precipitate was collected by vacuum filtration, washed with water, and dissolved in ethyl acetate. The ethyl acetate solution was washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The crude product was purified by flash chromatography on silica gel (4:1 hexane/ethyl acetate) to give 8-bromo-2-(trifluoromethyl)quinolin-4-ol (4.76 g, 63% yield) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 12.60 (s, 1H), 8.16−8.22 (m, 2H), 7.52 (t, <i>J</i> = 8.2 Hz, 1H), 7.19 (s, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 291, 293 ([M − H]<sup>−</sup>).</div><div class="NLM_p last">To a solution of 8-bromo-2-(trifluoromethyl)quinolin-4-ol (0.50 g, 1.71 mmol) in acetone (15 mL) was added anhydrous potassium carbonate (0.50 g, 3.60 mmol), followed by iodomethane (0.53 g, 3.76 mmol). The resulting mixture was stirred at reflux for 1.5 h. An additional aliquot of iodomethane (0.53 g, 3.76 mmol) was added, and reflux was continued for an additional hour. The reaction was cooled to room temperature, poured onto ice, and extracted three times with ethyl acetate (50 mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator to give <b>16m</b> (0.42 g, 79% yield) as a beige solid, which was used without further purification. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.18−8.27 (m, 2H), 7.58 (t, <i>J</i> = 8.0 Hz, 1H), 7.47 (s, 1H), 4.15 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 305, 307 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 8-Chloro-5-fluoro-2-(trifluoromethyl)quinoline (<b>16n</b>)</h4><div class="NLM_p">A solution of 4,4,4-trifluoroacetoacetate (4 mL, 27.3 mmol) in polyphosphoric acid (22 mL) was heated to 100 °C. 2-Chloro-5-fluoroaniline (3.78 g, 26.0 mmol) was added portionwise to the stirred solution. The resulting reaction mixture was heated to 150 °C and then stirred at that temperature overnight. The reaction was cooled to room temperature, and water was added carefully. The resulting light-brown precipitate was collected by vacuum filtration, washed with water, and dissolved in ethyl acetate. The ethyl acetate solution was washed with water and brine, dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (4:1 ethyl acetate/hexane) to afford 8-chloro-5-fluoro-2-(trifluoromethyl)quinolin-4-ol (3.54 g, 51% yield) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 12.74 (br s, 1H), 7.94−8.01 (m, 1H), 7.37 (7.34−7.43 (m, 1H), 7.23 (s, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 264 ([M − H]<sup>−</sup>).</div><div class="NLM_p">To phosphorus oxybromide (6.4 g, 23.00 mmol)) heated at 75 °C was slowly added 8-chloro-5-fluoro-2-(trifluoromethyl)quinolin-4-ol (3.04 g, 11.45 mmol) and the temperature was raised to 150 °C for 2 h. After cooling to room temperature, the reaction was poured over ice and three times extracted with ethyl acetate (100 mL). The combined organic layers were washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The crude product was purified by flash chromatography on silica gel (10% ethyl acetate in hexane) using hexane/ethyl acetate to give 4-bromo-8-chloro-5-fluoro-2-(trifluoromethyl)quinoline (3.13 g, 83% yield) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.50 (s, 1H), 8.12−8.18 (m, 1H), 7.67−7.75 (m, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 328, 330 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">A stirred mixture of 1.6 <i>n</i>-butyl lithium/hexane (6.8 mL, 10.8 mmol) in dry tetrahydrofuran (10 mL) under a nitrogen atmosphere was cooled to −78 °C with a dry ice/acetone bath. A solution of 4-bromo-8-chloro-5-fluoro-2-(trifluoromethyl)quinoline (2.9 g, 8.8 mmol) in dry tetrahydrofuran (15 mL) was added dropwise over 15 min. The resulting reaction mixture was stirred at −78 °C for 20 min and then quenched by addition of methanol (2 mL). The reaction was warmed to room temperature, poured into brine, and partially concentrated on a rotary evaporator to remove the tetrahydrofuran. The resulting aqueous mixture was extracted twice with ethyl acetate (75 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The crude residue was purified by flash chromatography on silica gel (20% dichloromethane in hexane) to provide <b>16n</b> (1.1 g, 50% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.83 (d, <i>J</i> = 8.7 Hz, 1H), 8.13 (d, <i>J</i> = 8.7 Hz, 1H), 8.05−8.15 (m, 1H), 7.62 (t, <i>J</i> = 8.7 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 250 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 8-Chloro-5-fluoro-3-(trifluoromethyl)quinoline (<b>16o</b>)</h4><div class="NLM_p">To a stirred mixture of 2-chloro-5-fluoroaniline (5.00 g, 34.3 mmol), glycerol (6.00 g, 65.2 mmol), and <i>m</i>-nitrobenzene sulfonic acid sodium salt (11.0 g, 48.9 mmol) was added dropwise 70% sulfuric acid. The reaction was then heated to 140 °C and stirred at that temperature for 2 h. The mixture was cooled to room temperature and then poured into water, filtered through a bed or celite, made slightly basic (pH = 8−9) with 50% aqueous sodium hydroxide, and extracted three times with dichloromethane (75 mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (100% dichloromethane) to afford the desired product (3.70 g, 59% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.04 (dd, <i>J</i><sub>1</sub> = 4.3 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 8.47 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1. Hz, 1H), 7.84−7.92 (m, 1H), 7.65−7.71 (m, 1H), 7.40 (t, <i>J</i> = 8.5 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 182 ([M + H]<sup>+</sup>).</div><div class="NLM_p">To a solution of 8-chloro-5-fluoroquinoline (3.50 g, 19.3 mmol) in glacial acetic acid (50 mL) was added, portionwise, <i>N</i>-iodosuccinimide (4.34 g, 19.3 mmol). The resulting mixture was stirred at 70 °C overnight, cooled to room temperature, and concentrated on a rotary evaporator. The residue was taken up in dichloromethane and washed with saturated aqueous sodium bicarbonate and brine. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (5% ethyl acetate/hexane) to afford the intermediate 8-bromo-5-fluoro-3-iodoquinoline (1.68 g, 28% yield) as an off-white solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.16 (d, <i>J</i> = 2.1 Hz, 1H), 8.79 (d, <i>J</i> = 2.1 Hz, 1H), 7.70−7.77 (m, 1H), 7.317 (t, <i>J</i> = 8.8 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 308 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">A mixture of copper(I) iodide (2.07 g, 10.9 mmol) and potassium fluoride (0.63 g, 10.9 mmol) was placed under a high vacuum and heated until the solid assumed a slightly green color. The cooled solid mass was suspended in anhydrous <i>N</i>-methylpyrrolidinone (20 mL) and then treated with the previously described 8-bromo-5-fluoro-3-iodoquinoline (1.68 g, 5.47 mmol), followed by trifluoromethyltrimethylsilane (2.33 g, 16.4 mmol). The resulting mixture was stirred under a nitrogen atmosphere at 50 °C overnight. The mixture was then cooled to room temperature and poured into 15% aqueous ammonium hydroxide. The aqueous mixture was extracted four times with diethyl ether (50 mL). The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (5% ethyl acetate/hexane) to afford the desired product <b>16o</b> (0.56 g, 41% yield) as an off-white solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.23 (s, 1H), 8.73 (s, 1H), 7.84−7.94 (m, 1 h), 7.29 (t, <i>J</i> = 8.6 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 250 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 8-Bromo-3,5-difluoroquinoline (<b>16p</b>)</h4><div class="NLM_p">Flash chromatography of the mixture of 5-amino-8-fluoroquinoline and 8-amino-3-fluoroquinoline obtained in the synthesis of <b>16h</b> on silica gel (30% ethyl acetate/hexane) afforded 5-amino-3-fluoroquinoline as a light-brown solid in 53% yield. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.79 (d, <i>J</i> = 2.8 Hz, 1H), 8.35 (dd, <i>J</i><sub>1</sub> = 10.9 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 7.39 (t, <i>J</i> = 8.0 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 1H), 6.73 (d, <i>J</i> = 7.5 Hz 1H), 5.94 (br s, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 163 ([M + H]<sup>+</sup>).</div><div class="NLM_p">3,5-Difluoroquinoline was obtained as a tan solid in 63% yield by treatment of 5-amino-3-fluoroquinoline with 48% fluoroboric acid using the procedure described for preparing 3-fluoroquinoline in the synthesis of <b>16h</b>. The crude reaction residue was purified by flash chromatography on silica using 5% ethyl acetate/hexane: <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.86 (d, <i>J</i> = 8.5 Hz, 1H), 8.02 (dd, <i>J</i><sub>1</sub> = 8.5 Hz, <i>J</i><sub>2</sub> = 2.6 Hz, 1H), 7.96 (d, <i>J</i> = 8.6 Hz, 1H), 7.60−7.71 (m, 1H), 7.26−7.35 (m, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 166 ([M + H]<sup>+</sup>).</div><div class="NLM_p">3,5-Difluoro-8-nitroquinoline was obtained as a yellow solid in 48% yield from 3,5-difluoroquinoline by treatment with fuming nitric acid in concentrated sulfuric acid using the procedure described for preparing 3-fluoro-8-nitroquinoline in the synthesis of <b>16h</b>. The product was obtained by vacuum filtration of the aqueous mixture and was pure enough to use in subsequent reactions. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.16 (d, <i>J</i> = 2.4 Hz, 1H), 8.52 (dd, <i>J</i><sub>1</sub> = 8.8 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 8.30−8.38 (m, 1H), 7.68 (t, <i>J</i> = 8.7). MS (ESI+) (<i>m</i>/<i>z</i>) 211 ([M + H]<sup>+</sup>).</div><div class="NLM_p">8-Amino-3,5-difluoroquinoline was obtained as a white solid in 83% yield by hydrogenation of 3,5-difluoro-8-nitroquinoline over 10% Pd/C at 55 psi. The crude reaction residue was purified by flash chromatography on silica gel using 30% ethyl acetate/hexane. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.77 (d, <i>J</i> = 2.8 Hz, 1H), 8.06 (dd, <i>J</i><sub>1</sub> = 9.6 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 7.19 (t, <i>J</i> = 9.2 Hz, 1H), 6.67−6.73 (m, 1H), 5.82 (br s, 2H). MS (ESI+) (<i>m</i>/<i>z</i>) 181 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">To a solution of 8-amino-3,5-difluoroquinoline (0.05 g, 0.28 mmol) in water (2 mL) was added concentrated hydrobromic acid (5 mL) and cooled to 0 °C. To the reaction was added sodium nitrite (0.038 g, 0.55 mmol) in water (1 mL). The resulting mixture was poured into a solution of copper(I) bromide (0.12 g, 0.84 mmol) in concentrated hydrobromic acid (5 mL). The reaction was stirred at room temperature overnight. The reaction was poured into cold 20% aqueous sodium hydroxide solution and extracted three times with diethyl ether (20 mL). The combined organic layers were concentrated on a rotary evaporator to give 0.061 g (89%) of 8-bromo-3,5-difluoroquinoline as a yellow oil, which was used without further purification. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 9.10 (d, <i>J</i> = 2.8 Hz, 1H), 8.38 (dd, <i>J</i><sub>1</sub> = 8.9 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 8.05−8.12 (m, 1H), 7.46 (t, <i>J</i> = 8.8 Hz, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 244, 246 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 8-Bromo-5-fluoro-2,4-dimethylquinoline (<b>16q</b>)</h4><div class="NLM_p last">A mixture of 2-bromo-5-fluoroaniline (3.0 g, 15.8 mmol) and 3-penten-2-one (65%, 2.44 g, 18.9 mmol) in concentrated HCl (30 mL), was stirred at reflux overnight. The reaction mixture was cooled to room temperature and then cooled in an ice bath. The pH was adjusted to 10 with 2.5 N aqueous sodium hydroxide, and the resulting aqueous mixture was extracted three times with dichloromethane (50 mL). The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (60% ethyl acetate/hexane) to afford the desired product (2.42 g, 60% yield) as a light-yellow solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 7.84−7.91 (m, 1H), 7.12 (s, 1H), 6.95−7.04 (m, 1H), 2.77 (d, <i>J</i> = 7.1 Hz (fluorine coupling), 3H), 2.71 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 254, 256 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 8-Chloro-5-fluoro-4-methoxy-2-(trifluoromethyl)quinoline (<b>16r</b>)</h4><div class="NLM_p">A solution of 4,4,4-trifluoroacetoacetate (4 mL, 27.3 mmol) in polyphosphoric acid (22 mL) was heated to 100 °C. 2-Chloro-5-fluoroaniline (3.78 g, 26.0 mmol) was added portionwise to the stirred solution. The resulting reaction mixture was heated to 150 °C and then stirred at that temperature overnight. The reaction was cooled to room temperature, and water was added carefully. The resulting light-brown precipitate was collected by vacuum filtration, washed with water, and dissolved in ethyl acetate. The ethyl acetate solution was washed with water and brine, dried over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The residue was purified by flash chromatography on silica gel (4:1 hexane/ethyl acetate) to afford 8-chloro-5-fluoro-2-(trifluoromethyl)quinolin-4-ol (3.54 g, 51% yield) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 12.74 (br s, 1H), 7.94−8.01 (m, 1H), 7.37 (7.34−7.43 (m, 1H), 7.23 (s, 1H). MS (ESI+) (<i>m</i>/<i>z</i>) 264 ([M − H]<sup>−</sup>).</div><div class="NLM_p">To a solution of 8-chloro-5-fluoro-2-(trifluoromethyl)quinolin-4-ol (3.54 g, 13.3 mmol, preparation described in the synthesis of <b>16n</b>) in acetone (75 mL) was added anhydrous potassium carbonate (3.88 g, 28.0 mmol), followed by iodomethane (1.8 mL, 28.9 mmol). The resulting mixture was stirred at reflux for 1.5 h. An additional aliquot of iodomethane (1.8 mL, 28.9 mmol) was added, and reflux was continued for an additional 1 h. The reaction was cooled to room temperature, poured onto ice, and extracted three times with ethyl acetate (50 mL). The combined organic layers were dired over anhydrous magnesium sulfate, filtered, and concentrated on a rotary evaporator. The desired <b>16r</b> (3.72 g, 100% yield) was isolated as a yellow solid and was pure enough to use in subsequent reactions without further purification. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.00−8.05 (m, 1H), 7.53 (s, 1H), 7.43−7.50 (m, 1H), 4.12 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 280 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">The synthesis of 8-(1,4-dioxa-8-azaspiro[4,5]dec-8-yl)quinoline (<b>17a</b>) illustrates the general sequence used to prepare compounds <b>17a</b>, <b>17c</b>−<b>d</b>, <b>17f</b>−<b>m</b> and <b>17p</b>−<b>q</b>.</div></div><div id="sec8_19_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 8-(1,4-Dioxa-8-azaspiro[4,5]dec-8-yl)quinoline (<b>17a</b>)</h4><div class="NLM_p">A solution of commercially available 8-bromoquinoline (<b>16a</b>) (4.0 g, 19.2 mmol) in anhydrous tetrahydrofuran (20 mL) was purged with nitrogen for 10 min and then placed under a nitrogen atmosphere. To the stirred solution was added tris(dibenzylideneacetone)dipalladium (0) (Pd<sub>2</sub>(dba)<sub>3</sub>, 0.2 g, 0.02 mmol), sodium <i>tert</i>-butoxide (2.6 g, 27.1 mmol), tetrakis(triphenylphosphino)-1,1-binapthyl (BINAP, 0.1 g, 0.16 mmol), and 1,4-dioxa-8-azaspiro-4,5-decane (3.3 g, 23.1 mmol). The resulting mixture was stirred at reflux for 3 h and then cooled to room temperature. The reaction mixture was diluted with diethyl ether, filtered through a pad of celite, and concentrated on a rotary evaporator. The resulting residue was purified by flash chromatography on silica gel (4:1 hexane/ethyl acetate) afforded the desired product (3.0 g, 58% yield) as a brown oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.83 (d, <i>J</i> = 4.2 Hz, 1H), 8.26 (d, <i>J</i> = 5.5 Hz, 1H), 7.40−7.51 (m, 3H), 7.15 (d, <i>J</i> = 7.2 Hz, 1H), 3.89 (s, 4H), 3.36 (t, <i>J</i> = 5.4 Hz, 4H), 1.83 (t, <i>J</i> = 5.4 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 244 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">The following compounds were prepared using a similar procedure:</div></div><div id="sec8_19_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-6-fluoroquinoline (<b>17c</b>)</h4><div class="NLM_p last">Prepared from <b>16c</b> in 36% overall yield and obtained as an off-white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.80 (dd, <i>J</i><sub>1</sub> = 4.1 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 8.25 (dd, <i>J</i><sub>1</sub> = 8.3 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 7.45−7.58 (m, 1H), 7.20−7.31 (m, 1H), 6.98 (dd, <i>J</i><sub>1</sub> = 11.8 Hz, <i>J</i><sub>2</sub> = 2.7 Hz, 1H), 3.93 (s, 4H), 3.46 (t, <i>J</i> = 5.6 Hz, 4H), 1.84 (t, <i>J</i> = 5.6 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 289 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-6-bromoquinoline (<b>17d</b>)</h4><div class="NLM_p last">Prepared from <b>16d</b> in 94% overall yield and obtained as a brown oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.86 (d, <i>J</i> = 4.1 Hz, 1H), 8.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.74 (d, <i>J</i> = 2.1 Hz, 1H), 7.50−7.55 (m, 1H), 7.15 (s, <i>J</i> = 2.1 Hz, 1H), 3.93 (s, 4H), 3.44 (t, <i>J</i> = 5.2 Hz, 4H), 1.84 (t, <i>J</i> = 5.4 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 348, 350 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-2-methylquinoline (<b>17f</b>)</h4><div class="NLM_p last">Prepared from <b>16f</b> in 52% overall yield and obtained as a brown oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 7.95 (d, <i>J</i> = 8.5 Hz, 1H), 7.28−7.46 (m, 2H), 7.15 (d, <i>J</i> = 7.1 Hz, 1H), 7.05−7.11 (m, 1H), 4.00 (s, 4H), 3.47 (t, <i>J</i> = 5.6 Hz, 4H), 2.71 (s, 3H), 2.04 (t, <i>J</i> = 5.6 HZ, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 285 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-2-(trifluoromethyl)quinoline (<b>17g</b>)</h4><div class="NLM_p last">Prepared from <b>16g</b> in 63% overall yield and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.86 (d, <i>J</i> = 8.6 Hz, 1H),7.91 (d, <i>J</i> = 8.4 Hz, 1H), 7.55−7.68 (m, 2H), 7.17−7.32 (m, 1H), 3.93 (s, 4H), 3.44 (t, <i>J</i> = 5.5 Hz, 4H), 1.83 (t, <i>J</i> = 5.5 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 339 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-3-fluoroquinoline (<b>17h</b>)</h4><div class="NLM_p last">Prepared from <b>16h</b> in 82% overall yield and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.85 (d, <i>J</i> = 3.0 Hz, 1H), 8.14 (dd, <i>J</i><sub>1</sub> = 9.7 Hz, <i>J</i><sub>2</sub> = 2.9 Hz, 1H), 7.44−7.52 (m, 2H), 7.12 (t, <i>J</i> = 4.6 Hz, 1H), 3.91 (s, 4H), 3.36 (t, <i>J</i> = 5.2 Hz, 4H), 1.84 (t, <i>J</i> = 5.2 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 289 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-3-methylquinoline (<b>17i</b>)</h4><div class="NLM_p last">Prepared from <b>16i</b> in 67% overall yield and obtained as a brown oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.73 (d, <i>J</i> = 2.2 Hz, 1H), 7.82 (d, <i>J</i> = 1.2 Hz, 1H), 7.28−7.42 (m, 2H), 7.08 (dd, <i>J</i><sub>1</sub> = 7.3 Hz, <i>J</i><sub>2</sub> = 1.5 Hz, 1H), 4.00 (s, 4H), 3.46 (t, <i>J</i> = 5.8 Hz, 4H), 2.05 (t, <i>J</i> = 5.8 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 285 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-3-(trifluoromethyl)quinoline (<b>17j</b>)</h4><div class="NLM_p last">Prepared from <b>16j</b> in 78% overall yield and obtained as a beige solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.07 (d, <i>J</i> = 2.3 Hz, 1H), 8.38 (s, 1H), 7.45−7.58 (m, 2H), 7.28 (dd, <i>J</i><sub>1</sub> = 7.2 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 4.03 (s, 4H), 3.48 (t, <i>J</i> = 5.5 Hz, 4H), 2.43 (s, 3H), 2.05 (t, <i>J</i> = 5.5 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 339 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-4-methylquinoline (<b>17k</b>)</h4><div class="NLM_p last">Prepared from <b>16k</b> in 52% overall yield and obtained as a brown oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.72 (d, <i>J</i> = 4.3 Hz, 1H), 7.59 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (t, <i>J</i> = 7.7 Hz, 1H), 7.05−7.12 (m, 2H), 4.00 (s, 4H), 3.44 (t, <i>J</i> = 4.8 Hz, 4H), 2.65 (s, 3H), 2.04 (t, <i>J</i> = 4.9 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 285 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-2,4-dmethylquinoline (<b>17l</b>)</h4><div class="NLM_p last">Prepared from <b>16l</b> in 43% overall yield and obtained as a brown oil. <sup>1</sup>H -NMR (chloroform-<i>d</i>) δ 7.55 (d, <i>J</i><sub>1</sub> = 8.4 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H), 7.13 (d, <i>J</i> = 8.6 Hz, 1H), 7.09 (s, 1H), 4.02 (s, 4H), 3.47 (t, <i>J</i> = 5.6 Hz, 4H), 2.68 (S, 3H), 2.62 (s, 3H), 2.05 (t, <i>J</i> = 5.6 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 299 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-4-methoxy-2-(trifluoromethyl)quinoline (<b>17m</b>)</h4><div class="NLM_p last">Prepared from <b>16m</b> in 71% overall yield and obtained as a yellow oil. <sup>1</sup>H -NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.51 (t, <i>J</i> = 7.8 Hz, 1H), 7.32 (s, 1H), 7.20 (d, <i>J</i> = 7.7 Hz, 1H), 4.08 (s, 3H), 3.89 (s, 4H), 3.37 (t, <i>J</i> = 5.1 Hz, 4H), 1.82 (t, <i>J</i> = 5.1 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 369 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-3,5-difluoroquinoline (<b>17p</b>)</h4><div class="NLM_p last">Prepared from 16 h in 39% overall yield and obtained as a yellow oil. <sup>1</sup>H -NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.55 (d, <i>J</i> = 2.9 Hz, 1H), 7.70 (d, <i>J</i> = 2.9 Hz, 1H), 6.98−7.15 (m, 2H), 3.90 (s, 4H), 2.82 (t, <i>J</i> = 5.6 Hz, 4H), 1.82 (t, <i>J</i> = 5.6 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 307 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-5-fluoro-2,4-dimethylquinoline (<b>17q</b>)</h4><div class="NLM_p">Prepared from <b>16q</b> in 30% overall yield and obtained as a brown oil. <sup>1</sup>H -NMR (chloroform-<i>d</i>) δ 7.10−7.16 (m, 1H), 6.95−7.05 (m, 2H), 3.99 (s, 4H), 3.34 (t, <i>J</i> = 5.3 Hz, 4H), 2.77 (s, 3H), 2.72 (s, 3H), 2.04 (t, <i>J</i> = 5.3 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 317 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">The synthesis of <b>17b</b> illustrates the general method used to prepare compounds <b>17b</b>, <b>17n</b>−<b>o</b> and <b>17r</b>.</div></div><div id="sec8_19_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-5-fluoro-quinoline (<b>17b</b>)</h4><div class="NLM_p">To a solution of <b>16b</b> (2.25 g, 12.4 mmol) in anhydrous tetrahydrofuran (40 mL), flushed with nitrogen, and kept under a nitrogen atmosphere, was added tris(dibenzylideneacetone)dipalladium (0) (Pd<sub>2</sub>(dba)<sub>3</sub>, 0.417 g, 0.02 mmol), sodium <i>tert</i>-butoxide (01.66 g, 16.3 mmol), 2-dicyclohexylphosphine-2′-(<i>N</i>,<i>N</i>-dimethylamino)biphenyl (CYMAP, 0.072 g, 0.02 mmol), and 1,4-dioxa-8-azaspiro-4,5 decane (2.10 mg, 14.7 mmol). The resulting mixture was stirred at 70 °C overnight. The reaction was cooled to room temperature, diluted with diethyl ether, filtered through a plug of silica gel, and concentrated on a rotary evaporator. The resulting residue was purified by flash chromatography on silica gel (40% ethyl acetate/hexane) to afford the desired product (2.10 g, 60% yield) as a beige solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.92 (d, <i>J</i> = 4.1 Hz, 1H), 8.38 (d, <i>J</i> = 8.4 Hz, 1H), 7.55−7.61 (m, 1H), 7.21−7.30 (m, 1H), 7.06−7.14 (m, 1H), 3.89 (s, 4H), 331 (t, <i>J</i> = 5.3 Hz, 4H), 1.82 (t, <i>J</i> = 5.3 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 289 ([M + H]<sup>+</sup>)</div><div class="NLM_p last">The following compounds were prepared using a similar procedure.</div></div><div id="sec8_19_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-5-fluoro-2-(trifluoromethyl)quinoline (<b>17n</b>)</h4><div class="NLM_p last">Prepared from <b>16n</b> in 44% overall yield and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.70 (d, <i>J</i> = 8.7 Hz, 1H), 8.01 (d, <i>J</i> = 8.7 Hz, 1H), 7.48 (t, <i>J</i> = 9.6 Hz, 1H), 7.19−7.27 (m, 1H), 3.92 (s, 4H), 3.35 (t, <i>J</i> = 5.6 Hz, 4H), 1.85 (t, <i>J</i> = 5.6 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 357 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-5-fluoro-3-(trifluoromethyl)quinoline (<b>17o</b>)</h4><div class="NLM_p last">Prepared from <b>16o</b> and isolated as a beige solid in 30% yield. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.10 (d, <i>J</i> = 2.2 Hz, 1H), 8.64 (d, <i>J</i> = 2.1 Hz, 1H), 7.10−7.25 (m, 2H), 4.00 (s, 4H), 3.39 (t, <i>J</i> = 4.9 Hz, 4H), 2.02 (t, <i>J</i> = 4.9 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 357 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 8-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-5-fluoro-4-methoxy--2-(trifluoromethyl)quinoline (<b>17r</b>)</h4><div class="NLM_p last">Prepared from <b>16r</b> and isolated as a beige solid in 64% yield. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 7.38 (s, 1H), 7.25−7.32 (m, 1H), 7.13−7.18 (m, 1H), 4.06 (s, 3H), 3.88 (s, 4H), 3.31 (t, <i>J</i> = 5.5 Hz, 4H), 1.80 (t, <i>J</i> = 5.5 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 387 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 7-(1,4-Dioxa-8-azaspiro[4,5]dec-8-yl)-8-fluoroquinoline (<b>17e</b>)</h4><div class="NLM_p">A mixture of <b>16e</b> (0.50 g, 3.03 mmol) and dioxa-8-azaspiro-4,5-decane (5 mL, 39.1 mmol) was stirred at 120 °C for 48 h. The reaction was cooled to room temperature, poured into water, and extracted three times with diethyl ether (30 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator to give a residue consisting of a mixture of 7- and 8-substituted regioisomers. The residue was subjected to flash chromatography on silica gel. Elution with 30% ethyl acetate/hexane afforded the desired 8-(1,4-dioxa-8-azaspiro[4,5]dec-8-yl)-7-fluoroquinoline (<b>17e</b>, 0.39 g,) as a yellow oil. <sup>1</sup>H -NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.80 (dd, <i>J</i><sub>1</sub> = 4.2 Hz, <i>J</i><sub>2</sub> = 1.5 Hz, 1H), 8.24 (d, <i>J</i> = 8.3 Hz, 1H), 7.66 (d, <i>J</i> = 8.9 Hz, 1H), 7.44 (t, <i>J</i> = 8.4 Hz, 1H), 7.34−7.39 (m, 1H), 3.89 (s, 4H), 3.27 (t, <i>J</i> = 5.1 Hz, 4H), 1.77 (t, <i>J</i> = 5.1 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 289 ([M + H]<sup>+</sup>).</div><div class="NLM_p">The eluent was switched to 50% ethyl acetate/hexane and the undesired 7-(1,4-dioxa-8-azaspiro[4,5]dec-8-yl)-8-fluoroquinoline eluted and was obtained as a white solid (0.23 g). The structures of both regioisomers were assigned by <sup>1</sup>H NMR and confirmed with a nuclear Overhauser effect spectroscopy experiment (data not shown).</div><div class="NLM_p last">The synthesis of 1-quinolin-8-yl-pipiridin-4-one (<b>18a</b>). illustrates the general sequence used to prepare compounds <b>18a</b>−<b>r</b>.</div></div><div id="sec8_19_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-Quinolin-8-yl-pipiridin-4-one (<b>18a</b>)</h4><div class="NLM_p">To a solution of <b>17a</b> (4.0 g, 14.8 mmol) in tetrahydrofuran (10 mL) was added 2N HCl/diethyl ether (10 mL). The resulting mixture was stirred at room temperature overnight. The resulting reaction mixture was diluted with water (100 mL), made basic with 2.5 N aqueous sodium hydroxide, and extracted three times with dichloromethane (100 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated on a rotary evaporator to give the desired product (3.2 g, 95% yield) as a yellow oil which was used without further purification. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.92 (dd, <i>J</i><sub>1</sub> = 4.2 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 8.14 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1.9 Hz, 1H), 7.35−7.53 (m, 3H), 7.17 (dd, <i>J</i><sub>1</sub> = 6.8 Hz, <i>J</i><sub>2</sub> = 1.9 Hz, 1H), 3.70 (t, <i>J</i> = 6.2 Hz, 4H), 2.79 (t, <i>J</i> = 6.1 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 227 ([M + H]<sup>+</sup>).</div><div class="NLM_p last">The following compounds were prepared using a similar procedure.</div></div><div id="sec8_19_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-(5-Fluoroquinolin-8-yl)piperidin-4-one (<b>18b</b>)</h4><div class="NLM_p last">Prepared from <b>17b</b> in 91% yield and obtained as a tan solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.95−9.00 (m, 1H), 8.43 (dd, <i>J</i><sub>1</sub> = 8.5 Hz, J2−2.4 Hz, 1H), 7.59−7.65 (m, 1H), 7.32 (t, <i>J</i> = 9.1 Hz, 1H), 7.13−7.19 (m, 1H), 3.58 (t, <i>J</i> = 6.0 Hz, 4H), 2.58 (t, <i>J</i> = 6.0 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 245 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 1-(6-Fluoroquinolin-8-yl)piperidin-4-one (<b>18c</b>)</h4><div class="NLM_p last">Prepared from <b>17c</b> in 66% yield and obtained as a white solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.79 (dd, <i>J</i><sub>1</sub> = 4.2 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 8.25 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 7.45−7.53 (m, 1H), 7.25 (dd, <i>J</i><sub>1</sub> = 9.0 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 7.02 (dd, <i>J</i><sub>1</sub> = 11.6 Hz, <i>J</i><sub>2</sub> = 2.8 Hz, 1H), 3.72 (t, <i>J</i> = 6.1 Hz, 4H), 2,56 (t, <i>J</i> = 6.1 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 245 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 1-(6-Bromoquinolin-8-yl)piperidin-4-one (<b>18d</b>)</h4><div class="NLM_p last">Prepared from <b>17d</b> in 79% yield and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.89 (dd, <i>J</i><sub>1</sub> = 4.1 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 8.28 (dd, <i>J</i><sub>1</sub> = 8.5 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 7.80 (d, <i>J</i> = 2.1 Hz, 1H), 7.54−7.58 (m, 1H), 7.22 (d, <i>J</i> = 2.1 Hz, 1H), 3.72 (t, <i>J</i> = 6.0 Hz, 4H), 2.59 (t, <i>J</i> = 6.0 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 305, 307 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 1-(7-Fluoroquinolin-8-yl)piperidin-4-one (<b>18e</b>)</h4><div class="NLM_p last">Prepared from <b>17e</b> in 80% yield and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.88 (dd, <i>J</i><sub>1</sub> = 4.2 Hz, <i>J</i><sub>2</sub> = 1.7 Hz, 1H), 8.31 (dd, <i>J</i><sub>1</sub> = 8.3 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 7.63−7.69 (m, 1H), 7.42−7.50 (m, 2H), 3.66 (t, <i>J</i> = 6.0 Hz, 4H), 2.53 t, <i>J</i> = 6.0 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 245 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-(2-Methylquinolin-8-yl)piperidin-4-one (<b>18f</b>)</h4><div class="NLM_p last">Prepared from <b>17f</b> in 95% yield and obtained as a yellow oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.32−7.41 (m, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.05−7.17 (m, 2H), 3.70 (t, <i>J</i> = 5.9 Hz, 4H), 2.76 (t, <i>J</i> = 5.9 Hz, 4H), 2.73 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 241 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1-[2-(Trifluoromethyl)-quinolin-8-yl]piperidin-4-one (<b>18g</b>)</h4><div class="NLM_p last">Prepared from <b>17g</b> in 13% yield and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.64 (d, <i>J</i> = 8.3 Hz, 1H), 7.82 (d, <i>J</i> = 8.4 Hz, 1H), 7.33−7.42 (m, 1H), 7.12−7.20 (m, 1H), 7.04−7.14 (m, 1H), 3.62 (t, <i>J</i> = 5.8 Hz, 4H), 2.57 (t, <i>J</i> = 6.2 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 295 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 1-[3-Fluoroquinolin-8-yl]piperidin-4-one (<b>18h</b>)</h4><div class="NLM_p last">Prepared from <b>17h</b> in 48% yield and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.81 (d, <i>J</i> = 2.6 Hz, 1H), 8.10 (dd, <i>J</i><sub>1</sub> = 9.1 Hz, <i>J</i><sub>2</sub> = 2.5 Hz, 1H), 7.39−7.47 (m, 2H), 7.08 (t, <i>J</i> = 5.2 Hz, 1H), 3.38 (t, <i>J</i> = 5.6 Hz, 4H), 1.88 (t, <i>J</i> = 5.6 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 245 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 1-(3-Methylquinolin-8-yl)piperidin-4-one (<b>18i</b>)</h4><div class="NLM_p last">Prepared from <b>17i</b> in 96% yield and obtained as a yellow oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.76 (s, 1H), 7.88 (s, 1H), 7.32−7.42 (m, 2H), 7.05−7.16 (m, 1H), 3.67 (t, <i>J</i> = 5.9 Hz, 4H), 2.76 (t, <i>J</i> = 5.9 Hz, 4H), 2.49 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 241 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 1-[3-(Trifluoromethyl)-quinolin-8-yl]piperidin-4-one (<b>18j</b>)</h4><div class="NLM_p last">Prepared from <b>17j</b> in 65% yield and obtained as a yellow oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.08 (d, <i>J</i> = 2.2 Hz, 1H), 8.40 (s, 1H), 7.53−7.60 (m, 2H), 7.21−7.30 (m, 1H), 3.70 (t, <i>J</i> = 5.9 Hz, 4H), 2.76 (t, <i>J</i> = 5.9 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 295 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 1-(4-Methylquinolin-8-yl)piperidin-4-one (<b>18k</b>)</h4><div class="NLM_p last">Prepared from <b>17k</b> in 92% yield and obtained as a brown oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 8.73 (d, <i>J</i> = 4.3 Hz, 1H), 7.63 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (t, <i>J</i> = 7.7 Hz,, 1H), 7.15−7.25 (m, 1H), 7.14 (d, <i>J</i> = 7.7 Hz, 1H), 3.65 (t, <i>J</i> = 6.0 Hz, 4H), 2.75 (t, <i>J</i> = 6.0 Hz, 4H), 2.66 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 241 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 1−2,4-Dimethylquinolin-8-yl)piperidin-4-one (<b>18l</b>)</h4><div class="NLM_p last">Prepared from <b>17l</b> in 75% yield and obtained as an off-white solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 7.62 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (t, <i>J</i> = 7.9 Hz, 1H), 7.10−7.18 (m, 2H), 3.69 (t, <i>J</i> = 6.0 Hz, 4H), 2.78 (t, <i>J</i> = 6.0 Hz, 4H), 2.70 (s, 3H), 2.64 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 255 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 1-[4-Methoxy-2-(trifluoromethyl)quinolin-8-yl]piperidin-4-one (<b>18m</b>)</h4><div class="NLM_p last">Prepared from <b>17m</b> in 65% yield and obtained as an off-white solid. <sup>1</sup>H -NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 7.57 (t, <i>J</i> = 8.0 Hz, 1H), 7.38 (s, 1H), 7.30 (d, <i>J</i> = 7.7 Hz, 1H), 4.12 (s, 3H), 3.68 (t, <i>J</i> = 5.9 Hz, 4H), 2.59 (t, <i>J</i> = 5.9 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 325 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 1-[5-Fluoro-2-(trifluoromethyl)quinolin-8-yl]piperidin-4-one (<b>18n</b>)</h4><div class="NLM_p last">Prepared from <b>17n</b> in 79% yield and obtained as a yellow solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.71 (d, <i>J</i> = 8.7 Hz, 1H), 8.02 (d, <i>J</i> = 8.8 Hz, 1H), 7.49 (t, <i>J</i> = 8.7 Hz, 1H), 7.24−7.30 (m, 1H), 3.62 (t, <i>J</i> = 6.0 Hz, 4H), 2.57 (t, <i>J</i> = 6.9 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 313 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 1-[5-Fluoro-3-(trifluoromethyl)quinolin-8-yl]piperidin-4-one (<b>18o</b>)</h4><div class="NLM_p last">Prepared from <b>17o</b> in 71% yield and obtained as a yellow solid. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 9.12 (d, <i>J</i> = 2.2 Hz, 1H), 8.66 (d, <i>J</i> = 2.2 Hz, 1H), 7.10−7.25 (m, 2H), 3.61 (t, <i>J</i> = 6.0 Hz, 4H), 2.74 (t, <i>J</i> = 6.0 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 313 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 1-(3,5-Difluoroquinolin-8-yl)piperidin-4-one (<b>18p</b>)</h4><div class="NLM_p last">Prepared in 68% yield from <b>17p</b> and obtained as a yellow oil. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 8.51 (d, <i>J</i> = 2.8 Hz, 1H), 7.68 (d, <i>J</i> = 2.8 Hz, 1H), 7.13−7.27 (m, 2H), 3.65 (t, <i>J</i> = 5.8 Hz, 4H), 2.69 (t, <i>J</i> = 5.8 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 263 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 1-[5-Fluoro-2,4-dimethylquinolin-8-yl]piperidin-4-one (<b>18q</b>)</h4><div class="NLM_p last">Prepared from <b>17q</b> in 65% yield and obtained as a yellow oil. <sup>1</sup>H NMR (chloroform-<i>d</i>) δ 7.54−7.60 (m, 1H), 7.06−7.15 (m, 1H), 6.99−7.05 (m, 1H), 3.58 (t, <i>J</i> = 6.0 Hz, 4H), 2.79 (t, <i>J</i> = 6.0 Hz, 4H), 2.77 (s, 3H), 2.69 (s, 3H). MS (ESI+) (<i>m</i>/<i>z</i>) 244 ([M + H]<sup>+</sup>).</div></div><div id="sec8_19_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 1-[5-Fluoro-4-methoxy-2-(trifluoromethyl)quinolin-8-yl]piperidin-4-one (<b>18r</b>)</h4><div class="NLM_p last">Prepared from <b>17r</b> in 77% yield and obtained as a light-yellow solid. <sup>1</sup>H NMR (DMSO-<i><i>d</i></i><sub>6</sub>) δ 7.44 (s, 1H), 7.32−7.40 (m, 1H), 7.22−7.28 (m, 1H), 4.10 (s, 3H), 3.56 (t, <i>J</i> = 5.8 Hz, 4H), 2.57 (t, <i>J</i> = 5.8 Hz, 4H). MS (ESI+) (<i>m</i>/<i>z</i>) 343 ([M + H]<sup>+</sup>).</div></div></div><div id="sec8_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Radioligand Binding Assays</h3><div class="NLM_p last">Affinity for the human 5-HT<sub>1A</sub> receptor was determined using a previously described method<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and employing a Chinese hampster ovary (CHO) cell line stably transfected with the human 5-HT<sub>1A</sub> receptor and [<sup>3</sup>H]-8-OH-DPAT as the standard radioligand. Results are expressed as <i>K</i><sub>i</sub> values and are the average of at least three repetitions.</div></div><div id="sec8_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> cAMP Accumulation Assays</h3><div class="NLM_p last">Intrinsic activity at the human 5-HT<sub>1A</sub> receptor was measured using a cAMP accumulation assay in a CHO cell line stably transfected with the human 5-HT<sub>1A</sub> receptor.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Details for the procedures used in this manuscript are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Microsomal Stability Studies</h3><div class="NLM_p last">Microsomal stability of the compounds was determined by incubating compounds with rat or human liver microsomes at 37 °C for 20 min in the presence of NADPH or a NADPH regenerating system. Details for this procedure area available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Pharmacokinetic Studies</h3><div class="NLM_p last">The pharmacokinetics of test compounds were determined in male Sprague−Dawley rats after a single 1 mg/kg iv dose (in 2% Tween 80) or a single 3 mg/kg po dose (in 2% Tween 80/0.5% methylcellulose). Details for these procedures are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> In Vivo Microdialysis</h3><div class="NLM_p last">In vivo microdialysis studies were carried out as previously described with some modifications.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Details for these procedures used in this manuscript are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> Novel Object Recognition</h3><div class="NLM_p last">Compound <b>10b</b> was assessed for its ability to improve cognitive function (recognition memory) in a rat novel object recognition model as previously described.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Details for this procedures used in this manuscript are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> Atlantis Water Maze</h3><div class="NLM_p last">The Atlantis water maze model has been described elsewhere.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Details for this procedures used in this manuscript are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Contextual Fear Conditioning</h3><div class="NLM_p last">The contextual fear conditioning (CFC) model using male Tg2576 mice has been described elsewhere.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Details for this procedures used in this manuscript are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Schedule-Induced Polydipsia</h3><div class="NLM_p last">The experimental details of the schedule-induced polydipsia model have been published elsewhere.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Details for the procedures used in this manuscript are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Olfactory Bulbectomy</h3><div class="NLM_p last">Test compounds were examined for their effects on olfactory bulbectomy-induced hyperactivity in the absence and presence of fluoxetine, a selective serotonin reuptake inhibitor. The experimental details of this model have been published elsewhere.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Details for the procedures used in this manuscript are available in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Fluoxetine-Induced Sexual Dysfunction</h3><div class="NLM_p last">The experimental details for performing this model have been published elsewhere.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Data and an experimental description can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109"><a href="/doi/suppl/10.1021/jm1000908">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental protocols for the pharmacology assays and a graph depicting the effect of compound <b>10b</b> on fluoxetine-induced sexual dysfunction. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1000908/suppl_file/jm1000908_si_001.pdf">jm1000908_si_001.pdf (194.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm1000908" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne E. Childers</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e1968289888d85849392a19880898e8ecf828e8c"><span class="__cf_email__" data-cfemail="aaddc9c2c3c6cecfd8d9ead3cbc2c5c584c9c5c7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa M. Havran</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magda Asselin</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James J. Bicksler</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan C. Chong</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George T. Grosu</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongqi Shen</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magid, A. Abou-Gharbia</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alvin C. Bach</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boyd L. Harrison</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natasha Kagan</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Teresa Kleintop</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald Magolda</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vasilios Marathias</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert J. Robichaud</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annmarie L. Sabb</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mei-Yi Zhang</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terrance H. Andree</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan H. Aschmies</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chad Beyer</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas A. Comery</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Day</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven M. Grauer</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zoe A. Hughes</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharon Rosenzweig-Lipson</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Platt</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudine Pulicicchio</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah E. Smith</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacy J. Sukoff-Rizzo</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly M. Sullivan</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adedayo Adedoyin</span> - <span class="hlFld-Affiliation affiliation">Drug Safety and Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Huselton</span> - <span class="hlFld-Affiliation affiliation">Drug Safety and Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Warren D. Hirst</span> - <span class="hlFld-Affiliation affiliation">Neuroscience</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the members of the Discovery Analytical Chemistry group for their assistance in the spectroscopic confirmation of the compounds described in this manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i110">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Pedigo, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. I.</span><span> </span><span class="NLM_article-title">Discrimination of multiple [<sup>3</sup>H] 5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1111%2Fj.1471-4159.1981.tb02397.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=7463047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaL3MXnslWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1981&pages=220-226&author=N.+W.+Pedigoauthor=H.+I.+Yamamuraauthor=D.+I.+Nelson&title=Discrimination+of+multiple+%5B3H%5D+5-hydroxytryptamine+binding+sites+by+the+neuroleptic+spiperone+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain</span></div><div class="casAuthors">Pedigo, N. W.; Yamamura, H. I.; Nelson, D. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-6</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Certain neuroleptic drugs, such as spiperone (I)  [749-02-0] and (+)-butaclamol  [56245-67-1] can discriminate between 2 populations of 3H-labeled 5-hydroxytryptamine (II)  [50-67-9] binding sites in rat brain.  I shows the greatest selectivity for these 2 binding sites, having at least a 3000-fold difference between its dissocn. consts. (2-12 nM vs. 35,000 nM) for the high- and low-affinity sites, resp.  Inhibition of II-3H binding by I in rat frontal cortex and corpus striatum yields distinctly biphasic inhibition curves with Hill slopes less than unity.  Results from nonlinear regression anal. of these inhibition studies were consistent with a 2-site model in each brain region.  In the frontal cortex the high-affinity neuroleptic sites comprised about 60% of the total II-3H binding sites whereas in the corpus striatum they accounted for only 20% of the sites.  Satn. studies of II-3H binding assayed in the absence or presence of 1 μM-I (a concn. that completely blocks the high-affinity site while having min. activity at the low-affinity site) reveal a parallel shift in the Scatchard plot with no change in the dissocn. const. of II-3H, but a decrease (64% in frontal cortex or 28% in corpus striatum) in the no. of sp. binding sites.  These observations are consistent with the existence of at least 2 populations of II-3H binding sites having a differential regional distribution in rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOwsKDV8Yk1LVg90H21EOLACvtfcHk0ljcxhE_idygSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXnslWquw%253D%253D&md5=cf0bb418780c102c22ea4a63ad3daa99</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1981.tb02397.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1981.tb02397.x%26sid%3Dliteratum%253Aachs%26aulast%3DPedigo%26aufirst%3DN.%2BW.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DNelson%26aufirst%3DD.%2BI.%26atitle%3DDiscrimination%2520of%2520multiple%2520%255B3H%255D%25205-hydroxytryptamine%2520binding%2520sites%2520by%2520the%2520neuroleptic%2520spiperone%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1981%26volume%3D36%26spage%3D220%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Fargin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">The genomic clone G-21 which ersembles a β-adrenergic reeptor sequence encodes the 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1988&pages=358-360&author=A.+Farginauthor=J.+R.+Raymondauthor=M.+J.+Lohseauthor=B.+K.+Kobilkaauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=The+genomic+clone+G-21+which+ersembles+a+%CE%B2-adrenergic+reeptor+sequence+encodes+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFargin%26aufirst%3DA.%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520genomic%2520clone%2520G-21%2520which%2520ersembles%2520a%2520%25CE%25B2-adrenergic%2520reeptor%2520sequence%2520encodes%2520the%25205-HT1A%2520receptor%26jtitle%3DNature%26date%3D1988%26volume%3D335%26spage%3D358%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">5-HT<sub>1A</sub> receptor, an old target for new therapeutic agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.2174%2F156802608785161385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=18691130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1024-1034&author=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Berardiauthor=R.+Perrone&title=5-HT1A+receptor%2C+an+old+target+for+new+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A receptor, an old target for new therapeutic agents</span></div><div class="casAuthors">Lacivita, Enza; Leopoldo, Marcello; Berardi, Francesco; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1024-1034</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacol. characterized.  Over the last twenty years the 5-HT1A receptor has been the object of intense research efforts as witnessed by the 5-HT1A acting drugs marketed as anxiolytics.  In recent years, several new chem. entities targeting the 5-HT1A receptor (alone or in combination with other mol. targets) have been proposed for novel therapeutic indications (neuroprotection, cognitive impairment, Parkinson Disease and related disorders, pain treatment).  The present review will focus on those 5-HT1A receptor agents that entered preclin. trials starting from 2000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquGiFKFKnqLrVg90H21EOLACvtfcHk0liXxj9fkMFtQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D&md5=cd19fc17c1edcfec3977fffe3920480d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802608785161385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161385%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D5-HT1A%2520receptor%252C%2520an%2520old%2520target%2520for%2520new%2520therapeutic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1024%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">King, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C. F.</span><span> </span><span class="NLM_article-title">A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=482-492&author=M.+V.+Kingauthor=C.+A.+Marsdenauthor=K.+C.+F.+Fone&title=A+role+for+the+5-HT1A%2C+5-HT4+and+5-HT6+receptors+in+learning+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DM.%2BV.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26aulast%3DFone%26aufirst%3DK.%2BC.%2BF.%26atitle%3DA%2520role%2520for%2520the%25205-HT1A%252C%25205-HT4%2520and%25205-HT6%2520receptors%2520in%2520learning%2520and%2520memory%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D482%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ogren, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikkson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elvander-Tottie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekstrom, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiedl, O.</span><span> </span><span class="NLM_article-title">The role of 5-HT<sub>1A</sub> receptors in learning and memory</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=54-77&author=S.+O.+Ogrenauthor=T.+M.+Erikksonauthor=E.+Elvander-Tottieauthor=C.+D%E2%80%99Addarioauthor=J.+C.+Ekstromauthor=P.+Svenningssonauthor=B.+Meisterauthor=J.+Kehrauthor=O.+Stiedl&title=The+role+of+5-HT1A+receptors+in+learning+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgren%26aufirst%3DS.%2BO.%26aulast%3DErikkson%26aufirst%3DT.%2BM.%26aulast%3DElvander-Tottie%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Addario%26aufirst%3DC.%26aulast%3DEkstrom%26aufirst%3DJ.%2BC.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DMeister%26aufirst%3DB.%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DStiedl%26aufirst%3DO.%26atitle%3DThe%2520role%2520of%25205-HT1A%2520receptors%2520in%2520learning%2520and%2520memory%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D195%26spage%3D54%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chalmers, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. J.</span><span> </span><span class="NLM_article-title">Comparative anatomical distribution of 5-HT<sub>1A</sub> messenger-RNA and 5-HT<sub>1A</sub> binding in rat brain—a combined in situ hybridisation in vitro receptor autoradiography study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">561</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0006-8993%2891%2990748-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=1797349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK38XjsV2hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=561&publication_year=1991&pages=51-60&author=D.+T.+Chalmersauthor=S.+J.+Watson&title=Comparative+anatomical+distribution+of+5-HT1A+messenger-RNA+and+5-HT1A+binding+in+rat+brain%E2%80%94a+combined+in+situ+hybridisation+in+vitro+receptor+autoradiography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain.  A combined in situ hybridization/in vitro receptor autoradiographic study</span></div><div class="casAuthors">Chalmers, D. T.; Watson, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">561</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-60</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The present study examd. the comparative distribution of 5-HT1A receptor mRNA and 5-HT1A receptors in rat brain using a combination of in situ hybridization histochem. and in vitro receptor autoradiog.  5-HT1A mRNA was visualized using a 910 bp cRNA probe synthesized from a BalI-PvuII fragment of the rat 5-HT1A receptor gene, whereas 5-HT1A receptors were labeled with the 5-HT1A-selective ligand 8-OH-DPAT.  In general terms, there was a complementary distribution of cells expressing 5-HT1A receptor mRNA and 5-HT1A receptor sites.  High levels of both 5-HT1A mRNA and 5-HT1A receptors were evident in the hippocampal formation (CA1, CA3, dentate gyrus), entorhinal cortex, and raphe nuclei and lower levels in neocortex and thalamus.  Although 5-HT1A mRNA was not expressed in any regions which did not also exhibit 5-HT1A receptors, within both the diagonal band and the medial septal nucleus mRNA levels were proportionately higher than 5-HT1A receptor levels, possibly reflecting receptor transport or a heterogeneity in 5-HT1A receptor turnover mechanisms.  The 5-HT1A receptor mRNA and 5-HT1A binding sites were undetectable in caudate/putamen and cerebellar regions.  Data support the synthesis of 5-HT1A receptors both in raphe serotonergic cells and anatomically specific serotoninergic projection areas, further supporting both a presynaptic autoregulatory and postsynaptic modulatory role for this receptor in serotonergic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIGWkgARuw3LVg90H21EOLACvtfcHk0liXxj9fkMFtQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XjsV2hsg%253D%253D&md5=ff983aee9366f5e5709ac7037c053a2e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990748-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990748-K%26sid%3Dliteratum%253Aachs%26aulast%3DChalmers%26aufirst%3DD.%2BT.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26atitle%3DComparative%2520anatomical%2520distribution%2520of%25205-HT1A%2520messenger-RNA%2520and%25205-HT1A%2520binding%2520in%2520rat%2520brain%25E2%2580%2594a%2520combined%2520in%2520situ%2520hybridisation%2520in%2520vitro%2520receptor%2520autoradiography%2520study%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D561%26spage%3D51%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feingold, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (<i>R</i>)-(2-methyl)-(4-indolyl-1-piperazinyl)ethyl)-<i>N</i>-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1124%2Fjpet.107.133082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=18182558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=134-145&author=W.+D.+Hirstauthor=T.+H.+Andreeauthor=S.+Aschmiesauthor=W.+E.+Childersauthor=T.+A.+Comeryauthor=L.+A.+Dawsonauthor=M.+Dayauthor=I.+B.+Feingoldauthor=S.+M.+Grauerauthor=B.+L.+Harrisonauthor=Z.+A.+Hughesauthor=J.+Kaoauthor=M.+G.+Kellyauthor=H.+van+der+Leeauthor=S.+Rosenzweig-Lipsonauthor=A.+L.+Saabauthor=D.+L.+Smithauthor=K.+Sullivanauthor=S.+J.+Sukoff-Rizzoauthor=C.+Tioauthor=M.-Y.+Zhangauthor=L.+E.+Schechter&title=Correlating+efficacy+in+rodent+cognition+models+with+in+vivo+5-hydroxytryptamine1A+receptor+occupancy+by+a+novel+antagonist%2C+%28R%29-%282-methyl%29-%284-indolyl-1-piperazinyl%29ethyl%29-N-%282-pyridinyl%29-cyclohexane+carboxamide+%28WAY-101405%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span></div><div class="casAuthors">Hirst, Warren D.; Andree, Terrance H.; Aschmies, Suzan; Childers, Wayne E.; Comery, Thomas A.; Dawson, Lee A.; Day, Mark; Feingold, Irene B.; Grauer, Steven M.; Harrison, Boyd L.; Hughes, Zoe A.; Kao, John; Kelly, Michael G.; van der Lee, Heidi; Rosenzweig-Lipson, Sharon; Saab, Annmarie L.; Smith, Deborah L.; Sullivan, Kelly; Rizzo, Stacey J. Sukoff; Tio, Cesario; Zhang, Mei-Yi; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-145</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)1A receptors play an important role in multiple cognitive processes, and compelling evidence suggests that 5-HT1A antagonists can reverse cognitive impairment.  We have examd. the therapeutic potential of a potent (Ki = 1.1 nM), selective (>100-fold), orally bioavailable, silent 5-HT1A receptor antagonist (KB = 1.3 nM) (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)-ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).  Oral administration of WAY-101405 was shown to be effective in multiple rodent models of learning and memory.  In a novel object recognition paradigm, 1 mg/kg enhanced retention (memory) for previously learned information, and it was able to reverse the memory deficits induced by scopolamine.  WAY-101405 (1 mg/kg) was also able to reverse scopolamine-induced deficits in a rat contextual fear conditioning model.  In the Morris water maze, WAY-101405 (3 mg/kg) significantly improved learning in a paradigm of increasing task difficulty.  In vivo microdialysis studies in the dorsal hippocampus of freely moving adult rats demonstrated that acute administration of WAY-101405 (10 mg/kg) increased extracellular acetylcholine levels.  The selective radioligand [3H]WAY-100635, administered i.v., was used for in vivo receptor occupancy studies, where WAY-101405 occupied 50HT1A receptors in the rat cortex, with an ED50 value of 0.1 mg/kg p.o.  Taken together, these studies demonstrate that WAY-101405 is a potent and selective, brain penetrant, orally bioavailable 5-HT1A receptor "silent" antagonist that is effective in preclin. memory paradigms at doses where approx. 90% of the postsynaptic 5-HT1A receptors are occupied.  These results further support the rationale for use of this compd. class in the treatment of cognitive dysfunction assocd. with psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHA4lNdFCubVg90H21EOLACvtfcHk0lhs0PQQ9jsgMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D&md5=32bf330b68ae1b11a2013e4563b8f686</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133082%26sid%3Dliteratum%253Aachs%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DFeingold%26aufirst%3DI.%2BB.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3Dvan%2Bder%2BLee%26aufirst%3DH.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSaab%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DTio%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DM.-Y.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DCorrelating%2520efficacy%2520in%2520rodent%2520cognition%2520models%2520with%2520in%2520vivo%25205-hydroxytryptamine1A%2520receptor%2520occupancy%2520by%2520a%2520novel%2520antagonist%252C%2520%2528R%2529-%25282-methyl%2529-%25284-indolyl-1-piperazinyl%2529ethyl%2529-N-%25282-pyridinyl%2529-cyclohexane%2520carboxamide%2520%2528WAY-101405%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D134%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsolt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocaer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dekeyne, A.</span><span> </span><span class="NLM_article-title">The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive runction in rodents: a combined neurochemical and behavioral analysis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1124%2Fjpet.104.069625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=15146031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVKrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=190-203&author=M.+J.+Millanauthor=A.+Gobertauthor=S.+Rouxauthor=R.+Porsoltauthor=A.+Menesesauthor=M.+Carliauthor=B.+Di+Caraauthor=R.+Jaffardauthor=J.-M.+Rivetauthor=P.+Lestageauthor=E.+Mocaerauthor=J.-L.+Peglionauthor=A.+dekeyne&title=The+serotonin1A+receptor+partial+agonist+S15535+%5B4-%28benzodioxan-5-yl%29-1-%28indan-2-yl%29piperazine%5D+enhances+cholinergic+transmission+and+cognitive+runction+in+rodents%3A+a+combined+neurochemical+and+behavioral+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: A combined neurochemical and behavioral analysis</span></div><div class="casAuthors">Millan, Mark J.; Gobert, Alain; Roux, Sylvain; Porsolt, Roger; Meneses, Alfredo; Carli, Mirjana; di Cara, Benjamin; Jaffard, Robert; Rivet, Jean-Michel; Lestage, Pierre; Mocaer, Elisabeth; Peglion, Jean-Louis; Dekeyne, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-203</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">These studies examd. the influence of the selective 5-hydroxytryptamine (serotonin) (5-HT)1A receptor partial agonist S15535 upon cholinergic transmission and cognitive function in rodents.  In the absence of acetylcholinesterase inhibitors, S15535 dose-dependently (0.04-5.0 mg/kg s.c.) elevated dialysis levels of acetylcholine in the frontal cortex and dorsal hippocampus of freely moving rats.  In the cortex, the selective 5-HT1A receptor antagonist WAY100,635 [(N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)cyclohexanecarboxamide) fumarate] dose-dependently (0.0025-0.63) blocked this action of S15535.  By contrast, in dorsal hippocampus, WAY100,635 mimicked the induction of acetylcholine release by S15535.  In a social recognition paradigm, S15535 dose-dependently (0.16-10.0) improved retention, an action blocked by WAY100,635 (0.16), which was ineffective alone.  Furthermore, S15535 dose-dependently (0.04-2.5) and WAY100,635 reversibly abolished amnesic properties of the muscarinic antagonist scopolamine (0.63) in this procedure.  Cognitive deficits provoked by scopolamine in autoshaping and Morris water-maze procedures were likewise blocked by S15535 at doses of 0.63 to 10.0 and 0.16 to 2.5, resp.  In a two-platform spatial discrimination task, in which S15535 similarly abrogates cognitive deficits elicited by scopolamine, injection of S15535 (1.0 and 10.0 μg) into dorsal hippocampus blocked amnesic effects of the 5-HT1A agonist 8-hydroxy-2-dipropylaminotetralin (0.5 μg).  Finally, S15535 (0.16-0.63) improved performance in a spatial, delayed nonmatching to sample model in mice, and in an operant delayed nonmatching to sample model in old rats, S15535 (1.25-5.0 mg/kg p.o.) increased response accuracy and reduced latency to respond.  In conclusion, S15535 reinforces frontocortical and hippocampal release of acetylcholine and displays a broad-based pattern of procognitive properties.  Its actions involve both blockade of postsynaptic 5-HT1A receptors and engagement of 5-HT1A autoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUnJVBszUICbVg90H21EOLACvtfcHk0lhs0PQQ9jsgMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVKrt7w%253D&md5=12bc1e3f88cfc729532b4eecb41e61fe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.069625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.069625%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DRoux%26aufirst%3DS.%26aulast%3DPorsolt%26aufirst%3DR.%26aulast%3DMeneses%26aufirst%3DA.%26aulast%3DCarli%26aufirst%3DM.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DJaffard%26aufirst%3DR.%26aulast%3DRivet%26aufirst%3DJ.-M.%26aulast%3DLestage%26aufirst%3DP.%26aulast%3DMocaer%26aufirst%3DE.%26aulast%3DPeglion%26aufirst%3DJ.-L.%26aulast%3Ddekeyne%26aufirst%3DA.%26atitle%3DThe%2520serotonin1A%2520receptor%2520partial%2520agonist%2520S15535%2520%255B4-%2528benzodioxan-5-yl%2529-1-%2528indan-2-yl%2529piperazine%255D%2520enhances%2520cholinergic%2520transmission%2520and%2520cognitive%2520runction%2520in%2520rodents%253A%2520a%2520combined%2520neurochemical%2520and%2520behavioral%2520analysis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D190%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawoschik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W.</span><span> </span><span class="NLM_article-title">Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1124%2Fjpet.105.086363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=15951399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1274-1289&author=L.+E.+Schechterauthor=D.+L.+Smithauthor=S.+Rosenzweig-Lipsonauthor=S.+J.+Sukoffauthor=L.+A.+Dawsonauthor=K.+Marquisauthor=D.+Jonesauthor=M.+Pieslaauthor=T.+Andreeauthor=S.+Nawoschikauthor=J.+A.+Harderauthor=M.+D.+Womackauthor=J.+Buccafuscoauthor=A.+V.+Terryauthor=B.+Hoebelauthor=P.+Radaauthor=M.+Kellyauthor=M.+Abou-Gharbiaauthor=J.+E.+Barrettauthor=W.+Childers&title=Lecozotan+%28SRA-333%29%3A+a+selective+serotonin+1A+receptor+antagonist+that+enhances+the+stimulated+release+of+glutamate+and+acetylcholine+in+the+hippocampus+and+possesses+cognitive-enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lecozotan (SRA-333): A selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span></div><div class="casAuthors">Schechter, L. E.; Smith, D. L.; Rosenzweig-Lipson, S.; Sukoff, S. J.; Dawson, L. A.; Marquis, K.; Jones, D.; Piesla, M.; Andree, T.; Nawoschik, S.; Harder, J. A.; Womack, M. D.; Buccafusco, J.; Terry, A. V.; Hoebel, B.; Rada, P.; Kelly, M.; Abou-Gharbia, M.; Barrett, J. E.; Childers, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1274-1289</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent data has suggested that the 5-hydroxytryptamine (5-HT)1A receptor is involved in cognitive processing.  A novel 5-HT1A receptor antagonist, 4-cyano-N-{2R-[4-(2,3-dihydrobenzo[1,4]-dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide HCl (lecozotan), which has been characterized in multiple in vitro and in vivo pharmacol. assays as a drug to treat cognitive dysfunction, is reported.  In vitro binding and intrinsic activity detns. demonstrated that lecozotan is a potent and selective 5-HT1A receptor antagonist.  Using in vivo microdialysis, lecozotan (0.3 mg/kg s.c.) antagonized the decrease in hippocampal extracellular 5-HT induced by a challenge dose (0.3 mg/kg s.c.) of 8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) and had no effects alone at doses 10-fold higher.  Lecozotan significantly potentiated the potassium chloride-stimulated release of glutamate and acetylcholine in the dentate gyrus of the hippocampus.  Chronic administration of lecozotan did not induce 5-HT1A receptor tolerance or desensitization in a behavioral model indicative of 5-HT1A receptor function.  In drug discrimination studies, lecozotan (0.01-1 mg/kg i.m.) did not substitute for 8-OH-DPAT and produced a dose-related blockade of the 5-HT1A agonist discriminative stimulus cue.  In aged rhesus monkeys, lecozotan produced a significant improvement in task performance efficiency at an optimal dose (1 mg/kg p.o.).  Learning deficits induced by the glutamatergic antagonist MK-801 [(-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate] (assessed by perceptually complex and visual spatial discrimination) and by specific cholinergic lesions of the hippocampus (assessed by visual spatial discrimination) were reversed by lecozotan (2 mg/kg i.m.) in marmosets.  The heterosynaptic nature of the effects of lecozotan imbues this compd. with a novel mechanism of action directed at the biochem. pathologies underlying cognitive loss in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDog5bWsysrLVg90H21EOLACvtfcHk0ljCLCA3-1mKBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D&md5=4d07a0db6675ddc2238dcca19a4c68b7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.086363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.086363%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DPiesla%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DNawoschik%26aufirst%3DS.%26aulast%3DHarder%26aufirst%3DJ.%2BA.%26aulast%3DWomack%26aufirst%3DM.%2BD.%26aulast%3DBuccafusco%26aufirst%3DJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DHoebel%26aufirst%3DB.%26aulast%3DRada%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DChilders%26aufirst%3DW.%26atitle%3DLecozotan%2520%2528SRA-333%2529%253A%2520a%2520selective%2520serotonin%25201A%2520receptor%2520antagonist%2520that%2520enhances%2520the%2520stimulated%2520release%2520of%2520glutamate%2520and%2520acetylcholine%2520in%2520the%2520hippocampus%2520and%2520possesses%2520cognitive-enhancing%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1274%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Katz, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekell, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bewden, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berm;an, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraer, A.</span><span> </span><span class="NLM_article-title">Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=566-579&author=M.+M.+Katzauthor=J.+L.+Tekellauthor=C.+L.+Bewdenauthor=S.+Brannaauthor=J.+P.+Houstonauthor=N.+Berm%3Banauthor=A.+Fraer&title=Onset+and+early+behavioral+effects+of+pharmacologically+different+antidepressants+and+placebo+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DM.%2BM.%26aulast%3DTekell%26aufirst%3DJ.%2BL.%26aulast%3DBewden%26aufirst%3DC.%2BL.%26aulast%3DBranna%26aufirst%3DS.%26aulast%3DHouston%26aufirst%3DJ.%2BP.%26aulast%3DBerm%253Ban%26aufirst%3DN.%26aulast%3DFraer%26aufirst%3DA.%26atitle%3DOnset%2520and%2520early%2520behavioral%2520effects%2520of%2520pharmacologically%2520different%2520antidepressants%2520and%2520placebo%2520in%2520depression%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D566%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Clayton, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradko, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montano, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadbetter, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolden-Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, R. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamerson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, A.</span><span> </span><span class="NLM_article-title">Prevalence of sexual dysfunction among newer antidepressants</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.4088%2FJCP.v63n0414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=12000211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A280%3ADC%252BD383lvFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=357-366&author=A.+H.+Claytonauthor=J.+F.+Pradkoauthor=J.+A.+Croftauthor=C.+B.+Montanoauthor=R.+A.+Leadbetterauthor=C.+Bolden-Watsonauthor=K.+I.+Bassauthor=R.+M.+J.+Donahueauthor=B.+D.+Jamersonauthor=A.+Metz&title=Prevalence+of+sexual+dysfunction+among+newer+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of sexual dysfunction among newer antidepressants</span></div><div class="casAuthors">Clayton Anita H; Pradko James F; Croft Harry A; Montano C Brendan; Leadbetter Robert A; Bolden-Watson Carolyn; Bass Kristin I; Donahue Rafe M J; Jamerson Brenda D; Metz Alan</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-66</span>
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    </div><div class="casAbstract">BACKGROUND:  Sexual dysfunction commonly occurs during antidepressant treatment.  However, the reported rates of sexual dysfunction vary across antidepressants and are typically underreported in product literature.  The objectives of this study were (1) to estimate the prevalence of sexual dysfunction among patients taking newer antidepressants (bupropion immediate release [IR], bupropion sustained release [SR], citalopram, fluoxetine, mirtazapine, nefazodone, paroxetine, sertraline, venlafaxine, and venlafaxine extended release [XR]) and (2) to compare physician-perceived with patient-reported prevalence rates of antidepressant-associated sexual dysfunction.  METHOD:  This cross-sectional, observational study was conducted in 1101 U.S. primary care clinics.  Adult outpatients (4534 women and 1763 men) receiving antidepressant monotherapy were enrolled.  The prevalence of sexual dysfunction was measured using the Changes in Sexual Functioning Questionnaire.  RESULTS:  In the overall population, bupropion IR (22%) and SR (25%) and nefazodone (28%) were associated with the lowest risk for sexual dysfunction, whereas selective serotonin reuptake inhibitor (SSRI) antidepressants, mirtazapine, and venlafaxine XR were associated with higher rates (36%-43%).  In a prospectively defined subpopulation unlikely to have predisposing factors for sexual dysfunction, the prevalence of sexual dysfunction ranged from 7% to 30%, with the odds of having sexual dysfunction 4 to 6 times greater with SSRIs or venlafaxine XR than with bupropion SR.  Physicians consistently underestimated the prevalence of antidepressant-associated sexual dysfunction.  CONCLUSION:  Ours is the first study to assess sexual dysfunction across the newer antidepressants using consistent methodology and a validated rating scale.  Overall, SSRIs and venlafaxine XR were associated with higher rates of sexual dysfunction than bupropion or nefazodone.  Because antidepressant-associated sexual dysfunction is considerably underestimated by physicians, greater recognition and education are imperative when prescribing antidepressant treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrVP0myb4HJpggzHGM8X5CfW6udTcc2eZsq0Dbx2zATbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383lvFKqtg%253D%253D&md5=02f295669a372600125d61121b1ce7c6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4088%2FJCP.v63n0414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v63n0414%26sid%3Dliteratum%253Aachs%26aulast%3DClayton%26aufirst%3DA.%2BH.%26aulast%3DPradko%26aufirst%3DJ.%2BF.%26aulast%3DCroft%26aufirst%3DJ.%2BA.%26aulast%3DMontano%26aufirst%3DC.%2BB.%26aulast%3DLeadbetter%26aufirst%3DR.%2BA.%26aulast%3DBolden-Watson%26aufirst%3DC.%26aulast%3DBass%26aufirst%3DK.%2BI.%26aulast%3DDonahue%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DJamerson%26aufirst%3DB.%2BD.%26aulast%3DMetz%26aufirst%3DA.%26atitle%3DPrevalence%2520of%2520sexual%2520dysfunction%2520among%2520newer%2520antidepressants%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2002%26volume%3D63%26spage%3D357%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kreiss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Effects of acute and repreated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo</span> <span class="citation_source-journal">J. Pharamcol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=7636750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFSjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=866-876&author=D.+S.+Kreissauthor=I.+Lucki&title=Effects+of+acute+and+repreated+administration+of+antidepressant+drugs+on+extracellular+levels+of+5-hydroxytryptamine+measured+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo</span></div><div class="casAuthors">Kreiss, Deborah S.; Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">866-76</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Extracellular levels of serotonin (5-HT) and the regulation of 5-HT release by the 5-HT1A receptor were examd. after single and repeated treatment with different types of antidepressant drugs: the selective 5-HT uptake inhibitor fluoxetine, the selective norepinephrine uptake inhibitor desipramine and the 5-HT1A/2C/A2 receptor antagonist mianserin (each at 15.0 mg/kg).  Extracellular levels of 5-HT were measured using in vivo microdialysis in the striatum and hippocampus of rats anesthetized with chloral hydrate.  Acute administration of fluoxetine transiently elevated the levels of 5-HT in the striatum and hippocampus; desipramine did not change 5-HT levels, and mianserin slightly decreased 5-HT levels in the hippocampus.  Rats were administered these antidepressant drugs for either 1 or 14 days and studied 48 h after the final injection.  Repeated treatment with fluoxetine increased base-line levels of 5-HT in the striatum and hippocampus; repeated treatment with desipramine increased base-line 5-HT levels in the striatum only, and repeated treatment with mianserin did not alter base-line 5-HT levels.  Repeated fluoxetine treatment attenuated the ability of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) to decrease 5-HT release in both the striatum and hippocampus.  Repeated desipramine treatment did not significantly alter the effects of 8-OH-DPAT on 5-HT release, but there was a hint of a decreased effect in the hippocampus.  Repeated mianserin treatment did not significantly alter the effects of 8-OH-DPAT on 5-HT release, but there was a hint of an increased effect in the striatum.  The results of the present study suggest that repeated treatment with antidepressant drugs alters extracellular levels of 5-HT and the ability of 5-HT1A receptors to regulate the release of 5-HT in a regionally selective manner.  These changes in the regulation of 5-HT release produced by antidepressant drugs may be assocd. with their therapeutic effects, because they are caused by repeated rather than acute treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Vbur4PgdCrVg90H21EOLACvtfcHk0lj1sMfTs3_fFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFSjtLw%253D&md5=b568a4aa72d53fe94acd061f1db7c5e3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreiss%26aufirst%3DD.%2BS.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DEffects%2520of%2520acute%2520and%2520repreated%2520administration%2520of%2520antidepressant%2520drugs%2520on%2520extracellular%2520levels%2520of%25205-hydroxytryptamine%2520measured%2520in%2520vivo%26jtitle%3DJ.%2520Pharamcol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D274%26spage%3D866%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R. J.</span><span> </span><span class="NLM_article-title">The use of pindolol to potentiate antidepressant medication</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=9635544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=16-23&issue=Suppl.+5&author=P.+Blierauthor=R.+J.+Bergeron&title=The+use+of+pindolol+to+potentiate+antidepressant+medication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The use of pindolol to potentiate antidepressant medication</span></div><div class="casAuthors">Blier, Pierre; Bergeron, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">Suppl..5</span>),
    <span class="NLM_cas:pages">16-25</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press</span>)
        </div><div class="casAbstract">A review with 32 refs. followed by a discussion.  Serotonin (5-HT) selective reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors are thought to have a delayed onset of antidepressant action attributable in part to the decrease in firing activity of 5-HT neurons they produce upon treatment initiation.  As cell body 5-HT1A autoreceptors desensitize, 5-HT neuronal firing is restored.  The agent pindolol, through its 5-HT1A receptor blocking property, has been shown to prevent the initial decrease in firing of rat 5-HT neurons assocd. with SSRI treatment.  Four open-label studies put into evidence a significant acceleration of the antidepressant effect of SSRIs when combined with pindolol.  Four of five placebo-controlled studies have confirmed this observation.  Controlled trials indicate that a greater rate of response may be obtained by combining pindolol from the beginning of the SSRI treatment.  The strategy of adding pindolol to the regimen of SSRI-resistant patients also appears to produce a therapeutic effect in a significant proportion of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz0q4Q6ACnhrVg90H21EOLACvtfcHk0lj1sMfTs3_fFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D&md5=a2d5fa78635c0e4427bd9c6fd6039271</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520use%2520of%2520pindolol%2520to%2520potentiate%2520antidepressant%2520medication%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1998%26volume%3D59%26issue%3DSuppl.%25205%26spage%3D16%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gartside, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, T.</span><span> </span><span class="NLM_article-title">Effects of (−) tertatolol, 9−0-penbutolol and (±) pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1038%2Fsj.bjp.0702546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=10369467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1999&pages=145-152&author=S.+E.+Gartsideauthor=E.+M.+Cliffordauthor=P.+J.+Cowenauthor=T.+Sharp&title=Effects+of+%28%E2%88%92%29+tertatolol%2C+9%E2%88%920-penbutolol+and+%28%C2%B1%29+pindolol+in+combination+with+paroxetine+on+presynaptic+5-HT+function%3A+an+in+vivo+microdialysis+and+electrophysiological+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study</span></div><div class="casAuthors">Gartside, S. E.; Clifford, E. M.; Cowen, P. J.; Sharp, T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">1 The antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) might be enhanced by co-administration of 5-HT1A receptor antagonists.  Thus, we have recently shown that the selective 5-HT1A receptor antagonist, WAY 100635, blocks the inhibitory effect of an SSRI on 5-HT cell firing, and enhances its ability to elevate extracellular 5-HT in the forebrain.  Here we detd. whether the β-adrenoceptor/5-HT1A receptor ligands (±)-pindolol, (-)-tertatolol and (-)-penbutolol, interact with paroxetine in a similar manner.  2 Both (-)-tertatolol (2.4 mg kg-1 i.v.) and (-)-penbutolol (2.4 mg kg-1 i.v.) enhanced the effect of paroxetine (0.8 mg kg-1 i.v.) on extracellular 5-HT in the frontal cortex, while (±)-pindolol (4 mg kg-1 i.v.) did not.  (-)-Tertatolol (2.4 mg kg-1 i.v.) alone caused a slight increase in 5-HT however, (-)-penbutolol (2.4 mg kg-1 i.v.) alone had no effect.  3 In electrophysiol. studies (-)-tetratolol (2.4 mg kg-1 i.v.) alone had no effect on 5-HT cell firing but blocked the inhibitory effect of paroxetine.  In contrast, (-)-penbutolol (0.1-0.8 mg kg-1 i.v.) itself inhibited 5-HT cell firing, and this effect was reversed by WAY 100635 (0.1 mg kg-1 i.v.).  We have recently shown that (±)-pindolol inhibits 5-HT cell firing via a WAY 100635-sensitive mechanism.  4 Our data suggest that (-)-tertatolol enhances the effect of paroxetine on forebrain 5-HT via blockade of 5-HT1A autoreceptors which mediate paroxetine-induced inhibition of 5-HT cell firing.  In comparison, the mechanisms by which (-)-penbutolol enhances the effect of paroxetine on extracellular 5-HT in unclear, since (-)-penbutolol itself appears to have agonist properties at the 5-HT1A autoreceptor.  Indeed, the agonist action of (±)-pindolol at 5-HT1A autoreceptors probably explains its inability to enhance the effect of paroxetine on 5-HT in the frontal cortex.  5 Overall, our data suggest that both (-)-tertatolol and (-)-penbutolol are superior to (±)-pindolol in terms of enhancing the effect of an SSRI on extracellular 5-HT.  Both (-)-tertatolol and (-)-penbutolol are worthy of investigation for use as adjuncts to SSRIs in the treatment of major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPl7th6PbxrVg90H21EOLACvtfcHk0lj1sMfTs3_fFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVGltrg%253D&md5=6b7d35ad8da449c499ff3e8c5d5ac6dd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702546%26sid%3Dliteratum%253Aachs%26aulast%3DGartside%26aufirst%3DS.%2BE.%26aulast%3DClifford%26aufirst%3DE.%2BM.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DEffects%2520of%2520%2528%25E2%2588%2592%2529%2520tertatolol%252C%25209%25E2%2588%25920-penbutolol%2520and%2520%2528%25C2%25B1%2529%2520pindolol%2520in%2520combination%2520with%2520paroxetine%2520on%2520presynaptic%25205-HT%2520function%253A%2520an%2520in%2520vivo%2520microdialysis%2520and%2520electrophysiological%2520study%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D127%26spage%3D145%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">A novel approach for predicting antidepressant-induced sexual dysfunction in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=459-467&author=S.+J.+Sukoff-Rizzoauthor=L.+E.+Schechterauthor=S.+Rosenzweig-Lipson&title=A+novel+approach+for+predicting+antidepressant-induced+sexual+dysfunction+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DA%2520novel%2520approach%2520for%2520predicting%2520antidepressant-induced%2520sexual%2520dysfunction%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D195%26spage%3D459%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Childers, W. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Lecozotan Hydrochloride</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1358%2Fdof.2007.032.05.1092901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=399-407&author=W.+E.+J.+Childersauthor=B.+L.+Harrisonauthor=M.+A.+Abou-Gharbiaauthor=S.+Rajeauthor=V.+Parksauthor=M.+N.+Pangalosauthor=L.+E.+Schechter&title=Lecozotan+Hydrochloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cognition enhancer treatment of Alzheimer's disease competitive 5-HT1A receptor antagonist</span></div><div class="casAuthors">Childers, Wayne E., Jr.; Harrison, Boyd L.; Abou-Gharbia, Magid A.; Raje, Sangeeta; Parks, Virginia; Pangalos, Menelas N.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Lecozotan is a potent, selective, competitive, orally active antagonist of the serotonin 5-HT1A receptor in development for the symptomatic treatment of cognitive deficits such as those seen in Alzheimer's disease.  The agent shows no intrinsic activity in a no. of in vitro and in vivo assays, supporting the conclusion that it is a full antagonist under several conditions.  In vivo, lecozotan enhances the potassium-stimulated release of both acetylcholine and glutamate, and it improves cognitive performance in multiple animal models of learning and memory.  The compd. was well tolerated in single- and multiple-ascending-dose (SAD and MAD) safety trials in both young and elderly subjects at total daily doses up to and including 10 mg (5 mg every 12 h) for the immediate-release formulation.  Sustained-release formulations have been developed which provide favorable pharmacokinetics for once-daily dosing.  Lecozotan is currently under investigation in advanced phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzPkCOymtxrVg90H21EOLACvtfcHk0lg5IQhOueLx-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D&md5=5149bb9b594cbc636ef22b9e7f57f10c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1358%2Fdof.2007.032.05.1092901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2007.032.05.1092901%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%2BJ.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DRaje%26aufirst%3DS.%26aulast%3DParks%26aufirst%3DV.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DLecozotan%2520Hydrochloride%26jtitle%3DDrugs%2520Future%26date%3D2007%26volume%3D32%26spage%3D399%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boast, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucharik, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of adatanserin: novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potent anxiolytic and antidepresant agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5077</span><span class="NLM_x">–</span> <span class="NLM_lpage">5094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9806704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5077-5094&author=M.+A.+Abou-Gharbiaauthor=W.+E.+Childersauthor=H.+Fletcherauthor=G.+McGaugheyauthor=U.+Patelauthor=M.+B.+Webbauthor=J.+Yardleyauthor=T.+Andreeauthor=C.+Boastauthor=R.+J.+Kucharikauthor=K.+Marquisauthor=H.+Morrisauthor=R.+Scerniauthor=J.+A.+Moyer&title=Synthesis+and+SAR+of+adatanserin%3A+novel+adamantyl+aryl-+and+heteroarylpiperazines+with+dual+serotonin+5-HT1A+and+5-HT2+activity+as+potent+anxiolytic+and+antidepresant+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9806704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9806704%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%2BB.%26aulast%3DYardley%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DBoast%26aufirst%3DC.%26aulast%3DKucharik%26aufirst%3DR.%2BJ.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DMorris%26aufirst%3DH.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520adatanserin%253A%2520novel%2520adamantyl%2520aryl-%2520and%2520heteroarylpiperazines%2520with%2520dual%2520serotonin%25205-HT1A%2520and%25205-HT2%2520activity%2520as%2520potent%2520anxiolytic%2520and%2520antidepresant%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5077%26epage%3D5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yocca, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyslop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maayani, S.</span><span> </span><span class="NLM_article-title">BMY 7378, a buspirone analog with hgih affinity, selectivity and low intrinsic activity at the 5-HT<sub>1A</sub> receptor in rat and guinea pig hippocampal membranes</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0014-2999%2887%2990241-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=2886356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaL2sXkvV2ktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1987&pages=293-294&author=F.+D.+Yoccaauthor=D.+K.+Hyslopauthor=D.+W.+Smithauthor=S.+Maayani&title=BMY+7378%2C+a+buspirone+analog+with+hgih+affinity%2C+selectivity+and+low+intrinsic+activity+at+the+5-HT1A+receptor+in+rat+and+guinea+pig+hippocampal+membranes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes</span></div><div class="casAuthors">Yocca, Frank D.; Hyslop, Deborah K.; Smith, David W.; Maayani, Saul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">293-4</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The buspirone analog BMY7378 (I) had a high affinity and selectivity for 5-HT1A binding sites in rat and guinea pig hippocampal membrane prepns.  The drug also had low intrinsic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8uDz1JHp-TrVg90H21EOLACvtfcHk0lguC45LTajj4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkvV2ktrg%253D&md5=8fbc365835446dea2348883e5e252aa3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2887%2990241-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252887%252990241-X%26sid%3Dliteratum%253Aachs%26aulast%3DYocca%26aufirst%3DF.%2BD.%26aulast%3DHyslop%26aufirst%3DD.%2BK.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DMaayani%26aufirst%3DS.%26atitle%3DBMY%25207378%252C%2520a%2520buspirone%2520analog%2520with%2520hgih%2520affinity%252C%2520selectivity%2520and%2520low%2520intrinsic%2520activity%2520at%2520the%25205-HT1A%2520receptor%2520in%2520rat%2520and%2520guinea%2520pig%2520hippocampal%2520membranes%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1987%26volume%3D137%26spage%3D293%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Butler, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meegan, M. J.</span><span> </span><span class="NLM_article-title">Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1737</span><span class="NLM_x">–</span> <span class="NLM_lpage">1761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.2174%2F092986708784872357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=18673223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1aqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1737-1761&author=S.+G.+Butlerauthor=M.+J.+Meegan&title=Recent+developments+in+the+design+of+anti-depressive+therapies%3A+targeting+the+serotonin+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter</span></div><div class="casAuthors">Butler, S. G.; Meegan, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1737-1761</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin transporter protein (SERT) has been the target for the development of several modern antidepressants with an objective of achieving selectivity over other monoamine transporters, thereby minimizing side effects obsd. in the older generation of tricyclic antidepressants.  The clin. selective serotonin reuptake inhibitors (SSRIs) have been shown to be among the most effective therapies in the treatment of depression.  However they have clin. disadvantages over other classes of antidepressant drugs such as slow onset of action nausea and sleep disruption.  The neg. feedback loop attributed to the presynaptic 5-HT1A receptors has been implicated in the "time lag" obsd. in many patients between the administration of the SSRI and its obsd. therapeutic action.  In recent years the focus has been on developing compds. with dual affinity for serotonergic auto-receptors along with an inhibitory activity at SERT.  These structurally diverse products promise to be the next generation of anti-depressant medicines.  This review presents an anal. of the recently reported structural classes with SSRI activity and rationalizes the unique relationship between their mol. properties and biol. activities.  Specific emphasis is placed on the development of mol. structures with dual serotonergic activity.  Recent advances in the design and synthesis of single mol. entities possessing 5-HT reuptake inhibition together with 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, DAT, NET, α2-adrenoceptor and acetylcholinesterase antagonism are reviewed.  The structural studies to identify proposed SERT binding sites together with the role of structure and ligand based design in the development of more effective SSRIs are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa7goytgkEtbVg90H21EOLACvtfcHk0lj9bWK8d1vapg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1aqs7g%253D&md5=52c784e6665b0cd7e0cd4f055259804f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F092986708784872357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784872357%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DS.%2BG.%26aulast%3DMeegan%26aufirst%3DM.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520the%2520design%2520of%2520anti-depressive%2520therapies%253A%2520targeting%2520the%2520serotonin%2520transporter%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D1737%26epage%3D1761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hatzenbuhler, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Failli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenecek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlenov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golembieski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Advanced toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6980</span><span class="NLM_x">–</span> <span class="NLM_lpage">7004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8007097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6980-7004&author=N.+T.+Hatzenbuhlerauthor=R.+Baudyauthor=D.+A.+Evrardauthor=A.+Failliauthor=B.+L.+Harrisonauthor=S.+Lenecekauthor=R.+E.+Mewshawauthor=A.+Saabauthor=U.+Shahauthor=J.+Szeauthor=M.+Zhangauthor=D.+Zhouauthor=M.+Chlenovauthor=M.+Kagenauthor=J.+Golembieskiauthor=G.+Hornbyauthor=M.+Laiauthor=D.+L.+Smithauthor=K.+M.+Sullivanauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=Advanced+toward+new+antidepressants+with+dual+serotonin+transporter+and+5-HT1A+receptor+affinity+within+a+class+of+3-aminochroman+derivatives.+Part+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm8007097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007097%26sid%3Dliteratum%253Aachs%26aulast%3DHatzenbuhler%26aufirst%3DN.%2BT.%26aulast%3DBaudy%26aufirst%3DR.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DFailli%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DLenecek%26aufirst%3DS.%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DSaab%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DU.%26aulast%3DSze%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DKagen%26aufirst%3DM.%26aulast%3DGolembieski%26aufirst%3DJ.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DAdvanced%2520toward%2520new%2520antidepressants%2520with%2520dual%2520serotonin%2520transporter%2520and%25205-HT1A%2520receptor%2520affinity%2520within%2520a%2520class%2520of%25203-aminochroman%2520derivatives.%2520Part%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6980%26epage%3D7004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hatzenbuhler, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraml, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4785</span><span class="NLM_x">–</span> <span class="NLM_lpage">4789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060218h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4785-4789&author=N.+T.+Hatzenbuhlerauthor=D.+A.+Evrardauthor=B.+L.+Harrisonauthor=D.+Hurynauthor=J.+Ingramauthor=C.+Kramlauthor=J.+F.+Matterauthor=R.+E.+Mewshawauthor=D.+Zhouauthor=G.+Hornbyauthor=Q.+Linauthor=D.+L.+Smithauthor=K.+M.+Sullivanauthor=L.+E.+Schechterauthor=T.+A.+Andree&title=Synthesis+and+biological+evaluation+of+novel+compounds+within+a+class+of+3-aminochroman+derivatives+with+dual+5-HT1A+receptor+and+serotonin+transporter+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm060218h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060218h%26sid%3Dliteratum%253Aachs%26aulast%3DHatzenbuhler%26aufirst%3DN.%2BT.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DIngram%26aufirst%3DJ.%26aulast%3DKraml%26aufirst%3DC.%26aulast%3DMatter%26aufirst%3DJ.%2BF.%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520compounds%2520within%2520a%2520class%2520of%25203-aminochroman%2520derivatives%2520with%2520dual%25205-HT1A%2520receptor%2520and%2520serotonin%2520transporter%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4785%26epage%3D4789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Asselin, M.; Grosu, G.; Childers, W.; Schecher, L.; Harrison, B.; Sabb, A.; Smith, D.; Hirst, W.; Andres, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel substituted aryl- and heteroaryl-4-(piperidin-4-yl) piperazines as serotonergic agents</span>. <span class="NLM_conf-name">41st National Organic Chemsitry Symposium</span>, <span class="NLM_conf-loc">Boulder</span>, <span class="NLM_conf-date">June 7−11, 2009</span>,  <span class="NLM_fpage">B11</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Asselin%2C+M.%3B+Grosu%2C+G.%3B+Childers%2C+W.%3B+Schecher%2C+L.%3B+Harrison%2C+B.%3B+Sabb%2C+A.%3B+Smith%2C+D.%3B+Hirst%2C+W.%3B+Andres%2C+T.+Design+and+synthesis+of+novel+substituted+aryl-+and+heteroaryl-4-%28piperidin-4-yl%29+piperazines+as+serotonergic+agents.+41st+National+Organic+Chemsitry+Symposium%2C+Boulder%2C+June+7%E2%88%9211%2C+2009%2C+B11."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520substituted%2520aryl-%2520and%2520heteroaryl-4-%2528piperidin-4-yl%2529%2520piperazines%2520as%2520serotonergic%2520agents%26spage%3DB11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Asselin, M.; Grosu, T. G.; Sabb, A. L.; Childers, W. E.; Havran, L. M.; Shen, Z.; Bicksler, J. J.; Chong, D. C.</span><span> </span><span class="NLM_article-title">Piperazine-piperidine antagonists and agonists of the 5-HT<sub>1A</sub> receptor</span>. U.S. Patent 7,671,056,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Asselin&author=T.+G.+Grosu&author=A.+L.+Sabb&author=W.+E.+Childers&author=L.+M.+Havran&author=Z.+Shen&author=J.+J.+Bicksler&author=D.+C.+Chong&title=Piperazine-piperidine+antagonists+and+agonists+of+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DM.%26atitle%3DPiperazine-piperidine%2520antagonists%2520and%2520agonists%2520of%2520the%25205-HT1A%2520receptor%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Skraup, Z. H.</span><span> </span><span class="NLM_article-title">Eine synthese des chinolins</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1880</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1880&pages=2086&author=Z.+H.+Skraup&title=Eine+synthese+des+chinolins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkraup%26aufirst%3DZ.%2BH.%26atitle%3DEine%2520synthese%2520des%2520chinolins%26jtitle%3DChem.%2520Ber.%26date%3D1880%26volume%3D13%26spage%3D2086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Guram, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Aromatic Aminations with in Situ Generated Aminostannanes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">7901</span><span class="NLM_x">–</span> <span class="NLM_lpage">7902</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00096a059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2cXmvVSgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=7901-7902&author=A.+S.+Guramauthor=S.+L.+Buchwald&title=Palladium-Catalyzed+Aromatic+Aminations+with+in+Situ+Generated+Aminostannanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Aromatic Aminations with in situ Generated Aminostannanes</span></div><div class="casAuthors">Guram, Anil S.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7901-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Aminostannes, generated in situ by the transamination reactions of N,N-diethylaminotributyltin with primary and secondary amines, undergo Pd-catalyzed reactions with aryl bromides to afford aryl amines in good yields.  Thus, e.g., in situ generation of Bu3SnNMeCH2Ph via transamination of Bu3SnNEt2 with HNMeCH2Ph, followed by reaction with 4-EtO2CC6H4Br in presence of PdCl2[P(o-tolyl)3]2 afforded 88% 4-EtO2CC6H4NMeCH2Ph.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHbgxIJwAw2rVg90H21EOLACvtfcHk0li6hcxLQsa2eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvVSgs74%253D&md5=01e7d965aef985f90b78c7c7bda73c9d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja00096a059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00096a059%26sid%3Dliteratum%253Aachs%26aulast%3DGuram%26aufirst%3DA.%2BS.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-Catalyzed%2520Aromatic%2520Aminations%2520with%2520in%2520Situ%2520Generated%2520Aminostannanes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D7901%26epage%3D7902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Louie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">–</span> <span class="NLM_lpage">3612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0040-4039%2895%2900605-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=3609-3612&author=J.+Louieauthor=J.+F.+Hartwig&title=Palladium-catalyzed+synthesis+of+arylamines+from+aryl+halides.+Mechanistic+studies+lead+to+coupling+in+the+absence+of+tin+reagents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span></div><div class="casAuthors">Louie, Janis; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3609-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The reaction of aryl halides with secondary amines in the presence of silylamide base and tri-o-tolyphospshine palladium complexes gives arylamine products.  This process provides a convenient method for performing these heterocross coupling reactions without the necessity for forming tin amides and disposing of tin halides.  This reaction follows from a mechanistic anal. of the coupling reaction with tin amides and occurs as a result of the cleavage of palladium aryl halide dimers with secondary amines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKpHJAivoR7Vg90H21EOLACvtfcHk0li6hcxLQsa2eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D&md5=7c4567c3e54efc05049d539c682696b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2900605-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252900605-C%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520synthesis%2520of%2520arylamines%2520from%2520aryl%2520halides.%2520Mechanistic%2520studies%2520lead%2520to%2520coupling%2520in%2520the%2520absence%2520of%2520tin%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D3609%26epage%3D3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Characterization of the 5-HT<sub>1A</sub> Receptor Functional Coupling in Cells Expressing the Human 5-HT<sub>1A</sub> Receptor as Assessed with the Cytosensor Microphysiometer</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2FS1056-8719%2898%2900035-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=9920534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1998&pages=47-55&author=J.+Dunlopauthor=Y.+Zhangauthor=D.+E.+Smithauthor=L.+E.+Schechter&title=Characterization+of+the+5-HT1A+Receptor+Functional+Coupling+in+Cells+Expressing+the+Human+5-HT1A+Receptor+as+Assessed+with+the+Cytosensor+Microphysiometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer</span></div><div class="casAuthors">Dunlop, John; Zhang, Yingxin; Smith, Deborah L.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The functional activity of a series of 5-HT1A receptor ligands has been evaluated in a cell line expressing the human 5-HT1A receptor (h5-HT1A · CHO) using the agonist-stimulated increase in extracellular acidification rate, measured with the microphysiometer, as a functional assay.  Both 5-CT and 8-OH-DPAT were potent agonists in stimulating an increase in extracellular acidification rate in h5-HT1A · CHO cells with estd. EC50 values of 1.2 and 7.8 nM, resp.  Addnl., these two 5-HT1A receptor agonists elicited a similar max. response.  Concn.-dependent agonist activity was also obsd. in the presence of buspirone, ipsapirone, BMY 7378, NAN-190 and WAY 100135, and each of these compds. behaved as partial 5-HT1A receptor agonists.  The selective 5-HT1A receptor antagonist WAY 100635 produced a potent (IC50, 2.3 nM) and complete block of the 8-OH-DPAT-stimulated response.  An evaluation of the inhibitory activity of a series of 5-HT1A receptor antagonists produced the following rank order of potency; WAY 100635 > LY 206130 (IC50, 7.1 nM) > WAY 100135 (30.8 nM) > pindolol (76.2 nM) > (-)UH-301 (92.8 nM).  Parallel studies on the inhibition of forskolin-stimulated adenylyl cyclase activity in h5-HT1A · CHO cells revealed that agonist potencies were generally similar between the two functional assays and were in good agreement with the estd. 5-HT1A receptor binding affinities.  However, the relative efficacies detd. for the partial agonists in the cAMP assay were substantially greater than those obsd. with the microphysiometer.  Finally, antagonists were considerably weaker in the cAMP assay compared with the microphysiometer.  The evaluation of 5-HT1A ligands using the microphysiometer, which represents a very distinct indice of 5-HT1A receptor function compared with the cAMP assay, results in a different profile of functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoE_crPJ1hc7Vg90H21EOLACvtfcHk0ljVlCfPp568uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWntQ%253D%253D&md5=4b458fdc01863486fc69b41a9575e868</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2898%2900035-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252898%252900035-5%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DCharacterization%2520of%2520the%25205-HT1A%2520Receptor%2520Functional%2520Coupling%2520in%2520Cells%2520Expressing%2520the%2520Human%25205-HT1A%2520Receptor%2520as%2520Assessed%2520with%2520the%2520Cytosensor%2520Microphysiometer%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D1998%26volume%3D40%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Assie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiek, W.</span><span> </span><span class="NLM_article-title">Effects of 5-HT<sub>1A</sub> receptor antagonists on hippocampal 5-hydroxy-tryptamine levels: (S)-WAY-100135 but not WAY-100635 has partial agonist properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0014-2999%2896%2900086-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=8813579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Wnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=1996&pages=15-21&author=M.+B.+Assieauthor=W.+Kiek&title=Effects+of+5-HT1A+receptor+antagonists+on+hippocampal+5-hydroxy-tryptamine+levels%3A+%28S%29-WAY-100135+but+not+WAY-100635+has+partial+agonist+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties</span></div><div class="casAuthors">Assie, Marie-Bernadette; Koek, Wouter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In vivo microdialysis measuring 5-hydroxytryptamine (5-HT) levels in the ventral hippocampus of chloral hydrate-anesthetized rats was used to characterize further the recently described 5-HT1A receptor antagonists (S)-WAY100135 ((S)-N-tert-butyl-3-(4-(2-meth- oxyphenyl)piperazine-1-yl)-2-phenylpropanamide) and WAY100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide).  In addn., binding expts. were performed to det. the affinity of the compds. for 5-HT1A receptors and for α1-adrenoceptors.  Both (S)-WAY100135 and WAY100635 exhibited high affinity for 5-HT1A receptors and moderate affinity for α1-adrenoceptors.  The effects of (S)-WAY100135 (0.63-20 mg/kg) and of WAY100635 (0.0025-0.16 mg/kg) on 5-HT levels were examd. alone, and in combination with the 5-HT1A receptor agonist, (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).  Both compds. dose-dependently reversed the 8-OH-DPAT-induced decrease in extracellular 5-HT levels with ED50 values of approx. 3.3 and 0.03 mg/kg, resp.  When given alone, WAY100635 did not alter 5-HT levels.  (S)-WAY100135, however, induced, by itself, a transient but significant and dose-dependent decrease in 5-HT levels.  WAY100635 (0.16 mg/kg) prevented the decrease induced by (S)-WAY100135 (10 mg/kg), but did not reverse the decrease induced by the α1-adrenoceptor antagonist, prazosin (0.16 mg/kg).  These results are further evidence that (S)-WAY100135 may modulate the release of 5-HT by acting as a partial agonist at somatodendritic 5-HT1A receptors.  In contrast, WAY100635 acts as a potent and selective 5-HT1A receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNFJxAA3tLbVg90H21EOLACvtfcHk0ljVlCfPp568uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Wnsrc%253D&md5=c90f1422670a73df50672e68a1953881</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900086-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900086-6%26sid%3Dliteratum%253Aachs%26aulast%3DAssie%26aufirst%3DM.%2BB.%26aulast%3DKiek%26aufirst%3DW.%26atitle%3DEffects%2520of%25205-HT1A%2520receptor%2520antagonists%2520on%2520hippocampal%25205-hydroxy-tryptamine%2520levels%253A%2520%2528S%2529-WAY-100135%2520but%2520not%2520WAY-100635%2520has%2520partial%2520agonist%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D304%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bowen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessel, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, M. T.</span><span> </span><span class="NLM_article-title">Neurotransmission—the link integrating Alzheimer’s disease?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1994&pages=149-150&author=D.+M.+Bowenauthor=P.+T.+Francisauthor=I.+P.+Chesselauthor=M.+T.+Webster&title=Neurotransmission%E2%80%94the+link+integrating+Alzheimer%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DD.%2BM.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DChessel%26aufirst%3DI.%2BP.%26aulast%3DWebster%26aufirst%3DM.%2BT.%26atitle%3DNeurotransmission%25E2%2580%2594the%2520link%2520integrating%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D1994%26volume%3D17%26spage%3D149%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ennaceur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacour, J.</span><span> </span><span class="NLM_article-title">A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=47-59&author=A.+Ennaceurauthor=J.+Delacour&title=A+new+one-trial+test+for+neurobiological+studies+of+memory+in+rats.+1%3A+behavioral+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEnnaceur%26aufirst%3DA.%26aulast%3DDelacour%26aufirst%3DJ.%26atitle%3DA%2520new%2520one-trial%2520test%2520for%2520neurobiological%2520studies%2520of%2520memory%2520in%2520rats.%25201%253A%2520behavioral%2520data%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1988%26volume%3D31%26spage%3D47%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, R. F.</span><span> </span><span class="NLM_article-title">Post-training <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor blockade offers protection from retrograde interference but does not affect consolidation of weak and strong memory traces in water maze</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2006&pages=19-28&author=M.+Dayauthor=R.+F.+Langston&title=Post-training+N-methyl-d-aspartate+receptor+blockade+offers+protection+from+retrograde+interference+but+does+not+affect+consolidation+of+weak+and+strong+memory+traces+in+water+maze"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DM.%26aulast%3DLangston%26aufirst%3DR.%2BF.%26atitle%3DPost-training%2520N-methyl-d-aspartate%2520receptor%2520blockade%2520offers%2520protection%2520from%2520retrograde%2520interference%2520but%2520does%2520not%2520affect%2520consolidation%2520of%2520weak%2520and%2520strong%2520memory%2520traces%2520in%2520water%2520maze%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D137%26spage%3D19%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hsiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harigaya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G.</span><span> </span><span class="NLM_article-title">Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=99-102&author=K.+Hsiaoauthor=P.+Chapmanauthor=S.+Nilsonauthor=C.+Eckmanauthor=Y.+Harigayaauthor=Y.+Younkinauthor=F.+Yangauthor=G.+Cole&title=Correlative+memory+deficits%2C+A%CE%B2+elevation+and+amyloid+plaques+in+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DChapman%26aufirst%3DP.%26aulast%3DNilson%26aufirst%3DS.%26aulast%3DEckman%26aufirst%3DC.%26aulast%3DHarigaya%26aufirst%3DY.%26aulast%3DYounkin%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DCole%26aufirst%3DG.%26atitle%3DCorrelative%2520memory%2520deficits%252C%2520A%25CE%25B2%2520elevation%2520and%2520amyloid%2520plaques%2520in%2520transgenic%2520mice%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Dineley, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweatt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span> </span><span class="NLM_article-title">Accelerated plaque accumulations, associative learning deficits, and up-regulation of α7 nicotinic receptor protein in transgenic mice co-expressing mutant human Presenilin-1 and amyloid precursor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">22768</span><span class="NLM_x">–</span> <span class="NLM_lpage">22780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2002&pages=22768-22780&author=K.+T.+Dineleyauthor=X.+Xiaauthor=D.+Buiauthor=D.+Sweattauthor=H.+Zheng&title=Accelerated+plaque+accumulations%2C+associative+learning+deficits%2C+and+up-regulation+of+%CE%B17+nicotinic+receptor+protein+in+transgenic+mice+co-expressing+mutant+human+Presenilin-1+and+amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DBui%26aufirst%3DD.%26aulast%3DSweatt%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DAccelerated%2520plaque%2520accumulations%252C%2520associative%2520learning%2520deficits%252C%2520and%2520up-regulation%2520of%2520%25CE%25B17%2520nicotinic%2520receptor%2520protein%2520in%2520transgenic%2520mice%2520co-expressing%2520mutant%2520human%2520Presenilin-1%2520and%2520amyloid%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D227%26spage%3D22768%26epage%3D22780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Corcoran, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maren, S.</span><span> </span><span class="NLM_article-title">Overexpression of hAPP-swe impairs rewarded alteration and contextual fear conditioning in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Learn. Mem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1101%2Flm.51002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=12359834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A280%3ADC%252BD38vpvVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=243-252&author=K.+A.+Corcoranauthor=Y.+Luauthor=R.+S.+Turnerauthor=S.+Maren&title=Overexpression+of+hAPP-swe+impairs+rewarded+alteration+and+contextual+fear+conditioning+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Corcoran Kevin A; Lu Ye; Turner R Scott; Maren Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Learning & memory (Cold Spring Harbor, N.Y.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">243-52</span>
        ISSN:<span class="NLM_cas:issn">1072-0502</span>.
    </div><div class="casAbstract">One of the hallmarks of the pathology in Alzheimer's disease is the deposition of amyloid plaques throughout the brain, especially within the hippocampus and amygdala.  Transgenic mice that overexpress the Swedish mutation of human amyloid precursor protein (hAPPswe; Tg2576) show age-dependent memory deficits in hippocampus-dependent learning tasks.  However, the performance of aged Tg2576 mice in amygdala-dependent learning tasks has not been thoroughly assessed.  We trained young (2-4 mo) and old (16-18 mo) Tg2576 and wild-type mice in a T-maze alternation task (hippocampus-dependent) and a Pavlovian fear-conditioning task (amygdala- and hippocampus-dependent).  As previously reported, old Tg2576 mice showed impaired acquisition of rewarded alternation; none of these mice reached the criterion of at least five out of six correct responses over three consecutive days.  In contrast, old Tg2576 mice showed normal levels of conditional freezing to an auditory conditional stimulus (CS) and acquired a contextual discrimination normally.  However, when the salience of the fear-conditioning context was decreased, old (12-14 mo) Tg2576 mice were impaired at acquiring fear to the conditioning context, but not to the tone CS.  Histological examination of a subset of the mice verified the existence of amyloid plaques in the cortex, hippocampus, and amygdala of old, but not young, Tg2576 mice.  Hence, learning and memory deficits in old Tg2576 mice are limited to hippocampus-dependent tasks, despite widespread amyloid deposition in cortex, hippocampus, and amygdala.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ26wKjowe1f4kFb3mqPUYDfW6udTcc2ebpYMDo1gzjxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vpvVaisw%253D%253D&md5=71fdb1b3c4e1c5e5231e7576343b3242</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1101%2Flm.51002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Flm.51002%26sid%3Dliteratum%253Aachs%26aulast%3DCorcoran%26aufirst%3DK.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DR.%2BS.%26aulast%3DMaren%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520hAPP-swe%2520impairs%2520rewarded%2520alteration%2520and%2520contextual%2520fear%2520conditioning%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLearn.%2520Mem.%26date%3D2002%26volume%3D9%26spage%3D243%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaput, Y.</span><span> </span><span class="NLM_article-title">Modifications of the serotonergic system by antidepressant treatment: implications for the therapeutic response in major depression</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">24S</span><span class="NLM_x">–</span> <span class="NLM_lpage">35S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1987&pages=24S-35S&author=P.+Blierauthor=C.+De+Montignyauthor=Y.+Chaput&title=Modifications+of+the+serotonergic+system+by+antidepressant+treatment%3A+implications+for+the+therapeutic+response+in+major+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26aulast%3DChaput%26aufirst%3DY.%26atitle%3DModifications%2520of%2520the%2520serotonergic%2520system%2520by%2520antidepressant%2520treatment%253A%2520implications%2520for%2520the%2520therapeutic%2520response%2520in%2520major%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1987%26volume%3D7%26spage%3D24S%26epage%3D35S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span> </span><span class="NLM_article-title">Effects of 5-HT<sub>1A</sub> antagonists on fluoxetine-induced changes in extracullular serotonin concentrations in rat frontal cortex</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2FS0014-2999%2897%2901580-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=1998&pages=41-46&author=L.+A.+Dawsonauthor=H.+Q.+Nguyen&title=Effects+of+5-HT1A+antagonists+on+fluoxetine-induced+changes+in+extracullular+serotonin+concentrations+in+rat+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901580-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901580-X%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26atitle%3DEffects%2520of%25205-HT1A%2520antagonists%2520on%2520fluoxetine-induced%2520changes%2520in%2520extracullular%2520serotonin%2520concentrations%2520in%2520rat%2520frontal%2520cortex%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D314%26spage%3D41%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1177%2F026988110201600205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=12095073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=145-152&author=L.+A.+Dawsonauthor=J.+Q.+Nguyenauthor=D.+L.+Smithauthor=L.+E.+Schechter&title=Effect+of+chronic+fluoxetine+and+WAY-100635+treatment+on+serotonergic+neurotransmission+in+the+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex</span></div><div class="casAuthors">Dawson, L. A.; Nguyen, H. Q.; Smith, D. L.; Schechter, L. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Clin. augmentation strategies have shown that some improvement in antidepressant efficacy can be achieved by combining the β-adrenergic/serotonin (5-HT)1A/1B receptor antagonist (±)pindolol with a selective serotonin reuptake inhibitor (SSRI).  This has lead to the hypothesis that a combination of a 5-HT1A receptor antagonist with an SSRI will lead to a faster onset of antidepressant action.  Although there is a significant accumulation of acute preclin. data supporting this rationale, until recently, there have been no investigations examg. the chronic effects of combining an SSRI with a 5-HT1A receptor antagonist.  Here, we detd. the chronic effects of fluoxetine (10 mg/kg o.d.), administered in combination with the selective 5-HT1A receptor antagonist WAY-100635 (1 mg/kg b.i.d.), on serotonergic neurotransmission in the frontal cortex using in-vivo microdialysis.  Following chronic administration of fluoxetine ± WAY-100635, functional changes in serotonergic neurotransmission, as well as 5-HT1A autoreceptors, were assessed by administering fluoxetine or (±) 8-hydroxy-2-(di-n-propylamino)tetralin [(±) 8-OH-DPAT] 24 h after the last chronic dose.  Chronic administration of WAY-100635 alone produced no detectable change in the functional status of the 5-HT1A receptor.  However, fluoxetine alone produced a time-dependent adaptation in serotonergic transmission such that fluoxetine (acutely administered on day 15) was able to produce a two-fold increase in extracellular 5-HT levels but the decrease in response to 8-OH-DPAT was completely attenuated.  These data indicate that the fluoxetine-induced adaptation was mediated by desensitization of the 5-HT1A receptor.  WAY-100635 given chronically in combination with fluoxetine blocked the SSRI-induced desensitization of the 5-HT1A receptor.  Furthermore, chronic treatment with this combination produced no tolerance in terms of its ability to acutely increase forebrain 5-HT levels.  These data suggest that augmentation of an SSRI by combined pharmacotherapy with a 5-HT1A antagonist would be effective upon prolonged exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg1tnS2Y2n_7Vg90H21EOLACvtfcHk0likR83GyBQ0vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVejtr8%253D&md5=e9cfcafe0b61b568853ee5118f07f736</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F026988110201600205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110201600205%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DNguyen%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DEffect%2520of%2520chronic%2520fluoxetine%2520and%2520WAY-100635%2520treatment%2520on%2520serotonergic%2520neurotransmission%2520in%2520the%2520frontal%2520cortex%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2002%26volume%3D16%26spage%3D145%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Czachura, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span> </span><span class="NLM_article-title">Effect of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1007%2Fs002100000290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=10997729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Wjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2000&pages=266-275&author=J.+F.+Czachuraauthor=K.+Rasmussen&title=Effect+of+acute+and+chronic+administration+of+fluoxetine+on+the+activity+of+serotonergic+neurons+in+the+dorsal+raphe+nucleus+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat</span></div><div class="casAuthors">Czachura, Janet F.; Rasmussen, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">266-275</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The gradual recovery of activity of serotonergic neurons following an initial inhibition has been hypothesized to play an important role in the delayed onset of efficacy of selective serotonin reuptake inhibitors.  This study explored the clin. relevance of this hypothesis by examg. the effects of different doses and routes of administration of fluoxetine on the recovery of activity of serotonergic neurons over the course of a 21-day exposure.  Single-unit, extracellular recordings of serotonergic neurons were made in the dorsal raphe nucleus of anesthetized male rats.  Acute i.v., s.c. and i.p. administration of fluoxetine inhibited the activity of serotonergic neurons.  With chronic administration of fluoxetine, at clin. relevant doses, the activity of serotonergic neurons gradually recovered to baseline levels over the course of 14-21 days.  The dose of fluoxetine (5, 10 or 20 mg/kg per day) did not make a significant difference in the time course of the recovery of activity of serotonergic neurons.  A significant, non-parallel shift in the dose-response curve of serotonergic neurons to the serotonin-1A (5-HT1A) agonist 8-OH-DPAT occurred over the 21 days of treatment with fluoxetine, indicating a desensitization of the 5-HT1A receptor during this period.  The recovery of firing did not correlate with either plasma or cerebrospinal fluid levels of fluoxetine or norfluoxetine.  These results indicate that, similar to the effects of dose on the speed of onset of the clin. effects of SSRIs, increasing the dose of fluoxetine does not hasten the recovery of firing of serotonergic neurons during chronic administration.  These results support the hypothesis that desensitization of the 5-HT1A receptor and consequent recovery of firing of 5-HT cells in the dorsal raphe nucleus plays a role in the delayed therapeutic onset of fluoxetine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVUJuqOMV8B7Vg90H21EOLACvtfcHk0likR83GyBQ0vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Wjurk%253D&md5=5d643f9f1a152872c4650b8c6f9148f8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs002100000290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000290%26sid%3Dliteratum%253Aachs%26aulast%3DCzachura%26aufirst%3DJ.%2BF.%26aulast%3DRasmussen%26aufirst%3DK.%26atitle%3DEffect%2520of%2520acute%2520and%2520chronic%2520administration%2520of%2520fluoxetine%2520on%2520the%2520activity%2520of%2520serotonergic%2520neurons%2520in%2520the%2520dorsal%2520raphe%2520nucleus%2520of%2520the%2520rat%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D362%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. R.</span><span> </span><span class="NLM_article-title">Onset of the effects of the 5-HT1A antagonist, WAY100635, alone and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat</span> <span class="citation_source-journal">Pharmacol. Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1999&pages=333-338&author=J.+F.+Cryanauthor=C.+McGrathauthor=B.+E.+Leonardauthor=T.+R.+Norman&title=Onset+of+the+effects+of+the+5-HT1A+antagonist%2C+WAY100635%2C+alone+and+in+combination+with+paroxetine%2C+on+olfactory+bulbectomy+and+8-OH-DPAT-induced+changes+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26aulast%3DNorman%26aufirst%3DT.%2BR.%26atitle%3DOnset%2520of%2520the%2520effects%2520of%2520the%25205-HT1A%2520antagonist%252C%2520WAY100635%252C%2520alone%2520and%2520in%2520combination%2520with%2520paroxetine%252C%2520on%2520olfactory%2520bulbectomy%2520and%25208-OH-DPAT-induced%2520changes%2520in%2520the%2520rat%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D63%26spage%3D333%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornfelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span> </span><span class="NLM_article-title">Selective serotonin reuptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1993&pages=195-198&author=A.+Woodsauthor=C.+Smithauthor=M.+Szewczakauthor=R.+W.+Dunnauthor=M.+Cornfeltauthor=R.+Corbett&title=Selective+serotonin+reuptake+inhibitors+decrease+schedule-induced+polydipsia+in+rats%3A+a+potential+model+for+obsessive+compulsive+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DSzewczak%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DR.%2BW.%26aulast%3DCornfelt%26aufirst%3DM.%26aulast%3DCorbett%26aufirst%3DR.%26atitle%3DSelective%2520serotonin%2520reuptake%2520inhibitors%2520decrease%2520schedule-induced%2520polydipsia%2520in%2520rats%253A%2520a%2520potential%2520model%2520for%2520obsessive%2520compulsive%2520disorder%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D112%26spage%3D195%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvi, A.</span><span> </span><span class="NLM_article-title">Acceleration of onset of action in schedule-induced polydipsia: combination of SSRI and 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptor antagonists</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2004&pages=69-75&author=S.+Hoggauthor=A.+Dalvi&title=Acceleration+of+onset+of+action+in+schedule-induced+polydipsia%3A+combination+of+SSRI+and+5-HT1A+and+5-HT1B+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DDalvi%26aufirst%3DA.%26atitle%3DAcceleration%2520of%2520onset%2520of%2520action%2520in%2520schedule-induced%2520polydipsia%253A%2520combination%2520of%2520SSRI%2520and%25205-HT1A%2520and%25205-HT1B%2520receptor%2520antagonists%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2004%26volume%3D77%26spage%3D69%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kelly, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrynn, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">The olfactory bulbectomy rat model of depression—an update</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2FS0163-7258%2897%2900004-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=9352586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2sXmsFCgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1997&pages=299-315&author=J.+P.+Kellyauthor=A.+S.+Wrynnauthor=B.+E.+Leonard&title=The+olfactory+bulbectomy+rat+model+of+depression%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The olfactory bulbectomized rat as a model of depression: an update</span></div><div class="casAuthors">Kelly, J. P.; Wrynn, A. S.; Leonard, B. E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-316</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 161 refs.  The olfactory bulbectomized (OB) rat has been proposed as an animal model of depression.  The following behavioral changes have been obsd. following bilateral olfactory bulbectomy: hyperactivity in an enclosed arena, such as the open-field; enhanced nocturnal hyperactivity in a 24-h home cage activity monitor; deficits in memory, as shown by passive avoidance behavior and in the Morris maze and the 8-arm radial maze; increased open arm entries in the elevated plus-maze; and changes in food motivated and conditioned taste aversion behavior.  Alterations in the noradrenergic, serotonergic, cholinergic, γ-aminobutyric acid (GAB)ergic and glutamatergic neurotransmitter systems are also assocd. with olfactory bulbectomy.  The variety of immune changes following olfactory bulbectomy includes reduced neutrophil phagocytosis, lymphocyte mitogenesis, lymphocyte no. and neg. acute phase proteins, increased leukocyte adhesiveness/aggregation, monocyte phagocytosis, neutrophil no. and pos. acute phase proteins.  An enhanced nocturnal secretion of corticosterone is obsd. in OB rats, which is normally suppressed by dexamethasone.  The most commonly employed behavioral indicator of antidepressant activity is attenuation of the OB-related hyperactivity in the open-field.  However, many of the other behavioral, neurotransmitter and immune changes have been shown to be attenuated by chronic (but not acute) antidepressant treatment.  Tricyclic antidepressants (amitriptyline, desipramine), atypical agents (mianserin), selective serotonin reuptake inhibitors (paroxetine, sertraline, fluvoxamine), reversible inhibitors of monoamine oxidase A (moclobemide), as well as putative antidepressants such as 5-hydroxytryptamine1A agonists (zalospirone, ipsapirone), noncompetitive N-methyl-D-aspartate antagonists (MK-801) and triazolobenzodiazepines (alprazolam, adinazolam), have demonstrated antidepressant-like activity in this model.  As many of the changes exhibited by the OB rat are qual. similar to those obsd. in depressed patients, it may be concluded that the OB rat is a model of depression and not just a means whereby putative antidepressants may be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoApMQoaubNgbVg90H21EOLACvtfcHk0lgTIpLMSl0iQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsFCgsL4%253D&md5=233bae5852dd681d966f0ee301738c13</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2897%2900004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252897%252900004-1%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BP.%26aulast%3DWrynn%26aufirst%3DA.%2BS.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DThe%2520olfactory%2520bulbectomy%2520rat%2520model%2520of%2520depression%25E2%2580%2594an%2520update%26jtitle%3DPharmacol.%2520Ther.%26date%3D1997%26volume%3D74%26spage%3D299%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Landen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikkson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlen, T.</span><span> </span><span class="NLM_article-title">Effects of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1097%2F00004714-199906000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=10350034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=268-271&author=M.+Landenauthor=E.+Erikksonauthor=H.+Agrenauthor=T.+Fahlen&title=Effects+of+buspirone+on+sexual+dysfunction+in+depressed+patients+treated+with+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors</span></div><div class="casAuthors">Landen, Mikael; Eriksson, Elias; Agren, Hans; Fahlen, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-271</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the possible influence of buspirone on sexual dysfunction in depressed patients treated with a selective serotonin reuptake inhibitor (SSRI; citalopram or paroxetine), data were analyzed from a placebo-controlled trial designed to explore the efficacy of buspirone as add-on treatment for patients not responding to an SSRI alone.  All the patients met the criteria for a major depressive episode according to DSM-IV and had received citalopram or paroxetine during a min. of 4 wk without responding to the treatment.  Buspirone (20-60 mg/day) or placebo was added to the SSRI for 4 wk; the mean daily dose of buspirone at endpoint was 48.5 mg/day.  Before starting medication with buspirone or placebo, 40% (47 of 117 patients) reported at least one kind of sexual dysfunction (decreased libido, ejaculatory dysfunction, orgasmic dysfunction).  During the 4 wk of treatment, approx. 58% of the subjects treated with buspirone reported an improvement with respect to sexual function; in the placebo group, the response rate was 30%.  The difference between placebo and active drug treatment was more pronounced in women than in men.  The response was obvious during the 1st week, with no further improvement during the course of the study.  It is suggested that the effect of buspirone on sexual dysfunction is a result of a reversal of SSRI-induced sexual side effects rather than of an antidepressant effect of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZbJOWG8AQ4rVg90H21EOLACvtfcHk0lgTIpLMSl0iQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ant7Y%253D&md5=2dfff4a62cec531824046f7500819000</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2F00004714-199906000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199906000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DLanden%26aufirst%3DM.%26aulast%3DErikkson%26aufirst%3DE.%26aulast%3DAgren%26aufirst%3DH.%26aulast%3DFahlen%26aufirst%3DT.%26atitle%3DEffects%2520of%2520buspirone%2520on%2520sexual%2520dysfunction%2520in%2520depressed%2520patients%2520treated%2520with%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1999%26volume%3D19%26spage%3D268%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Norden, M. J.</span><span> </span><span class="NLM_article-title">Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Depression</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1002%2Fdepr.3050020208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=109-112&author=M.+J.+Norden&title=Buspirone+treatment+of+sexual+dysfunction+associated+with+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fdepr.3050020208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdepr.3050020208%26sid%3Dliteratum%253Aachs%26aulast%3DNorden%26aufirst%3DM.%2BJ.%26atitle%3DBuspirone%2520treatment%2520of%2520sexual%2520dysfunction%2520associated%2520with%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DDepression%26date%3D1994%26volume%3D2%26spage%3D109%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Baldwin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, A.</span><span> </span><span class="NLM_article-title">Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1177%2F0269881107078490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=17715211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1emtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=55-63&author=D.+Baldwinauthor=J.+Hutchinsonauthor=K.+Donaldsonauthor=B.+Shawauthor=A.+Smithers&title=Selective+serotonin+re-uptake+inhibitor+treatment-emergent+sexual+dysfunction%3A+randomized+double-blind+placebo-controlled+parallel-group+fixed-dose+study+of+a+potential+adjuvant+compound"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670</span></div><div class="casAuthors">Baldwin, David; Hutchison, John; Donaldson, Kirsteen; Shaw, Bob; Smithers, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Sexual dysfunction is common during acute and continuation treatment of depressed patients with selective serotonin (5-hydroxytryptamine, 5-HT) re-uptake inhibitors (SSRIs), but there is no consensus on clin. management.  Compds. with 5-HT1A agonist properties have been proposed as adjuvant agents in patients continuing with SSRIs.  Randomized double-blind placebo-controlled parallel-group fixed-dose 4-wk treatment study.  Previously depressed male or female patients in symptomatic remission receiving stable doses of fluoxetine or paroxetine but experiencing treatment-emergent sexual dysfunction were randomised to double-blind treatment with placebo or VML-670 (a 5-HT1A and 5-HT1D agonist).  Sexual dysfunction was assessed by the Arizona Sexual Experiences Scale (ASEX).  Two-hundred and eighty-eight patients (204 women, 84 men; mean age 44.2 years) received VML-670 (n = 149; 107 women, 42 men) or placebo (n = 139; 97 women, 42 men).  In the intention-to-treat, last-observation carried forward anal. (n = 282), proportionately more patients became free of sexual dysfunction with VML-670 (34.3% vs. 27.9% with placebo) but this difference was not statistically significant.  Male patients treated with VML-670 showed a significantly greater (p = 0.01) improvement in ability to achieve and maintain penile erection (a secondary outcome measure).  A similar proportion of patients reported on-treatment, treatment-emergent adverse events with VML-670 (71.1%) and placebo (68.3%), and a similar proportion experienced at least one treatment-related adverse event (36.9% vs. 35.3%).  Double-blind treatment with VML-670 offered no significant advantage over placebo on the primary outcome measure in the overall sample.  Further studies may be warranted in larger groups of male patients with sexual dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPDYgF8UnulrVg90H21EOLACvtfcHk0lg9DViRAEw0hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1emtrc%253D&md5=9b8b7c7002f1c2997717ec145e51ed8b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1177%2F0269881107078490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881107078490%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DD.%26aulast%3DHutchinson%26aufirst%3DJ.%26aulast%3DDonaldson%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DB.%26aulast%3DSmithers%26aufirst%3DA.%26atitle%3DSelective%2520serotonin%2520re-uptake%2520inhibitor%2520treatment-emergent%2520sexual%2520dysfunction%253A%2520randomized%2520double-blind%2520placebo-controlled%2520parallel-group%2520fixed-dose%2520study%2520of%2520a%2520potential%2520adjuvant%2520compound%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2008%26volume%3D22%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">A novel approach for predicting antidepressant-induced sexual dysfunction in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=459-467&author=S.+J.+Sukoff-Rizzoauthor=L.+E.+Schechterauthor=S.+Rosenzweig-Lipson&title=A+novel+approach+for+predicting+antidepressant-induced+sexual+dysfunction+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DA%2520novel%2520approach%2520for%2520predicting%2520antidepressant-induced%2520sexual%2520dysfunction%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D195%26spage%3D459%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulicicchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats</span> <span class="citation_source-journal">J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1017%2FS1461145709000406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=1045-1053&author=S.+J.+Sukoff-Rizzoauthor=C.+Pulicicchioauthor=J.+E.+Malbergauthor=T.+H.+Andreeauthor=G.+P.+Stackauthor=Z.+A.+Hughesauthor=L.+E.+Schechterauthor=S.+Rosenzweig-Lipson&title=5-HT1A+receptor+antagonism+reverses+and+prevents+fluoxetine-induced+sexual+dysfunction+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats</span></div><div class="casAuthors">Sukoff Rizzo, Stacey J.; Pulicicchio, Claudine; Malberg, Jessica E.; Andree, Terrance H.; Stack, Gary P.; Hughes, Zoe A.; Schechter, Lee E.; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1045-1053</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Sexual dysfunction assocd. with antidepressant treatment continues to be a major compliance issue for antidepressant therapies. 5-HT1A antagonists have been suggested as beneficial adjunctive treatment in respect of antidepressant efficacy; however, the effects of 5-HT1A antagonism on antidepressant-induced side-effects has not been fully examd.  The present study was conducted to evaluate the ability of acute or chronic treatment with 5-HT1A antagonists to alter chronic fluoxetine-induced impairments in sexual function.  Chronic 14-d treatment with fluoxetine resulted in a marked redn. in the no. of non-contact penile erections in sexually experienced male rats, relative to vehicle-treated controls.  Acute administration of the 5-HT1A antagonist WAY-101405 resulted in a complete reversal of chronic fluoxetine-induced deficits on non-contact penile erections at doses that did not significantly alter baselines.  Chronic co-administration of the 5-HT1A antagonists WAY-100635 or WAY-101405 with fluoxetine prevented fluoxetine-induced deficits in non-contact penile erections in sexually experienced male rats.  Moreover, withdrawal of WAY-100635 from co-treatment with chonic fluoxetine, resulted in a time-dependent reinstatement of chronic fluoxetine-induced deficits in non-contact penile erections.  Addnl., chronic administration of SSA-426, a mol. with dual activity as both a SSRI and 5-HT1A antagonist, did not produce deficits in non-contact penile erections at doses demonstrated to have antidepressant-like activity in the olfactory bulbectomy model.  Taken together, these data suggest that 5-HT1A antagonist treatment may have utility for the management of SSRI-induced sexual dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0jkpTIMFXhrVg90H21EOLACvtfcHk0lg9DViRAEw0hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurnL&md5=103c7ed40454ca39883ae32165bc5499</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1017%2FS1461145709000406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145709000406%26sid%3Dliteratum%253Aachs%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DStack%26aufirst%3DG.%2BP.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3D5-HT1A%2520receptor%2520antagonism%2520reverses%2520and%2520prevents%2520fluoxetine-induced%2520sexual%2520dysfunction%2520in%2520rats%26jtitle%3DJ.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D12%26spage%3D1045%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wen, H.; Goolcharran, C.; Ghosh, K.; Nagi, A.</span><span> </span><span class="NLM_article-title">Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-HT<sub>1A</sub> receptor having enhanced intestinal dissolution</span>. Patent WO 2008101139, <span class="NLM_month">8</span>/<span class="NLM_day">21</span>/<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Wen&author=C.+Goolcharran&author=K.+Ghosh&author=A.+Nagi&title=Sustained-release+tablet+formulations+of+piperazine-piperidine+antagonists+and+agonists+of+the+5-HT1A+receptor+having+enhanced+intestinal+dissolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DH.%26atitle%3DSustained-release%2520tablet%2520formulations%2520of%2520piperazine-piperidine%2520antagonists%2520and%2520agonists%2520of%2520the%25205-HT1A%2520receptor%2520having%2520enhanced%2520intestinal%2520dissolution%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ku, M. S.; Dulin, W. A.; Lin, Y. A.</span><span> </span><span class="NLM_article-title">Controlled-release formulation of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution</span>. Patent WO 2008067399, <span class="NLM_month">6</span>/<span class="NLM_day">6</span>/<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+S.+Ku&author=W.+A.+Dulin&author=Y.+A.+Lin&title=Controlled-release+formulation+of+piperazine-piperidine+antagonists+and+agonists+of+the+5-HT1A+receptor+having+enhanced+intestinal+dissolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKu%26aufirst%3DM.%2BS.%26atitle%3DControlled-release%2520formulation%2520of%2520piperazine-piperidine%2520antagonists%2520and%2520agonists%2520of%2520the%25205-HT1A%2520receptor%2520having%2520enhanced%2520intestinal%2520dissolution%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Cottet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosser, M.</span><span> </span><span class="NLM_article-title">Recommendable routes to trifluoro-substituted pyridine- and quinolinecarboxylic acids</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=1559-1568&author=F.+Cottetauthor=M.+Marullauthor=O.+Lefebvreauthor=M.+Schlosser&title=Recommendable+routes+to+trifluoro-substituted+pyridine-+and+quinolinecarboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCottet%26aufirst%3DF.%26aulast%3DMarull%26aufirst%3DM.%26aulast%3DLefebvre%26aufirst%3DO.%26aulast%3DSchlosser%26aufirst%3DM.%26atitle%3DRecommendable%2520routes%2520to%2520trifluoro-substituted%2520pyridine-%2520and%2520quinolinecarboxylic%2520acids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2003%26spage%3D1559%26epage%3D1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchinson, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">Acute g-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">8898</span><span class="NLM_x">–</span> <span class="NLM_lpage">8902</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1523%2FJNEUROSCI.2693-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=16192379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=8898-8902&author=T.+A.+Comeryauthor=R.+L.+Martoneauthor=S.+Achmiesauthor=K.+P.+Atchinsonauthor=G.+Diamantidisauthor=X.+Gongauthor=H.+Zhouauthor=A.+F.+Kreftauthor=M.+N.+Pangalosauthor=J.+Sonnenberg-Reinesauthor=J.+S.+Jacobsenauthor=K.+L.+Marquis&title=Acute+g-secretase+inhibition+improves+contextual+fear+conditioning+in+the+Tg2576+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Acute γ-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease</span></div><div class="casAuthors">Comery, Thomas A.; Martone, Robert L.; Aschmies, Suzan; Atchison, Kevin P.; Diamantidis, George; Gong, Xiaohai; Zhou, Hua; Kreft, Anthony F.; Pangalos, Menelas N.; Sonnenberg-Reines, June; Jacobsen, J. Steven; Marquis, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">8898-8902</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Transgenic mice (Tg2576) overexpressing the Swedish mutation of the human amyloid precursor protein display biochem., pathol., and behavioral markers consistent with many aspects of Alzheimer's disease, including impaired hippocampal function.  Impaired, hippocampal-dependent, contextual fear conditioning (CFC) is obsd. in mice as young as 20 wk of age.  This impairment can be attenuated after treatment before training with the phosphodiesterase-4 inhibitor rolipram (0.1 mg/kg, i.p.).  A rolipram-assocd. improvement is also obsd. in the littermate controls, suggesting that the effect of rolipram is independent of β-amyloid.  Acute treatment before training (but not after training or before testing) with the γ-secretase inhibitor (GSI) N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine tert-Bu ester (DAPT), at a dose that reduces brain concns. of β-amyloid (100 mg/kg), attenuates the impairment in 20- to 65-wk-old Tg2576 mice.  Importantly, DAPT had no effect on performance of control littermates.  These data are supportive of a role of β-amyloid in the impairment of CFC in Tg2576 mice.  Furthermore, they suggest that acute treatment with GSI may provide improved cognitive functioning as well as disease-modifying effects in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXYk2LoMtDdrVg90H21EOLACvtfcHk0li4lEab6XgQIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7rE&md5=fbfc0b5caefdde799667072b5683799a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2693-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2693-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DMartone%26aufirst%3DR.%2BL.%26aulast%3DAchmies%26aufirst%3DS.%26aulast%3DAtchinson%26aufirst%3DK.%2BP.%26aulast%3DDiamantidis%26aufirst%3DG.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DAcute%2520g-secretase%2520inhibition%2520improves%2520contextual%2520fear%2520conditioning%2520in%2520the%2520Tg2576%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D8898%26epage%3D8902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2008&pages=159-170&author=S+Rosenzweig-Lipsonauthor=A.+Sabbauthor=G.+Stackauthor=P.+Mitchelauthor=I.+Luckiauthor=J.+E.+Malbergauthor=S.+Grauerauthor=J.+Brennanauthor=J.+F.+Cryanauthor=S.+J.+Sukoff-Rizzoauthor=J.+Dunlopauthor=J.+E.+Barrettauthor=K.+L.+Marquis&title=Antidepressant-like+effects+of+the+novel%2C+selective%2C+5-HT2C+receptor+agonist+WAY-163909+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS%26aulast%3DSabb%26aufirst%3DA.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMitchel%26aufirst%3DP.%26aulast%3DLucki%26aufirst%3DI.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520novel%252C%2520selective%252C%25205-HT2C%2520receptor%2520agonist%2520WAY-163909%2520in%2520rodents%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D192%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="ref53_1"><span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potestio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Benzodioxanylpiperazine Derivatives as Potent Serotonin 5-HT<sub>1A</sub> Antagonists: The Discovery of Lecozotan</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3467</span><span class="NLM_x">–</span> <span class="NLM_lpage">3470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049493z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3467-3470&author=W.+E.+Childersauthor=M.+A.+Abou-Gharbiaauthor=M.+G.+Kellyauthor=T.+H.+Andreeauthor=B.+L.+Harrisonauthor=D.+M.+Hoauthor=G.+Hornbyauthor=D.+M.+Hurynauthor=L.+Potestioauthor=S.+J.+Rosenzweig-Lipsonauthor=J.+Schmidauthor=D.+L.+Smithauthor=S.+J.+Sukoffauthor=G.+Zhangauthor=L.+E.+Schechter&title=Synthesis+and+Biological+Evaluation+of+Benzodioxanylpiperazine+Derivatives+as+Potent+Serotonin+5-HT1A+Antagonists%3A+The+Discovery+of+Lecozotan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref53_1&amp;dbid=16384&amp;doi=10.1021%2Fjm049493z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049493z%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHo%26aufirst%3DD.%2BM.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DPotestio%26aufirst%3DL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%2BJ.%26aulast%3DSchmid%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Benzodioxanylpiperazine%2520Derivatives%2520as%2520Potent%2520Serotonin%25205-HT1A%2520Antagonists%253A%2520The%2520Discovery%2520of%2520Lecozotan%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3467%26epage%3D3470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['ref53_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xudong Cao, Yifang Zhang, Yin Chen, Yinli Qiu, Minquan Yu, Xiangqing Xu, Xin Liu, Bi-Feng Liu, Liangren Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Guisen Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10017-10039. <a href="https://doi.org/10.1021/acs.jmedchem.8b01096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BFused%252BTricyclic%252BHeterocycle%252BPiperazine%252B%252528Piperidine%252529%252BDerivatives%252BAs%252BPotential%252BMultireceptor%252BAtypical%252BAntipsychotics%26aulast%3DCao%26aufirst%3DXudong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D09112018%26date%3D01112018%26volume%3D61%26issue%3D22%26spage%3D10017%26epage%3D10039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Dilly</span> and <span class="hlFld-ContribAuthor ">Jean-François  Liégeois</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Insights into 5-HT1A/D4 Selectivity of WAY-100635 Analogues: Molecular Modeling, Synthesis, and in Vitro Binding. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (7)
                                     , 1324-1331. <a href="https://doi.org/10.1021/acs.jcim.5b00753" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00753%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructural%252BInsights%252Binto%252B5-HT1A%25252FD4%252BSelectivity%252Bof%252BWAY-100635%252BAnalogues%25253A%252BMolecular%252BModeling%25252C%252BSynthesis%25252C%252Band%252Bin%252BVitro%252BBinding%26aulast%3DDilly%26aufirst%3DS%25C3%25A9bastien%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D28122015%26date%3D13072016%26date%3D25072016%26date%3D22062016%26volume%3D56%26issue%3D7%26spage%3D1324%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olesya A.  Tomashenko</span> and <span class="hlFld-ContribAuthor ">Vladimir V.  Grushin</span>  . </span><span class="cited-content_cbyCitation_article-title">Aromatic Trifluoromethylation with Metal Complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2011,</strong> <em>111 </em>
                                    (8)
                                     , 4475-4521. <a href="https://doi.org/10.1021/cr1004293" title="DOI URL">https://doi.org/10.1021/cr1004293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr1004293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr1004293%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DAromatic%252BTrifluoromethylation%252Bwith%252BMetal%252BComplexes%26aulast%3DTomashenko%26aufirst%3DOlesya%2BA.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D15122010%26date%3D01042011%26date%3D10082011%26volume%3D111%26issue%3D8%26spage%3D4475%26epage%3D4521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Xuefei  Tan</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Liping  Song</span>, <span class="hlFld-ContribAuthor ">Weiguo  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of perfluoroalkylated quinolines via a metal-free cascade Michael addition/intramolecular rearrangement cyclization process. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (43)
                                     , 131518. <a href="https://doi.org/10.1016/j.tet.2020.131518" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131518%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bperfluoroalkylated%252Bquinolines%252Bvia%252Ba%252Bmetal-free%252Bcascade%252BMichael%252Baddition%25252Fintramolecular%252Brearrangement%252Bcyclization%252Bprocess%26aulast%3DWu%26aufirst%3DJun%26date%3D2020%26volume%3D76%26issue%3D43%26spage%3D131518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa C.  Denler</span>, <span class="hlFld-ContribAuthor ">Gayan B.  Wijeratne</span>, <span class="hlFld-ContribAuthor ">Derek B.  Rice</span>, <span class="hlFld-ContribAuthor ">Hannah E.  Colmer</span>, <span class="hlFld-ContribAuthor ">Victor W.  Day</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Mn
              III
              -Peroxo adduct supported by a new tetradentate ligand shows acid-sensitive aldehyde deformylation reactivity. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2018,</strong> <em>47 </em>
                                    (38)
                                     , 13442-13458. <a href="https://doi.org/10.1039/C8DT02300J" title="DOI URL">https://doi.org/10.1039/C8DT02300J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8DT02300J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8DT02300J%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DMn%252BIII%252B-Peroxo%252Badduct%252Bsupported%252Bby%252Ba%252Bnew%252Btetradentate%252Bligand%252Bshows%252Bacid-sensitive%252Baldehyde%252Bdeformylation%252Breactivity%26aulast%3DDenler%26aufirst%3DMelissa%2BC.%26date%3D2018%26date%3D2018%26volume%3D47%26issue%3D38%26spage%3D13442%26epage%3D13458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amra  Ibric</span>, <span class="hlFld-ContribAuthor ">Kathrin  Dutter</span>, <span class="hlFld-ContribAuthor ">Brigitte  Marian</span>, <span class="hlFld-ContribAuthor ">Norbert  Haider</span>. </span><span class="cited-content_cbyCitation_article-title">A Facile Oxidative Opening of the C-Ring in Luotonin A and Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (9)
                                     , 1540. <a href="https://doi.org/10.3390/molecules22091540" title="DOI URL">https://doi.org/10.3390/molecules22091540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22091540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22091540%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BFacile%252BOxidative%252BOpening%252Bof%252Bthe%252BC-Ring%252Bin%252BLuotonin%252BA%252Band%252BDerivatives%26aulast%3DIbric%26aufirst%3DAmra%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D9%26spage%3D1540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandrina D.  Skolyapova</span>, <span class="hlFld-ContribAuthor ">Galina A.  Selivanova</span>, <span class="hlFld-ContribAuthor ">Evgeny V.  Tretyakov</span>, <span class="hlFld-ContribAuthor ">Tatjana F.  Bogdanova</span>, <span class="hlFld-ContribAuthor ">Lyudmila N.  Shchegoleva</span>, <span class="hlFld-ContribAuthor ">Irina Yu.  Bagryanskaya</span>, <span class="hlFld-ContribAuthor ">Larisa Yu.  Gurskaya</span>, <span class="hlFld-ContribAuthor ">Vitalij D.  Shteingarts</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of polyfluorinated 2-chloroquinolines with ammonia. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (9)
                                     , 1219-1229. <a href="https://doi.org/10.1016/j.tet.2017.01.026" title="DOI URL">https://doi.org/10.1016/j.tet.2017.01.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.01.026%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DInteraction%252Bof%252Bpolyfluorinated%252B2-chloroquinolines%252Bwith%252Bammonia%26aulast%3DSkolyapova%26aufirst%3DAlexandrina%2BD.%26date%3D2017%26volume%3D73%26issue%3D9%26spage%3D1219%26epage%3D1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galina N.  Lipunova</span>, <span class="hlFld-ContribAuthor ">Emiliya V.  Nosova</span>, <span class="hlFld-ContribAuthor ">Valery N.  Charushin</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorinated Quinolines: Synthesis, Properties and Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 59-109. <a href="https://doi.org/10.1007/978-3-319-04435-4_2" title="DOI URL">https://doi.org/10.1007/978-3-319-04435-4_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-04435-4_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-04435-4_2%26sid%3Dliteratum%253Aachs%26atitle%3DFluorinated%252BQuinolines%25253A%252BSynthesis%25252C%252BProperties%252Band%252BApplications%26aulast%3DLipunova%26aufirst%3DGalina%2BN.%26date%3D2014%26date%3D2014%26spage%3D59%26epage%3D109%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DFluorine%252Bin%252BHeterocyclic%252BChemistry%252BVolume%252B2%26aulast%3DNenajdenko%26aufirst%3DValentine%26date%3D2014%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Floriane  Mangin</span>, <span class="hlFld-ContribAuthor ">Sébastien  Dilly</span>, <span class="hlFld-ContribAuthor ">Benoît  Joly</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Scuvée-Moreau</span>, <span class="hlFld-ContribAuthor ">Jon  Evans</span>, <span class="hlFld-ContribAuthor ">Vincent  Setola</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Jean-François  Liégeois</span>. </span><span class="cited-content_cbyCitation_article-title">Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (14)
                                     , 4550-4554. <a href="https://doi.org/10.1016/j.bmcl.2012.05.119" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.119%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DModerate%252Bchemical%252Bmodifications%252Bof%252BWAY-100635%252Bimprove%252Bthe%252Bselectivity%252Bfor%252B5-HT1A%252Bversus%252BD4%252Breceptors%26aulast%3DMangin%26aufirst%3DFloriane%26date%3D2012%26volume%3D22%26issue%3D14%26spage%3D4550%26epage%3D4554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Werner J.  Geldenhuys</span>, <span class="hlFld-ContribAuthor ">Cornelis J.  Van der Schyf</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Serotonin in Alzheimerʼs Disease. </span><span class="cited-content_cbyCitation_journal-name">CNS Drugs</span><span> <strong>2011,</strong> <em>25 </em>
                                    (9)
                                     , 765-781. <a href="https://doi.org/10.2165/11590190-000000000-00000" title="DOI URL">https://doi.org/10.2165/11590190-000000000-00000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2165/11590190-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2165%2F11590190-000000000-00000%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Drugs%26atitle%3DRole%252Bof%252BSerotonin%252Bin%252BAlzheimer%2525CA%2525BCs%252BDisease%26aulast%3DGeldenhuys%26aufirst%3DWerner%2BJ.%26date%3D2011%26volume%3D25%26issue%3D9%26spage%3D765%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaobo  Gu</span>, <span class="hlFld-ContribAuthor ">Sari  Izenwasser</span>, <span class="hlFld-ContribAuthor ">Dean  Wade</span>, <span class="hlFld-ContribAuthor ">Amy  Housman</span>, <span class="hlFld-ContribAuthor ">Gerard  Gulasey</span>, <span class="hlFld-ContribAuthor ">Jill B.  Rhoden</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Savoie</span>, <span class="hlFld-ContribAuthor ">David L.  Mobley</span>, <span class="hlFld-ContribAuthor ">Stacey A.  Lomenzo</span>, <span class="hlFld-ContribAuthor ">Mark L.  Trudell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity studies of benzyl ester meperidine and normeperidine derivatives as selective serotonin transporter ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (23)
                                     , 8356-8364. <a href="https://doi.org/10.1016/j.bmc.2010.09.060" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.09.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.09.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.09.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Bstudies%252Bof%252Bbenzyl%252Bester%252Bmeperidine%252Band%252Bnormeperidine%252Bderivatives%252Bas%252Bselective%252Bserotonin%252Btransporter%252Bligands%26aulast%3DGu%26aufirst%3DXiaobo%26date%3D2010%26volume%3D18%26issue%3D23%26spage%3D8356%26epage%3D8364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative 5-HT<sub>1A</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Aryl-piperazine 5-HT<sub>1A</sub> antagonists and partial agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Recently identified 5-HT<sub>1A</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaBH<sub>3</sub>CN, room temperature, overnight.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Fe<sub>2</sub>(SO<sub>4</sub>)<sub>3</sub>, glycerol, H<sub>3</sub>BO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, 150 °C; (ii) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>; (iii) <i>tert</i>-butoxycarbonylpiperazine, sodium <i>tert</i>-butoxide, CYMAP, Pd<sub>2</sub>(dba)<sub>3</sub>; (iv) 4N HCl/dioxane.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) for X = Cl, 1,4-dioxa-8-azaspiro-4,5-decane, <i>tert</i>-butoxide, CYMAP, Pd<sub>2</sub>(dba)<sub>3</sub>; For X = Br, 1,4-dioxo-8-azaspiro-4,5-decane, <i>tert</i>-butoxide, BINAP, Pd<sub>2</sub>(dba)<sub>3</sub>; (ii) 2N NCl/diethyl ether.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1,4-dioxa-8-azaspiro-4,5-decane, 120 °C; (ii) separation of 7- and 8-fluororegioisomers by flash chromatography; (iii) 2N HCl/diethyl ether.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Microsomal metabolism of compound <b>10a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Microsomal metabolism of compound <b>10b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of compounds <b>10b</b> and <b>10r</b> (10 mg/kg po) on rat cortical 5-HT levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>10b</b> (10 mg/kg po) on rat hippocampal acetylcholine levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0015.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (a) Effect of <b>10b</b> novel object recognition; (b) receptor occupancy of <b>10b</b> in rat cortex and hippocampus.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0016.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Reversal of MK-801-induced deficit in novel object recognition by <b>10b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0017.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Reversal of scopolamine-induced deficit in novel object recognition by <b>10b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0018.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cognitive-enhancing synergy of <b>10b</b> and donepazil in novel object recognition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0019.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Cognitive enhancing effects of <b>10b</b> in the Atlantis water maze model: (a) training/dosing schedule; (b) training phase; (c) memory trials.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0020.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Cognitive enhancing effect of <b>10b</b> on contextual memory in Tg2576 mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0021.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <b>10b</b> enhances the acute effect of fluoxetine on rat cortical 5-HT levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0022.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. <b>10b</b> enhances the effect of fluoxetine on adjuvant drinking in schedule-induced polydipsia: (a) fluoxetine dose−response; (b) effect of <b>10b</b>/fluoxetine combination on SIP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/medium/jm-2010-000908_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0023.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. <b>10b</b> (10 mg/kg po) enhances the antidepressant-like effect of fluoxetine on olfactory bulbectomized rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-10/jm1000908/production/images/large/jm-2010-000908_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1000908&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i110">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Pedigo, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. I.</span><span> </span><span class="NLM_article-title">Discrimination of multiple [<sup>3</sup>H] 5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1111%2Fj.1471-4159.1981.tb02397.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=7463047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaL3MXnslWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1981&pages=220-226&author=N.+W.+Pedigoauthor=H.+I.+Yamamuraauthor=D.+I.+Nelson&title=Discrimination+of+multiple+%5B3H%5D+5-hydroxytryptamine+binding+sites+by+the+neuroleptic+spiperone+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain</span></div><div class="casAuthors">Pedigo, N. W.; Yamamura, H. I.; Nelson, D. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">220-6</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Certain neuroleptic drugs, such as spiperone (I)  [749-02-0] and (+)-butaclamol  [56245-67-1] can discriminate between 2 populations of 3H-labeled 5-hydroxytryptamine (II)  [50-67-9] binding sites in rat brain.  I shows the greatest selectivity for these 2 binding sites, having at least a 3000-fold difference between its dissocn. consts. (2-12 nM vs. 35,000 nM) for the high- and low-affinity sites, resp.  Inhibition of II-3H binding by I in rat frontal cortex and corpus striatum yields distinctly biphasic inhibition curves with Hill slopes less than unity.  Results from nonlinear regression anal. of these inhibition studies were consistent with a 2-site model in each brain region.  In the frontal cortex the high-affinity neuroleptic sites comprised about 60% of the total II-3H binding sites whereas in the corpus striatum they accounted for only 20% of the sites.  Satn. studies of II-3H binding assayed in the absence or presence of 1 μM-I (a concn. that completely blocks the high-affinity site while having min. activity at the low-affinity site) reveal a parallel shift in the Scatchard plot with no change in the dissocn. const. of II-3H, but a decrease (64% in frontal cortex or 28% in corpus striatum) in the no. of sp. binding sites.  These observations are consistent with the existence of at least 2 populations of II-3H binding sites having a differential regional distribution in rat brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOwsKDV8Yk1LVg90H21EOLACvtfcHk0lhlwAVN_IYq5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXnslWquw%253D%253D&md5=cf0bb418780c102c22ea4a63ad3daa99</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1981.tb02397.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1981.tb02397.x%26sid%3Dliteratum%253Aachs%26aulast%3DPedigo%26aufirst%3DN.%2BW.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DNelson%26aufirst%3DD.%2BI.%26atitle%3DDiscrimination%2520of%2520multiple%2520%255B3H%255D%25205-hydroxytryptamine%2520binding%2520sites%2520by%2520the%2520neuroleptic%2520spiperone%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1981%26volume%3D36%26spage%3D220%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Fargin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">The genomic clone G-21 which ersembles a β-adrenergic reeptor sequence encodes the 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">335</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=1988&pages=358-360&author=A.+Farginauthor=J.+R.+Raymondauthor=M.+J.+Lohseauthor=B.+K.+Kobilkaauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=The+genomic+clone+G-21+which+ersembles+a+%CE%B2-adrenergic+reeptor+sequence+encodes+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFargin%26aufirst%3DA.%26aulast%3DRaymond%26aufirst%3DJ.%2BR.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520genomic%2520clone%2520G-21%2520which%2520ersembles%2520a%2520%25CE%25B2-adrenergic%2520reeptor%2520sequence%2520encodes%2520the%25205-HT1A%2520receptor%26jtitle%3DNature%26date%3D1988%26volume%3D335%26spage%3D358%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span> </span><span class="NLM_article-title">5-HT<sub>1A</sub> receptor, an old target for new therapeutic agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024</span><span class="NLM_x">–</span> <span class="NLM_lpage">1034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.2174%2F156802608785161385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=18691130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1024-1034&author=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Berardiauthor=R.+Perrone&title=5-HT1A+receptor%2C+an+old+target+for+new+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A receptor, an old target for new therapeutic agents</span></div><div class="casAuthors">Lacivita, Enza; Leopoldo, Marcello; Berardi, Francesco; Perrone, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1024-1034</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin receptor subtype 5-HT1A was one of the first serotonin receptor subtypes pharmacol. characterized.  Over the last twenty years the 5-HT1A receptor has been the object of intense research efforts as witnessed by the 5-HT1A acting drugs marketed as anxiolytics.  In recent years, several new chem. entities targeting the 5-HT1A receptor (alone or in combination with other mol. targets) have been proposed for novel therapeutic indications (neuroprotection, cognitive impairment, Parkinson Disease and related disorders, pain treatment).  The present review will focus on those 5-HT1A receptor agents that entered preclin. trials starting from 2000.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquGiFKFKnqLrVg90H21EOLACvtfcHk0ljGuGzBcIlcmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1Ohtb4%253D&md5=cd19fc17c1edcfec3977fffe3920480d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156802608785161385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161385%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26atitle%3D5-HT1A%2520receptor%252C%2520an%2520old%2520target%2520for%2520new%2520therapeutic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1024%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">King, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fone, K. C. F.</span><span> </span><span class="NLM_article-title">A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">482</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=482-492&author=M.+V.+Kingauthor=C.+A.+Marsdenauthor=K.+C.+F.+Fone&title=A+role+for+the+5-HT1A%2C+5-HT4+and+5-HT6+receptors+in+learning+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DM.%2BV.%26aulast%3DMarsden%26aufirst%3DC.%2BA.%26aulast%3DFone%26aufirst%3DK.%2BC.%2BF.%26atitle%3DA%2520role%2520for%2520the%25205-HT1A%252C%25205-HT4%2520and%25205-HT6%2520receptors%2520in%2520learning%2520and%2520memory%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D482%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ogren, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikkson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elvander-Tottie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addario, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekstrom, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meister, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiedl, O.</span><span> </span><span class="NLM_article-title">The role of 5-HT<sub>1A</sub> receptors in learning and memory</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=54-77&author=S.+O.+Ogrenauthor=T.+M.+Erikksonauthor=E.+Elvander-Tottieauthor=C.+D%E2%80%99Addarioauthor=J.+C.+Ekstromauthor=P.+Svenningssonauthor=B.+Meisterauthor=J.+Kehrauthor=O.+Stiedl&title=The+role+of+5-HT1A+receptors+in+learning+and+memory"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgren%26aufirst%3DS.%2BO.%26aulast%3DErikkson%26aufirst%3DT.%2BM.%26aulast%3DElvander-Tottie%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Addario%26aufirst%3DC.%26aulast%3DEkstrom%26aufirst%3DJ.%2BC.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DMeister%26aufirst%3DB.%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DStiedl%26aufirst%3DO.%26atitle%3DThe%2520role%2520of%25205-HT1A%2520receptors%2520in%2520learning%2520and%2520memory%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D195%26spage%3D54%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chalmers, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. J.</span><span> </span><span class="NLM_article-title">Comparative anatomical distribution of 5-HT<sub>1A</sub> messenger-RNA and 5-HT<sub>1A</sub> binding in rat brain—a combined in situ hybridisation in vitro receptor autoradiography study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">561</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0006-8993%2891%2990748-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=1797349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK38XjsV2hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=561&publication_year=1991&pages=51-60&author=D.+T.+Chalmersauthor=S.+J.+Watson&title=Comparative+anatomical+distribution+of+5-HT1A+messenger-RNA+and+5-HT1A+binding+in+rat+brain%E2%80%94a+combined+in+situ+hybridisation+in+vitro+receptor+autoradiography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain.  A combined in situ hybridization/in vitro receptor autoradiographic study</span></div><div class="casAuthors">Chalmers, D. T.; Watson, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">561</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-60</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The present study examd. the comparative distribution of 5-HT1A receptor mRNA and 5-HT1A receptors in rat brain using a combination of in situ hybridization histochem. and in vitro receptor autoradiog.  5-HT1A mRNA was visualized using a 910 bp cRNA probe synthesized from a BalI-PvuII fragment of the rat 5-HT1A receptor gene, whereas 5-HT1A receptors were labeled with the 5-HT1A-selective ligand 8-OH-DPAT.  In general terms, there was a complementary distribution of cells expressing 5-HT1A receptor mRNA and 5-HT1A receptor sites.  High levels of both 5-HT1A mRNA and 5-HT1A receptors were evident in the hippocampal formation (CA1, CA3, dentate gyrus), entorhinal cortex, and raphe nuclei and lower levels in neocortex and thalamus.  Although 5-HT1A mRNA was not expressed in any regions which did not also exhibit 5-HT1A receptors, within both the diagonal band and the medial septal nucleus mRNA levels were proportionately higher than 5-HT1A receptor levels, possibly reflecting receptor transport or a heterogeneity in 5-HT1A receptor turnover mechanisms.  The 5-HT1A receptor mRNA and 5-HT1A binding sites were undetectable in caudate/putamen and cerebellar regions.  Data support the synthesis of 5-HT1A receptors both in raphe serotonergic cells and anatomically specific serotoninergic projection areas, further supporting both a presynaptic autoregulatory and postsynaptic modulatory role for this receptor in serotonergic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIGWkgARuw3LVg90H21EOLACvtfcHk0ljGuGzBcIlcmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XjsV2hsg%253D%253D&md5=ff983aee9366f5e5709ac7037c053a2e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990748-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990748-K%26sid%3Dliteratum%253Aachs%26aulast%3DChalmers%26aufirst%3DD.%2BT.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26atitle%3DComparative%2520anatomical%2520distribution%2520of%25205-HT1A%2520messenger-RNA%2520and%25205-HT1A%2520binding%2520in%2520rat%2520brain%25E2%2580%2594a%2520combined%2520in%2520situ%2520hybridisation%2520in%2520vitro%2520receptor%2520autoradiography%2520study%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D561%26spage%3D51%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aschmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feingold, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (<i>R</i>)-(2-methyl)-(4-indolyl-1-piperazinyl)ethyl)-<i>N</i>-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1124%2Fjpet.107.133082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=18182558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=134-145&author=W.+D.+Hirstauthor=T.+H.+Andreeauthor=S.+Aschmiesauthor=W.+E.+Childersauthor=T.+A.+Comeryauthor=L.+A.+Dawsonauthor=M.+Dayauthor=I.+B.+Feingoldauthor=S.+M.+Grauerauthor=B.+L.+Harrisonauthor=Z.+A.+Hughesauthor=J.+Kaoauthor=M.+G.+Kellyauthor=H.+van+der+Leeauthor=S.+Rosenzweig-Lipsonauthor=A.+L.+Saabauthor=D.+L.+Smithauthor=K.+Sullivanauthor=S.+J.+Sukoff-Rizzoauthor=C.+Tioauthor=M.-Y.+Zhangauthor=L.+E.+Schechter&title=Correlating+efficacy+in+rodent+cognition+models+with+in+vivo+5-hydroxytryptamine1A+receptor+occupancy+by+a+novel+antagonist%2C+%28R%29-%282-methyl%29-%284-indolyl-1-piperazinyl%29ethyl%29-N-%282-pyridinyl%29-cyclohexane+carboxamide+%28WAY-101405%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)</span></div><div class="casAuthors">Hirst, Warren D.; Andree, Terrance H.; Aschmies, Suzan; Childers, Wayne E.; Comery, Thomas A.; Dawson, Lee A.; Day, Mark; Feingold, Irene B.; Grauer, Steven M.; Harrison, Boyd L.; Hughes, Zoe A.; Kao, John; Kelly, Michael G.; van der Lee, Heidi; Rosenzweig-Lipson, Sharon; Saab, Annmarie L.; Smith, Deborah L.; Sullivan, Kelly; Rizzo, Stacey J. Sukoff; Tio, Cesario; Zhang, Mei-Yi; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-145</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)1A receptors play an important role in multiple cognitive processes, and compelling evidence suggests that 5-HT1A antagonists can reverse cognitive impairment.  We have examd. the therapeutic potential of a potent (Ki = 1.1 nM), selective (>100-fold), orally bioavailable, silent 5-HT1A receptor antagonist (KB = 1.3 nM) (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)-ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).  Oral administration of WAY-101405 was shown to be effective in multiple rodent models of learning and memory.  In a novel object recognition paradigm, 1 mg/kg enhanced retention (memory) for previously learned information, and it was able to reverse the memory deficits induced by scopolamine.  WAY-101405 (1 mg/kg) was also able to reverse scopolamine-induced deficits in a rat contextual fear conditioning model.  In the Morris water maze, WAY-101405 (3 mg/kg) significantly improved learning in a paradigm of increasing task difficulty.  In vivo microdialysis studies in the dorsal hippocampus of freely moving adult rats demonstrated that acute administration of WAY-101405 (10 mg/kg) increased extracellular acetylcholine levels.  The selective radioligand [3H]WAY-100635, administered i.v., was used for in vivo receptor occupancy studies, where WAY-101405 occupied 50HT1A receptors in the rat cortex, with an ED50 value of 0.1 mg/kg p.o.  Taken together, these studies demonstrate that WAY-101405 is a potent and selective, brain penetrant, orally bioavailable 5-HT1A receptor "silent" antagonist that is effective in preclin. memory paradigms at doses where approx. 90% of the postsynaptic 5-HT1A receptors are occupied.  These results further support the rationale for use of this compd. class in the treatment of cognitive dysfunction assocd. with psychiatric and neurol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiHA4lNdFCubVg90H21EOLACvtfcHk0lgnQ-RxolqTvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFGjtL0%253D&md5=32bf330b68ae1b11a2013e4563b8f686</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133082%26sid%3Dliteratum%253Aachs%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DAschmies%26aufirst%3DS.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DDay%26aufirst%3DM.%26aulast%3DFeingold%26aufirst%3DI.%2BB.%26aulast%3DGrauer%26aufirst%3DS.%2BM.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DKao%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3Dvan%2Bder%2BLee%26aufirst%3DH.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSaab%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DTio%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DM.-Y.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DCorrelating%2520efficacy%2520in%2520rodent%2520cognition%2520models%2520with%2520in%2520vivo%25205-hydroxytryptamine1A%2520receptor%2520occupancy%2520by%2520a%2520novel%2520antagonist%252C%2520%2528R%2529-%25282-methyl%2529-%25284-indolyl-1-piperazinyl%2529ethyl%2529-N-%25282-pyridinyl%2529-cyclohexane%2520carboxamide%2520%2528WAY-101405%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D134%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsolt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meneses, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cara, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivet, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocaer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peglion, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dekeyne, A.</span><span> </span><span class="NLM_article-title">The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive runction in rodents: a combined neurochemical and behavioral analysis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1124%2Fjpet.104.069625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=15146031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVKrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2004&pages=190-203&author=M.+J.+Millanauthor=A.+Gobertauthor=S.+Rouxauthor=R.+Porsoltauthor=A.+Menesesauthor=M.+Carliauthor=B.+Di+Caraauthor=R.+Jaffardauthor=J.-M.+Rivetauthor=P.+Lestageauthor=E.+Mocaerauthor=J.-L.+Peglionauthor=A.+dekeyne&title=The+serotonin1A+receptor+partial+agonist+S15535+%5B4-%28benzodioxan-5-yl%29-1-%28indan-2-yl%29piperazine%5D+enhances+cholinergic+transmission+and+cognitive+runction+in+rodents%3A+a+combined+neurochemical+and+behavioral+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: A combined neurochemical and behavioral analysis</span></div><div class="casAuthors">Millan, Mark J.; Gobert, Alain; Roux, Sylvain; Porsolt, Roger; Meneses, Alfredo; Carli, Mirjana; di Cara, Benjamin; Jaffard, Robert; Rivet, Jean-Michel; Lestage, Pierre; Mocaer, Elisabeth; Peglion, Jean-Louis; Dekeyne, Anne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-203</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">These studies examd. the influence of the selective 5-hydroxytryptamine (serotonin) (5-HT)1A receptor partial agonist S15535 upon cholinergic transmission and cognitive function in rodents.  In the absence of acetylcholinesterase inhibitors, S15535 dose-dependently (0.04-5.0 mg/kg s.c.) elevated dialysis levels of acetylcholine in the frontal cortex and dorsal hippocampus of freely moving rats.  In the cortex, the selective 5-HT1A receptor antagonist WAY100,635 [(N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl)cyclohexanecarboxamide) fumarate] dose-dependently (0.0025-0.63) blocked this action of S15535.  By contrast, in dorsal hippocampus, WAY100,635 mimicked the induction of acetylcholine release by S15535.  In a social recognition paradigm, S15535 dose-dependently (0.16-10.0) improved retention, an action blocked by WAY100,635 (0.16), which was ineffective alone.  Furthermore, S15535 dose-dependently (0.04-2.5) and WAY100,635 reversibly abolished amnesic properties of the muscarinic antagonist scopolamine (0.63) in this procedure.  Cognitive deficits provoked by scopolamine in autoshaping and Morris water-maze procedures were likewise blocked by S15535 at doses of 0.63 to 10.0 and 0.16 to 2.5, resp.  In a two-platform spatial discrimination task, in which S15535 similarly abrogates cognitive deficits elicited by scopolamine, injection of S15535 (1.0 and 10.0 μg) into dorsal hippocampus blocked amnesic effects of the 5-HT1A agonist 8-hydroxy-2-dipropylaminotetralin (0.5 μg).  Finally, S15535 (0.16-0.63) improved performance in a spatial, delayed nonmatching to sample model in mice, and in an operant delayed nonmatching to sample model in old rats, S15535 (1.25-5.0 mg/kg p.o.) increased response accuracy and reduced latency to respond.  In conclusion, S15535 reinforces frontocortical and hippocampal release of acetylcholine and displays a broad-based pattern of procognitive properties.  Its actions involve both blockade of postsynaptic 5-HT1A receptors and engagement of 5-HT1A autoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUnJVBszUICbVg90H21EOLACvtfcHk0lgnQ-RxolqTvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVKrt7w%253D&md5=12bc1e3f88cfc729532b4eecb41e61fe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.069625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.069625%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DGobert%26aufirst%3DA.%26aulast%3DRoux%26aufirst%3DS.%26aulast%3DPorsolt%26aufirst%3DR.%26aulast%3DMeneses%26aufirst%3DA.%26aulast%3DCarli%26aufirst%3DM.%26aulast%3DDi%2BCara%26aufirst%3DB.%26aulast%3DJaffard%26aufirst%3DR.%26aulast%3DRivet%26aufirst%3DJ.-M.%26aulast%3DLestage%26aufirst%3DP.%26aulast%3DMocaer%26aufirst%3DE.%26aulast%3DPeglion%26aufirst%3DJ.-L.%26aulast%3Ddekeyne%26aufirst%3DA.%26atitle%3DThe%2520serotonin1A%2520receptor%2520partial%2520agonist%2520S15535%2520%255B4-%2528benzodioxan-5-yl%2529-1-%2528indan-2-yl%2529piperazine%255D%2520enhances%2520cholinergic%2520transmission%2520and%2520cognitive%2520runction%2520in%2520rodents%253A%2520a%2520combined%2520neurochemical%2520and%2520behavioral%2520analysis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D311%26spage%3D190%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawoschik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W.</span><span> </span><span class="NLM_article-title">Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1124%2Fjpet.105.086363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=15951399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1274-1289&author=L.+E.+Schechterauthor=D.+L.+Smithauthor=S.+Rosenzweig-Lipsonauthor=S.+J.+Sukoffauthor=L.+A.+Dawsonauthor=K.+Marquisauthor=D.+Jonesauthor=M.+Pieslaauthor=T.+Andreeauthor=S.+Nawoschikauthor=J.+A.+Harderauthor=M.+D.+Womackauthor=J.+Buccafuscoauthor=A.+V.+Terryauthor=B.+Hoebelauthor=P.+Radaauthor=M.+Kellyauthor=M.+Abou-Gharbiaauthor=J.+E.+Barrettauthor=W.+Childers&title=Lecozotan+%28SRA-333%29%3A+a+selective+serotonin+1A+receptor+antagonist+that+enhances+the+stimulated+release+of+glutamate+and+acetylcholine+in+the+hippocampus+and+possesses+cognitive-enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Lecozotan (SRA-333): A selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span></div><div class="casAuthors">Schechter, L. E.; Smith, D. L.; Rosenzweig-Lipson, S.; Sukoff, S. J.; Dawson, L. A.; Marquis, K.; Jones, D.; Piesla, M.; Andree, T.; Nawoschik, S.; Harder, J. A.; Womack, M. D.; Buccafusco, J.; Terry, A. V.; Hoebel, B.; Rada, P.; Kelly, M.; Abou-Gharbia, M.; Barrett, J. E.; Childers, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1274-1289</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent data has suggested that the 5-hydroxytryptamine (5-HT)1A receptor is involved in cognitive processing.  A novel 5-HT1A receptor antagonist, 4-cyano-N-{2R-[4-(2,3-dihydrobenzo[1,4]-dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide HCl (lecozotan), which has been characterized in multiple in vitro and in vivo pharmacol. assays as a drug to treat cognitive dysfunction, is reported.  In vitro binding and intrinsic activity detns. demonstrated that lecozotan is a potent and selective 5-HT1A receptor antagonist.  Using in vivo microdialysis, lecozotan (0.3 mg/kg s.c.) antagonized the decrease in hippocampal extracellular 5-HT induced by a challenge dose (0.3 mg/kg s.c.) of 8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) and had no effects alone at doses 10-fold higher.  Lecozotan significantly potentiated the potassium chloride-stimulated release of glutamate and acetylcholine in the dentate gyrus of the hippocampus.  Chronic administration of lecozotan did not induce 5-HT1A receptor tolerance or desensitization in a behavioral model indicative of 5-HT1A receptor function.  In drug discrimination studies, lecozotan (0.01-1 mg/kg i.m.) did not substitute for 8-OH-DPAT and produced a dose-related blockade of the 5-HT1A agonist discriminative stimulus cue.  In aged rhesus monkeys, lecozotan produced a significant improvement in task performance efficiency at an optimal dose (1 mg/kg p.o.).  Learning deficits induced by the glutamatergic antagonist MK-801 [(-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate] (assessed by perceptually complex and visual spatial discrimination) and by specific cholinergic lesions of the hippocampus (assessed by visual spatial discrimination) were reversed by lecozotan (2 mg/kg i.m.) in marmosets.  The heterosynaptic nature of the effects of lecozotan imbues this compd. with a novel mechanism of action directed at the biochem. pathologies underlying cognitive loss in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDog5bWsysrLVg90H21EOLACvtfcHk0liOjjSyJRR_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D&md5=4d07a0db6675ddc2238dcca19a4c68b7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.086363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.086363%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DPiesla%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DNawoschik%26aufirst%3DS.%26aulast%3DHarder%26aufirst%3DJ.%2BA.%26aulast%3DWomack%26aufirst%3DM.%2BD.%26aulast%3DBuccafusco%26aufirst%3DJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DHoebel%26aufirst%3DB.%26aulast%3DRada%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DChilders%26aufirst%3DW.%26atitle%3DLecozotan%2520%2528SRA-333%2529%253A%2520a%2520selective%2520serotonin%25201A%2520receptor%2520antagonist%2520that%2520enhances%2520the%2520stimulated%2520release%2520of%2520glutamate%2520and%2520acetylcholine%2520in%2520the%2520hippocampus%2520and%2520possesses%2520cognitive-enhancing%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1274%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Katz, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekell, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bewden, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berm;an, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraer, A.</span><span> </span><span class="NLM_article-title">Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=566-579&author=M.+M.+Katzauthor=J.+L.+Tekellauthor=C.+L.+Bewdenauthor=S.+Brannaauthor=J.+P.+Houstonauthor=N.+Berm%3Banauthor=A.+Fraer&title=Onset+and+early+behavioral+effects+of+pharmacologically+different+antidepressants+and+placebo+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DM.%2BM.%26aulast%3DTekell%26aufirst%3DJ.%2BL.%26aulast%3DBewden%26aufirst%3DC.%2BL.%26aulast%3DBranna%26aufirst%3DS.%26aulast%3DHouston%26aufirst%3DJ.%2BP.%26aulast%3DBerm%253Ban%26aufirst%3DN.%26aulast%3DFraer%26aufirst%3DA.%26atitle%3DOnset%2520and%2520early%2520behavioral%2520effects%2520of%2520pharmacologically%2520different%2520antidepressants%2520and%2520placebo%2520in%2520depression%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D566%26epage%3D579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Clayton, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradko, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montano, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadbetter, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolden-Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, R. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamerson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, A.</span><span> </span><span class="NLM_article-title">Prevalence of sexual dysfunction among newer antidepressants</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.4088%2FJCP.v63n0414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=12000211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A280%3ADC%252BD383lvFKqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=357-366&author=A.+H.+Claytonauthor=J.+F.+Pradkoauthor=J.+A.+Croftauthor=C.+B.+Montanoauthor=R.+A.+Leadbetterauthor=C.+Bolden-Watsonauthor=K.+I.+Bassauthor=R.+M.+J.+Donahueauthor=B.+D.+Jamersonauthor=A.+Metz&title=Prevalence+of+sexual+dysfunction+among+newer+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of sexual dysfunction among newer antidepressants</span></div><div class="casAuthors">Clayton Anita H; Pradko James F; Croft Harry A; Montano C Brendan; Leadbetter Robert A; Bolden-Watson Carolyn; Bass Kristin I; Donahue Rafe M J; Jamerson Brenda D; Metz Alan</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">357-66</span>
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    </div><div class="casAbstract">BACKGROUND:  Sexual dysfunction commonly occurs during antidepressant treatment.  However, the reported rates of sexual dysfunction vary across antidepressants and are typically underreported in product literature.  The objectives of this study were (1) to estimate the prevalence of sexual dysfunction among patients taking newer antidepressants (bupropion immediate release [IR], bupropion sustained release [SR], citalopram, fluoxetine, mirtazapine, nefazodone, paroxetine, sertraline, venlafaxine, and venlafaxine extended release [XR]) and (2) to compare physician-perceived with patient-reported prevalence rates of antidepressant-associated sexual dysfunction.  METHOD:  This cross-sectional, observational study was conducted in 1101 U.S. primary care clinics.  Adult outpatients (4534 women and 1763 men) receiving antidepressant monotherapy were enrolled.  The prevalence of sexual dysfunction was measured using the Changes in Sexual Functioning Questionnaire.  RESULTS:  In the overall population, bupropion IR (22%) and SR (25%) and nefazodone (28%) were associated with the lowest risk for sexual dysfunction, whereas selective serotonin reuptake inhibitor (SSRI) antidepressants, mirtazapine, and venlafaxine XR were associated with higher rates (36%-43%).  In a prospectively defined subpopulation unlikely to have predisposing factors for sexual dysfunction, the prevalence of sexual dysfunction ranged from 7% to 30%, with the odds of having sexual dysfunction 4 to 6 times greater with SSRIs or venlafaxine XR than with bupropion SR.  Physicians consistently underestimated the prevalence of antidepressant-associated sexual dysfunction.  CONCLUSION:  Ours is the first study to assess sexual dysfunction across the newer antidepressants using consistent methodology and a validated rating scale.  Overall, SSRIs and venlafaxine XR were associated with higher rates of sexual dysfunction than bupropion or nefazodone.  Because antidepressant-associated sexual dysfunction is considerably underestimated by physicians, greater recognition and education are imperative when prescribing antidepressant treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrVP0myb4HJpggzHGM8X5CfW6udTcc2ebo8FFzstvG87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383lvFKqtg%253D%253D&md5=02f295669a372600125d61121b1ce7c6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4088%2FJCP.v63n0414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.v63n0414%26sid%3Dliteratum%253Aachs%26aulast%3DClayton%26aufirst%3DA.%2BH.%26aulast%3DPradko%26aufirst%3DJ.%2BF.%26aulast%3DCroft%26aufirst%3DJ.%2BA.%26aulast%3DMontano%26aufirst%3DC.%2BB.%26aulast%3DLeadbetter%26aufirst%3DR.%2BA.%26aulast%3DBolden-Watson%26aufirst%3DC.%26aulast%3DBass%26aufirst%3DK.%2BI.%26aulast%3DDonahue%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DJamerson%26aufirst%3DB.%2BD.%26aulast%3DMetz%26aufirst%3DA.%26atitle%3DPrevalence%2520of%2520sexual%2520dysfunction%2520among%2520newer%2520antidepressants%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2002%26volume%3D63%26spage%3D357%26epage%3D366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kreiss, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">Effects of acute and repreated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo</span> <span class="citation_source-journal">J. Pharamcol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=7636750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2MXnsFSjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=866-876&author=D.+S.+Kreissauthor=I.+Lucki&title=Effects+of+acute+and+repreated+administration+of+antidepressant+drugs+on+extracellular+levels+of+5-hydroxytryptamine+measured+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo</span></div><div class="casAuthors">Kreiss, Deborah S.; Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">866-76</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Extracellular levels of serotonin (5-HT) and the regulation of 5-HT release by the 5-HT1A receptor were examd. after single and repeated treatment with different types of antidepressant drugs: the selective 5-HT uptake inhibitor fluoxetine, the selective norepinephrine uptake inhibitor desipramine and the 5-HT1A/2C/A2 receptor antagonist mianserin (each at 15.0 mg/kg).  Extracellular levels of 5-HT were measured using in vivo microdialysis in the striatum and hippocampus of rats anesthetized with chloral hydrate.  Acute administration of fluoxetine transiently elevated the levels of 5-HT in the striatum and hippocampus; desipramine did not change 5-HT levels, and mianserin slightly decreased 5-HT levels in the hippocampus.  Rats were administered these antidepressant drugs for either 1 or 14 days and studied 48 h after the final injection.  Repeated treatment with fluoxetine increased base-line levels of 5-HT in the striatum and hippocampus; repeated treatment with desipramine increased base-line 5-HT levels in the striatum only, and repeated treatment with mianserin did not alter base-line 5-HT levels.  Repeated fluoxetine treatment attenuated the ability of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) to decrease 5-HT release in both the striatum and hippocampus.  Repeated desipramine treatment did not significantly alter the effects of 8-OH-DPAT on 5-HT release, but there was a hint of a decreased effect in the hippocampus.  Repeated mianserin treatment did not significantly alter the effects of 8-OH-DPAT on 5-HT release, but there was a hint of an increased effect in the striatum.  The results of the present study suggest that repeated treatment with antidepressant drugs alters extracellular levels of 5-HT and the ability of 5-HT1A receptors to regulate the release of 5-HT in a regionally selective manner.  These changes in the regulation of 5-HT release produced by antidepressant drugs may be assocd. with their therapeutic effects, because they are caused by repeated rather than acute treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Vbur4PgdCrVg90H21EOLACvtfcHk0lj01gCMg9-yzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsFSjtLw%253D&md5=b568a4aa72d53fe94acd061f1db7c5e3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreiss%26aufirst%3DD.%2BS.%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DEffects%2520of%2520acute%2520and%2520repreated%2520administration%2520of%2520antidepressant%2520drugs%2520on%2520extracellular%2520levels%2520of%25205-hydroxytryptamine%2520measured%2520in%2520vivo%26jtitle%3DJ.%2520Pharamcol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D274%26spage%3D866%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R. J.</span><span> </span><span class="NLM_article-title">The use of pindolol to potentiate antidepressant medication</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 5</span><span class="NLM_x">) </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=9635544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=16-23&issue=Suppl.+5&author=P.+Blierauthor=R.+J.+Bergeron&title=The+use+of+pindolol+to+potentiate+antidepressant+medication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The use of pindolol to potentiate antidepressant medication</span></div><div class="casAuthors">Blier, Pierre; Bergeron, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">Suppl..5</span>),
    <span class="NLM_cas:pages">16-25</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press</span>)
        </div><div class="casAbstract">A review with 32 refs. followed by a discussion.  Serotonin (5-HT) selective reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors are thought to have a delayed onset of antidepressant action attributable in part to the decrease in firing activity of 5-HT neurons they produce upon treatment initiation.  As cell body 5-HT1A autoreceptors desensitize, 5-HT neuronal firing is restored.  The agent pindolol, through its 5-HT1A receptor blocking property, has been shown to prevent the initial decrease in firing of rat 5-HT neurons assocd. with SSRI treatment.  Four open-label studies put into evidence a significant acceleration of the antidepressant effect of SSRIs when combined with pindolol.  Four of five placebo-controlled studies have confirmed this observation.  Controlled trials indicate that a greater rate of response may be obtained by combining pindolol from the beginning of the SSRI treatment.  The strategy of adding pindolol to the regimen of SSRI-resistant patients also appears to produce a therapeutic effect in a significant proportion of patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz0q4Q6ACnhrVg90H21EOLACvtfcHk0lhYBnGHstg8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslGksLs%253D&md5=a2d5fa78635c0e4427bd9c6fd6039271</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520use%2520of%2520pindolol%2520to%2520potentiate%2520antidepressant%2520medication%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D1998%26volume%3D59%26issue%3DSuppl.%25205%26spage%3D16%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gartside, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowen, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, T.</span><span> </span><span class="NLM_article-title">Effects of (−) tertatolol, 9−0-penbutolol and (±) pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1038%2Fsj.bjp.0702546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=10369467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1999&pages=145-152&author=S.+E.+Gartsideauthor=E.+M.+Cliffordauthor=P.+J.+Cowenauthor=T.+Sharp&title=Effects+of+%28%E2%88%92%29+tertatolol%2C+9%E2%88%920-penbutolol+and+%28%C2%B1%29+pindolol+in+combination+with+paroxetine+on+presynaptic+5-HT+function%3A+an+in+vivo+microdialysis+and+electrophysiological+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of (-)-tertatolol, (-)-penbutolol and (±)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study</span></div><div class="casAuthors">Gartside, S. E.; Clifford, E. M.; Cowen, P. J.; Sharp, T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">1 The antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) might be enhanced by co-administration of 5-HT1A receptor antagonists.  Thus, we have recently shown that the selective 5-HT1A receptor antagonist, WAY 100635, blocks the inhibitory effect of an SSRI on 5-HT cell firing, and enhances its ability to elevate extracellular 5-HT in the forebrain.  Here we detd. whether the β-adrenoceptor/5-HT1A receptor ligands (±)-pindolol, (-)-tertatolol and (-)-penbutolol, interact with paroxetine in a similar manner.  2 Both (-)-tertatolol (2.4 mg kg-1 i.v.) and (-)-penbutolol (2.4 mg kg-1 i.v.) enhanced the effect of paroxetine (0.8 mg kg-1 i.v.) on extracellular 5-HT in the frontal cortex, while (±)-pindolol (4 mg kg-1 i.v.) did not.  (-)-Tertatolol (2.4 mg kg-1 i.v.) alone caused a slight increase in 5-HT however, (-)-penbutolol (2.4 mg kg-1 i.v.) alone had no effect.  3 In electrophysiol. studies (-)-tetratolol (2.4 mg kg-1 i.v.) alone had no effect on 5-HT cell firing but blocked the inhibitory effect of paroxetine.  In contrast, (-)-penbutolol (0.1-0.8 mg kg-1 i.v.) itself inhibited 5-HT cell firing, and this effect was reversed by WAY 100635 (0.1 mg kg-1 i.v.).  We have recently shown that (±)-pindolol inhibits 5-HT cell firing via a WAY 100635-sensitive mechanism.  4 Our data suggest that (-)-tertatolol enhances the effect of paroxetine on forebrain 5-HT via blockade of 5-HT1A autoreceptors which mediate paroxetine-induced inhibition of 5-HT cell firing.  In comparison, the mechanisms by which (-)-penbutolol enhances the effect of paroxetine on extracellular 5-HT in unclear, since (-)-penbutolol itself appears to have agonist properties at the 5-HT1A autoreceptor.  Indeed, the agonist action of (±)-pindolol at 5-HT1A autoreceptors probably explains its inability to enhance the effect of paroxetine on 5-HT in the frontal cortex.  5 Overall, our data suggest that both (-)-tertatolol and (-)-penbutolol are superior to (±)-pindolol in terms of enhancing the effect of an SSRI on extracellular 5-HT.  Both (-)-tertatolol and (-)-penbutolol are worthy of investigation for use as adjuncts to SSRIs in the treatment of major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFPl7th6PbxrVg90H21EOLACvtfcHk0lhYBnGHstg8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVGltrg%253D&md5=6b7d35ad8da449c499ff3e8c5d5ac6dd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702546%26sid%3Dliteratum%253Aachs%26aulast%3DGartside%26aufirst%3DS.%2BE.%26aulast%3DClifford%26aufirst%3DE.%2BM.%26aulast%3DCowen%26aufirst%3DP.%2BJ.%26aulast%3DSharp%26aufirst%3DT.%26atitle%3DEffects%2520of%2520%2528%25E2%2588%2592%2529%2520tertatolol%252C%25209%25E2%2588%25920-penbutolol%2520and%2520%2528%25C2%25B1%2529%2520pindolol%2520in%2520combination%2520with%2520paroxetine%2520on%2520presynaptic%25205-HT%2520function%253A%2520an%2520in%2520vivo%2520microdialysis%2520and%2520electrophysiological%2520study%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D127%26spage%3D145%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">A novel approach for predicting antidepressant-induced sexual dysfunction in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=459-467&author=S.+J.+Sukoff-Rizzoauthor=L.+E.+Schechterauthor=S.+Rosenzweig-Lipson&title=A+novel+approach+for+predicting+antidepressant-induced+sexual+dysfunction+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DA%2520novel%2520approach%2520for%2520predicting%2520antidepressant-induced%2520sexual%2520dysfunction%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D195%26spage%3D459%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Childers, W. E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Lecozotan Hydrochloride</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1358%2Fdof.2007.032.05.1092901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=399-407&author=W.+E.+J.+Childersauthor=B.+L.+Harrisonauthor=M.+A.+Abou-Gharbiaauthor=S.+Rajeauthor=V.+Parksauthor=M.+N.+Pangalosauthor=L.+E.+Schechter&title=Lecozotan+Hydrochloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Cognition enhancer treatment of Alzheimer's disease competitive 5-HT1A receptor antagonist</span></div><div class="casAuthors">Childers, Wayne E., Jr.; Harrison, Boyd L.; Abou-Gharbia, Magid A.; Raje, Sangeeta; Parks, Virginia; Pangalos, Menelas N.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Lecozotan is a potent, selective, competitive, orally active antagonist of the serotonin 5-HT1A receptor in development for the symptomatic treatment of cognitive deficits such as those seen in Alzheimer's disease.  The agent shows no intrinsic activity in a no. of in vitro and in vivo assays, supporting the conclusion that it is a full antagonist under several conditions.  In vivo, lecozotan enhances the potassium-stimulated release of both acetylcholine and glutamate, and it improves cognitive performance in multiple animal models of learning and memory.  The compd. was well tolerated in single- and multiple-ascending-dose (SAD and MAD) safety trials in both young and elderly subjects at total daily doses up to and including 10 mg (5 mg every 12 h) for the immediate-release formulation.  Sustained-release formulations have been developed which provide favorable pharmacokinetics for once-daily dosing.  Lecozotan is currently under investigation in advanced phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzPkCOymtxrVg90H21EOLACvtfcHk0li55Iumq2iD5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D&md5=5149bb9b594cbc636ef22b9e7f57f10c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1358%2Fdof.2007.032.05.1092901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2007.032.05.1092901%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%2BJ.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DRaje%26aufirst%3DS.%26aulast%3DParks%26aufirst%3DV.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DLecozotan%2520Hydrochloride%26jtitle%3DDrugs%2520Future%26date%3D2007%26volume%3D32%26spage%3D399%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boast, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucharik, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of adatanserin: novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potent anxiolytic and antidepresant agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">5077</span><span class="NLM_x">–</span> <span class="NLM_lpage">5094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9806704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5077-5094&author=M.+A.+Abou-Gharbiaauthor=W.+E.+Childersauthor=H.+Fletcherauthor=G.+McGaugheyauthor=U.+Patelauthor=M.+B.+Webbauthor=J.+Yardleyauthor=T.+Andreeauthor=C.+Boastauthor=R.+J.+Kucharikauthor=K.+Marquisauthor=H.+Morrisauthor=R.+Scerniauthor=J.+A.+Moyer&title=Synthesis+and+SAR+of+adatanserin%3A+novel+adamantyl+aryl-+and+heteroarylpiperazines+with+dual+serotonin+5-HT1A+and+5-HT2+activity+as+potent+anxiolytic+and+antidepresant+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm9806704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9806704%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%2BB.%26aulast%3DYardley%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DBoast%26aufirst%3DC.%26aulast%3DKucharik%26aufirst%3DR.%2BJ.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DMorris%26aufirst%3DH.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520adatanserin%253A%2520novel%2520adamantyl%2520aryl-%2520and%2520heteroarylpiperazines%2520with%2520dual%2520serotonin%25205-HT1A%2520and%25205-HT2%2520activity%2520as%2520potent%2520anxiolytic%2520and%2520antidepresant%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5077%26epage%3D5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yocca, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyslop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maayani, S.</span><span> </span><span class="NLM_article-title">BMY 7378, a buspirone analog with hgih affinity, selectivity and low intrinsic activity at the 5-HT<sub>1A</sub> receptor in rat and guinea pig hippocampal membranes</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0014-2999%2887%2990241-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=2886356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaL2sXkvV2ktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1987&pages=293-294&author=F.+D.+Yoccaauthor=D.+K.+Hyslopauthor=D.+W.+Smithauthor=S.+Maayani&title=BMY+7378%2C+a+buspirone+analog+with+hgih+affinity%2C+selectivity+and+low+intrinsic+activity+at+the+5-HT1A+receptor+in+rat+and+guinea+pig+hippocampal+membranes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes</span></div><div class="casAuthors">Yocca, Frank D.; Hyslop, Deborah K.; Smith, David W.; Maayani, Saul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">293-4</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The buspirone analog BMY7378 (I) had a high affinity and selectivity for 5-HT1A binding sites in rat and guinea pig hippocampal membrane prepns.  The drug also had low intrinsic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8uDz1JHp-TrVg90H21EOLACvtfcHk0li55Iumq2iD5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXkvV2ktrg%253D&md5=8fbc365835446dea2348883e5e252aa3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2887%2990241-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252887%252990241-X%26sid%3Dliteratum%253Aachs%26aulast%3DYocca%26aufirst%3DF.%2BD.%26aulast%3DHyslop%26aufirst%3DD.%2BK.%26aulast%3DSmith%26aufirst%3DD.%2BW.%26aulast%3DMaayani%26aufirst%3DS.%26atitle%3DBMY%25207378%252C%2520a%2520buspirone%2520analog%2520with%2520hgih%2520affinity%252C%2520selectivity%2520and%2520low%2520intrinsic%2520activity%2520at%2520the%25205-HT1A%2520receptor%2520in%2520rat%2520and%2520guinea%2520pig%2520hippocampal%2520membranes%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1987%26volume%3D137%26spage%3D293%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Butler, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meegan, M. J.</span><span> </span><span class="NLM_article-title">Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1737</span><span class="NLM_x">–</span> <span class="NLM_lpage">1761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.2174%2F092986708784872357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=18673223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1aqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1737-1761&author=S.+G.+Butlerauthor=M.+J.+Meegan&title=Recent+developments+in+the+design+of+anti-depressive+therapies%3A+targeting+the+serotonin+transporter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter</span></div><div class="casAuthors">Butler, S. G.; Meegan, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1737-1761</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serotonin transporter protein (SERT) has been the target for the development of several modern antidepressants with an objective of achieving selectivity over other monoamine transporters, thereby minimizing side effects obsd. in the older generation of tricyclic antidepressants.  The clin. selective serotonin reuptake inhibitors (SSRIs) have been shown to be among the most effective therapies in the treatment of depression.  However they have clin. disadvantages over other classes of antidepressant drugs such as slow onset of action nausea and sleep disruption.  The neg. feedback loop attributed to the presynaptic 5-HT1A receptors has been implicated in the "time lag" obsd. in many patients between the administration of the SSRI and its obsd. therapeutic action.  In recent years the focus has been on developing compds. with dual affinity for serotonergic auto-receptors along with an inhibitory activity at SERT.  These structurally diverse products promise to be the next generation of anti-depressant medicines.  This review presents an anal. of the recently reported structural classes with SSRI activity and rationalizes the unique relationship between their mol. properties and biol. activities.  Specific emphasis is placed on the development of mol. structures with dual serotonergic activity.  Recent advances in the design and synthesis of single mol. entities possessing 5-HT reuptake inhibition together with 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, DAT, NET, α2-adrenoceptor and acetylcholinesterase antagonism are reviewed.  The structural studies to identify proposed SERT binding sites together with the role of structure and ligand based design in the development of more effective SSRIs are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa7goytgkEtbVg90H21EOLACvtfcHk0lgw58nqNHM3qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1aqs7g%253D&md5=52c784e6665b0cd7e0cd4f055259804f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F092986708784872357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784872357%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DS.%2BG.%26aulast%3DMeegan%26aufirst%3DM.%2BJ.%26atitle%3DRecent%2520developments%2520in%2520the%2520design%2520of%2520anti-depressive%2520therapies%253A%2520targeting%2520the%2520serotonin%2520transporter%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D1737%26epage%3D1761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hatzenbuhler, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baudy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Failli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenecek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saab, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chlenov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golembieski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Advanced toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6980</span><span class="NLM_x">–</span> <span class="NLM_lpage">7004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8007097" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6980-7004&author=N.+T.+Hatzenbuhlerauthor=R.+Baudyauthor=D.+A.+Evrardauthor=A.+Failliauthor=B.+L.+Harrisonauthor=S.+Lenecekauthor=R.+E.+Mewshawauthor=A.+Saabauthor=U.+Shahauthor=J.+Szeauthor=M.+Zhangauthor=D.+Zhouauthor=M.+Chlenovauthor=M.+Kagenauthor=J.+Golembieskiauthor=G.+Hornbyauthor=M.+Laiauthor=D.+L.+Smithauthor=K.+M.+Sullivanauthor=L.+E.+Schechterauthor=T.+H.+Andree&title=Advanced+toward+new+antidepressants+with+dual+serotonin+transporter+and+5-HT1A+receptor+affinity+within+a+class+of+3-aminochroman+derivatives.+Part+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm8007097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8007097%26sid%3Dliteratum%253Aachs%26aulast%3DHatzenbuhler%26aufirst%3DN.%2BT.%26aulast%3DBaudy%26aufirst%3DR.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DFailli%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DLenecek%26aufirst%3DS.%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DSaab%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DU.%26aulast%3DSze%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DKagen%26aufirst%3DM.%26aulast%3DGolembieski%26aufirst%3DJ.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DLai%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DAdvanced%2520toward%2520new%2520antidepressants%2520with%2520dual%2520serotonin%2520transporter%2520and%25205-HT1A%2520receptor%2520affinity%2520within%2520a%2520class%2520of%25203-aminochroman%2520derivatives.%2520Part%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6980%26epage%3D7004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hatzenbuhler, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraml, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. A.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4785</span><span class="NLM_x">–</span> <span class="NLM_lpage">4789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060218h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4785-4789&author=N.+T.+Hatzenbuhlerauthor=D.+A.+Evrardauthor=B.+L.+Harrisonauthor=D.+Hurynauthor=J.+Ingramauthor=C.+Kramlauthor=J.+F.+Matterauthor=R.+E.+Mewshawauthor=D.+Zhouauthor=G.+Hornbyauthor=Q.+Linauthor=D.+L.+Smithauthor=K.+M.+Sullivanauthor=L.+E.+Schechterauthor=T.+A.+Andree&title=Synthesis+and+biological+evaluation+of+novel+compounds+within+a+class+of+3-aminochroman+derivatives+with+dual+5-HT1A+receptor+and+serotonin+transporter+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm060218h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060218h%26sid%3Dliteratum%253Aachs%26aulast%3DHatzenbuhler%26aufirst%3DN.%2BT.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHuryn%26aufirst%3DD.%26aulast%3DIngram%26aufirst%3DJ.%26aulast%3DKraml%26aufirst%3DC.%26aulast%3DMatter%26aufirst%3DJ.%2BF.%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSullivan%26aufirst%3DK.%2BM.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520compounds%2520within%2520a%2520class%2520of%25203-aminochroman%2520derivatives%2520with%2520dual%25205-HT1A%2520receptor%2520and%2520serotonin%2520transporter%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4785%26epage%3D4789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Asselin, M.; Grosu, G.; Childers, W.; Schecher, L.; Harrison, B.; Sabb, A.; Smith, D.; Hirst, W.; Andres, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel substituted aryl- and heteroaryl-4-(piperidin-4-yl) piperazines as serotonergic agents</span>. <span class="NLM_conf-name">41st National Organic Chemsitry Symposium</span>, <span class="NLM_conf-loc">Boulder</span>, <span class="NLM_conf-date">June 7−11, 2009</span>,  <span class="NLM_fpage">B11</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Asselin%2C+M.%3B+Grosu%2C+G.%3B+Childers%2C+W.%3B+Schecher%2C+L.%3B+Harrison%2C+B.%3B+Sabb%2C+A.%3B+Smith%2C+D.%3B+Hirst%2C+W.%3B+Andres%2C+T.+Design+and+synthesis+of+novel+substituted+aryl-+and+heteroaryl-4-%28piperidin-4-yl%29+piperazines+as+serotonergic+agents.+41st+National+Organic+Chemsitry+Symposium%2C+Boulder%2C+June+7%E2%88%9211%2C+2009%2C+B11."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520substituted%2520aryl-%2520and%2520heteroaryl-4-%2528piperidin-4-yl%2529%2520piperazines%2520as%2520serotonergic%2520agents%26spage%3DB11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Asselin, M.; Grosu, T. G.; Sabb, A. L.; Childers, W. E.; Havran, L. M.; Shen, Z.; Bicksler, J. J.; Chong, D. C.</span><span> </span><span class="NLM_article-title">Piperazine-piperidine antagonists and agonists of the 5-HT<sub>1A</sub> receptor</span>. U.S. Patent 7,671,056,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Asselin&author=T.+G.+Grosu&author=A.+L.+Sabb&author=W.+E.+Childers&author=L.+M.+Havran&author=Z.+Shen&author=J.+J.+Bicksler&author=D.+C.+Chong&title=Piperazine-piperidine+antagonists+and+agonists+of+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAsselin%26aufirst%3DM.%26atitle%3DPiperazine-piperidine%2520antagonists%2520and%2520agonists%2520of%2520the%25205-HT1A%2520receptor%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Skraup, Z. H.</span><span> </span><span class="NLM_article-title">Eine synthese des chinolins</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1880</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2086</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1880&pages=2086&author=Z.+H.+Skraup&title=Eine+synthese+des+chinolins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkraup%26aufirst%3DZ.%2BH.%26atitle%3DEine%2520synthese%2520des%2520chinolins%26jtitle%3DChem.%2520Ber.%26date%3D1880%26volume%3D13%26spage%3D2086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Guram, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Aromatic Aminations with in Situ Generated Aminostannanes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">7901</span><span class="NLM_x">–</span> <span class="NLM_lpage">7902</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00096a059" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2cXmvVSgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=7901-7902&author=A.+S.+Guramauthor=S.+L.+Buchwald&title=Palladium-Catalyzed+Aromatic+Aminations+with+in+Situ+Generated+Aminostannanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Aromatic Aminations with in situ Generated Aminostannanes</span></div><div class="casAuthors">Guram, Anil S.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7901-2</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Aminostannes, generated in situ by the transamination reactions of N,N-diethylaminotributyltin with primary and secondary amines, undergo Pd-catalyzed reactions with aryl bromides to afford aryl amines in good yields.  Thus, e.g., in situ generation of Bu3SnNMeCH2Ph via transamination of Bu3SnNEt2 with HNMeCH2Ph, followed by reaction with 4-EtO2CC6H4Br in presence of PdCl2[P(o-tolyl)3]2 afforded 88% 4-EtO2CC6H4NMeCH2Ph.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHbgxIJwAw2rVg90H21EOLACvtfcHk0ljDD8sZ6zN0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmvVSgs74%253D&md5=01e7d965aef985f90b78c7c7bda73c9d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja00096a059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00096a059%26sid%3Dliteratum%253Aachs%26aulast%3DGuram%26aufirst%3DA.%2BS.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-Catalyzed%2520Aromatic%2520Aminations%2520with%2520in%2520Situ%2520Generated%2520Aminostannanes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D7901%26epage%3D7902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Louie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">–</span> <span class="NLM_lpage">3612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0040-4039%2895%2900605-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=3609-3612&author=J.+Louieauthor=J.+F.+Hartwig&title=Palladium-catalyzed+synthesis+of+arylamines+from+aryl+halides.+Mechanistic+studies+lead+to+coupling+in+the+absence+of+tin+reagents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed synthesis of arylamines from aryl halides. Mechanistic studies lead to coupling in the absence of tin reagents</span></div><div class="casAuthors">Louie, Janis; Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3609-12</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The reaction of aryl halides with secondary amines in the presence of silylamide base and tri-o-tolyphospshine palladium complexes gives arylamine products.  This process provides a convenient method for performing these heterocross coupling reactions without the necessity for forming tin amides and disposing of tin halides.  This reaction follows from a mechanistic anal. of the coupling reaction with tin amides and occurs as a result of the cleavage of palladium aryl halide dimers with secondary amines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKpHJAivoR7Vg90H21EOLACvtfcHk0ljDD8sZ6zN0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtFCjtLo%253D&md5=7c4567c3e54efc05049d539c682696b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0040-4039%2895%2900605-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4039%252895%252900605-C%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520synthesis%2520of%2520arylamines%2520from%2520aryl%2520halides.%2520Mechanistic%2520studies%2520lead%2520to%2520coupling%2520in%2520the%2520absence%2520of%2520tin%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D3609%26epage%3D3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Characterization of the 5-HT<sub>1A</sub> Receptor Functional Coupling in Cells Expressing the Human 5-HT<sub>1A</sub> Receptor as Assessed with the Cytosensor Microphysiometer</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2FS1056-8719%2898%2900035-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=9920534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1998&pages=47-55&author=J.+Dunlopauthor=Y.+Zhangauthor=D.+E.+Smithauthor=L.+E.+Schechter&title=Characterization+of+the+5-HT1A+Receptor+Functional+Coupling+in+Cells+Expressing+the+Human+5-HT1A+Receptor+as+Assessed+with+the+Cytosensor+Microphysiometer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer</span></div><div class="casAuthors">Dunlop, John; Zhang, Yingxin; Smith, Deborah L.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The functional activity of a series of 5-HT1A receptor ligands has been evaluated in a cell line expressing the human 5-HT1A receptor (h5-HT1A · CHO) using the agonist-stimulated increase in extracellular acidification rate, measured with the microphysiometer, as a functional assay.  Both 5-CT and 8-OH-DPAT were potent agonists in stimulating an increase in extracellular acidification rate in h5-HT1A · CHO cells with estd. EC50 values of 1.2 and 7.8 nM, resp.  Addnl., these two 5-HT1A receptor agonists elicited a similar max. response.  Concn.-dependent agonist activity was also obsd. in the presence of buspirone, ipsapirone, BMY 7378, NAN-190 and WAY 100135, and each of these compds. behaved as partial 5-HT1A receptor agonists.  The selective 5-HT1A receptor antagonist WAY 100635 produced a potent (IC50, 2.3 nM) and complete block of the 8-OH-DPAT-stimulated response.  An evaluation of the inhibitory activity of a series of 5-HT1A receptor antagonists produced the following rank order of potency; WAY 100635 > LY 206130 (IC50, 7.1 nM) > WAY 100135 (30.8 nM) > pindolol (76.2 nM) > (-)UH-301 (92.8 nM).  Parallel studies on the inhibition of forskolin-stimulated adenylyl cyclase activity in h5-HT1A · CHO cells revealed that agonist potencies were generally similar between the two functional assays and were in good agreement with the estd. 5-HT1A receptor binding affinities.  However, the relative efficacies detd. for the partial agonists in the cAMP assay were substantially greater than those obsd. with the microphysiometer.  Finally, antagonists were considerably weaker in the cAMP assay compared with the microphysiometer.  The evaluation of 5-HT1A ligands using the microphysiometer, which represents a very distinct indice of 5-HT1A receptor function compared with the cAMP assay, results in a different profile of functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoE_crPJ1hc7Vg90H21EOLACvtfcHk0ljAWdrzXpQ8BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWntQ%253D%253D&md5=4b458fdc01863486fc69b41a9575e868</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1056-8719%2898%2900035-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8719%252898%252900035-5%26sid%3Dliteratum%253Aachs%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DCharacterization%2520of%2520the%25205-HT1A%2520Receptor%2520Functional%2520Coupling%2520in%2520Cells%2520Expressing%2520the%2520Human%25205-HT1A%2520Receptor%2520as%2520Assessed%2520with%2520the%2520Cytosensor%2520Microphysiometer%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D1998%26volume%3D40%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Assie, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiek, W.</span><span> </span><span class="NLM_article-title">Effects of 5-HT<sub>1A</sub> receptor antagonists on hippocampal 5-hydroxy-tryptamine levels: (S)-WAY-100135 but not WAY-100635 has partial agonist properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2F0014-2999%2896%2900086-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=8813579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Wnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=1996&pages=15-21&author=M.+B.+Assieauthor=W.+Kiek&title=Effects+of+5-HT1A+receptor+antagonists+on+hippocampal+5-hydroxy-tryptamine+levels%3A+%28S%29-WAY-100135+but+not+WAY-100635+has+partial+agonist+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties</span></div><div class="casAuthors">Assie, Marie-Bernadette; Koek, Wouter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In vivo microdialysis measuring 5-hydroxytryptamine (5-HT) levels in the ventral hippocampus of chloral hydrate-anesthetized rats was used to characterize further the recently described 5-HT1A receptor antagonists (S)-WAY100135 ((S)-N-tert-butyl-3-(4-(2-meth- oxyphenyl)piperazine-1-yl)-2-phenylpropanamide) and WAY100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide).  In addn., binding expts. were performed to det. the affinity of the compds. for 5-HT1A receptors and for α1-adrenoceptors.  Both (S)-WAY100135 and WAY100635 exhibited high affinity for 5-HT1A receptors and moderate affinity for α1-adrenoceptors.  The effects of (S)-WAY100135 (0.63-20 mg/kg) and of WAY100635 (0.0025-0.16 mg/kg) on 5-HT levels were examd. alone, and in combination with the 5-HT1A receptor agonist, (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).  Both compds. dose-dependently reversed the 8-OH-DPAT-induced decrease in extracellular 5-HT levels with ED50 values of approx. 3.3 and 0.03 mg/kg, resp.  When given alone, WAY100635 did not alter 5-HT levels.  (S)-WAY100135, however, induced, by itself, a transient but significant and dose-dependent decrease in 5-HT levels.  WAY100635 (0.16 mg/kg) prevented the decrease induced by (S)-WAY100135 (10 mg/kg), but did not reverse the decrease induced by the α1-adrenoceptor antagonist, prazosin (0.16 mg/kg).  These results are further evidence that (S)-WAY100135 may modulate the release of 5-HT by acting as a partial agonist at somatodendritic 5-HT1A receptors.  In contrast, WAY100635 acts as a potent and selective 5-HT1A receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCNFJxAA3tLbVg90H21EOLACvtfcHk0ljAWdrzXpQ8BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Wnsrc%253D&md5=c90f1422670a73df50672e68a1953881</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900086-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900086-6%26sid%3Dliteratum%253Aachs%26aulast%3DAssie%26aufirst%3DM.%2BB.%26aulast%3DKiek%26aufirst%3DW.%26atitle%3DEffects%2520of%25205-HT1A%2520receptor%2520antagonists%2520on%2520hippocampal%25205-hydroxy-tryptamine%2520levels%253A%2520%2528S%2529-WAY-100135%2520but%2520not%2520WAY-100635%2520has%2520partial%2520agonist%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D304%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bowen, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessel, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, M. T.</span><span> </span><span class="NLM_article-title">Neurotransmission—the link integrating Alzheimer’s disease?</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1994&pages=149-150&author=D.+M.+Bowenauthor=P.+T.+Francisauthor=I.+P.+Chesselauthor=M.+T.+Webster&title=Neurotransmission%E2%80%94the+link+integrating+Alzheimer%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowen%26aufirst%3DD.%2BM.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DChessel%26aufirst%3DI.%2BP.%26aulast%3DWebster%26aufirst%3DM.%2BT.%26atitle%3DNeurotransmission%25E2%2580%2594the%2520link%2520integrating%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DTrends%2520Neurosci.%26date%3D1994%26volume%3D17%26spage%3D149%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ennaceur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacour, J.</span><span> </span><span class="NLM_article-title">A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=47-59&author=A.+Ennaceurauthor=J.+Delacour&title=A+new+one-trial+test+for+neurobiological+studies+of+memory+in+rats.+1%3A+behavioral+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEnnaceur%26aufirst%3DA.%26aulast%3DDelacour%26aufirst%3DJ.%26atitle%3DA%2520new%2520one-trial%2520test%2520for%2520neurobiological%2520studies%2520of%2520memory%2520in%2520rats.%25201%253A%2520behavioral%2520data%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1988%26volume%3D31%26spage%3D47%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Day, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, R. F.</span><span> </span><span class="NLM_article-title">Post-training <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor blockade offers protection from retrograde interference but does not affect consolidation of weak and strong memory traces in water maze</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2006&pages=19-28&author=M.+Dayauthor=R.+F.+Langston&title=Post-training+N-methyl-d-aspartate+receptor+blockade+offers+protection+from+retrograde+interference+but+does+not+affect+consolidation+of+weak+and+strong+memory+traces+in+water+maze"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DM.%26aulast%3DLangston%26aufirst%3DR.%2BF.%26atitle%3DPost-training%2520N-methyl-d-aspartate%2520receptor%2520blockade%2520offers%2520protection%2520from%2520retrograde%2520interference%2520but%2520does%2520not%2520affect%2520consolidation%2520of%2520weak%2520and%2520strong%2520memory%2520traces%2520in%2520water%2520maze%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D137%26spage%3D19%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hsiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harigaya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younkin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G.</span><span> </span><span class="NLM_article-title">Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=99-102&author=K.+Hsiaoauthor=P.+Chapmanauthor=S.+Nilsonauthor=C.+Eckmanauthor=Y.+Harigayaauthor=Y.+Younkinauthor=F.+Yangauthor=G.+Cole&title=Correlative+memory+deficits%2C+A%CE%B2+elevation+and+amyloid+plaques+in+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DChapman%26aufirst%3DP.%26aulast%3DNilson%26aufirst%3DS.%26aulast%3DEckman%26aufirst%3DC.%26aulast%3DHarigaya%26aufirst%3DY.%26aulast%3DYounkin%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DCole%26aufirst%3DG.%26atitle%3DCorrelative%2520memory%2520deficits%252C%2520A%25CE%25B2%2520elevation%2520and%2520amyloid%2520plaques%2520in%2520transgenic%2520mice%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Dineley, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweatt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span> </span><span class="NLM_article-title">Accelerated plaque accumulations, associative learning deficits, and up-regulation of α7 nicotinic receptor protein in transgenic mice co-expressing mutant human Presenilin-1 and amyloid precursor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">22768</span><span class="NLM_x">–</span> <span class="NLM_lpage">22780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=2002&pages=22768-22780&author=K.+T.+Dineleyauthor=X.+Xiaauthor=D.+Buiauthor=D.+Sweattauthor=H.+Zheng&title=Accelerated+plaque+accumulations%2C+associative+learning+deficits%2C+and+up-regulation+of+%CE%B17+nicotinic+receptor+protein+in+transgenic+mice+co-expressing+mutant+human+Presenilin-1+and+amyloid+precursor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDineley%26aufirst%3DK.%2BT.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DBui%26aufirst%3DD.%26aulast%3DSweatt%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DAccelerated%2520plaque%2520accumulations%252C%2520associative%2520learning%2520deficits%252C%2520and%2520up-regulation%2520of%2520%25CE%25B17%2520nicotinic%2520receptor%2520protein%2520in%2520transgenic%2520mice%2520co-expressing%2520mutant%2520human%2520Presenilin-1%2520and%2520amyloid%2520precursor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D227%26spage%3D22768%26epage%3D22780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Corcoran, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maren, S.</span><span> </span><span class="NLM_article-title">Overexpression of hAPP-swe impairs rewarded alteration and contextual fear conditioning in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Learn. Mem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1101%2Flm.51002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=12359834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A280%3ADC%252BD38vpvVaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=243-252&author=K.+A.+Corcoranauthor=Y.+Luauthor=R.+S.+Turnerauthor=S.+Maren&title=Overexpression+of+hAPP-swe+impairs+rewarded+alteration+and+contextual+fear+conditioning+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Corcoran Kevin A; Lu Ye; Turner R Scott; Maren Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Learning & memory (Cold Spring Harbor, N.Y.)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">243-52</span>
        ISSN:<span class="NLM_cas:issn">1072-0502</span>.
    </div><div class="casAbstract">One of the hallmarks of the pathology in Alzheimer's disease is the deposition of amyloid plaques throughout the brain, especially within the hippocampus and amygdala.  Transgenic mice that overexpress the Swedish mutation of human amyloid precursor protein (hAPPswe; Tg2576) show age-dependent memory deficits in hippocampus-dependent learning tasks.  However, the performance of aged Tg2576 mice in amygdala-dependent learning tasks has not been thoroughly assessed.  We trained young (2-4 mo) and old (16-18 mo) Tg2576 and wild-type mice in a T-maze alternation task (hippocampus-dependent) and a Pavlovian fear-conditioning task (amygdala- and hippocampus-dependent).  As previously reported, old Tg2576 mice showed impaired acquisition of rewarded alternation; none of these mice reached the criterion of at least five out of six correct responses over three consecutive days.  In contrast, old Tg2576 mice showed normal levels of conditional freezing to an auditory conditional stimulus (CS) and acquired a contextual discrimination normally.  However, when the salience of the fear-conditioning context was decreased, old (12-14 mo) Tg2576 mice were impaired at acquiring fear to the conditioning context, but not to the tone CS.  Histological examination of a subset of the mice verified the existence of amyloid plaques in the cortex, hippocampus, and amygdala of old, but not young, Tg2576 mice.  Hence, learning and memory deficits in old Tg2576 mice are limited to hippocampus-dependent tasks, despite widespread amyloid deposition in cortex, hippocampus, and amygdala.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ26wKjowe1f4kFb3mqPUYDfW6udTcc2eZJZHOjnG3OSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vpvVaisw%253D%253D&md5=71fdb1b3c4e1c5e5231e7576343b3242</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1101%2Flm.51002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Flm.51002%26sid%3Dliteratum%253Aachs%26aulast%3DCorcoran%26aufirst%3DK.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DR.%2BS.%26aulast%3DMaren%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520hAPP-swe%2520impairs%2520rewarded%2520alteration%2520and%2520contextual%2520fear%2520conditioning%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLearn.%2520Mem.%26date%3D2002%26volume%3D9%26spage%3D243%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaput, Y.</span><span> </span><span class="NLM_article-title">Modifications of the serotonergic system by antidepressant treatment: implications for the therapeutic response in major depression</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">24S</span><span class="NLM_x">–</span> <span class="NLM_lpage">35S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1987&pages=24S-35S&author=P.+Blierauthor=C.+De+Montignyauthor=Y.+Chaput&title=Modifications+of+the+serotonergic+system+by+antidepressant+treatment%3A+implications+for+the+therapeutic+response+in+major+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26aulast%3DChaput%26aufirst%3DY.%26atitle%3DModifications%2520of%2520the%2520serotonergic%2520system%2520by%2520antidepressant%2520treatment%253A%2520implications%2520for%2520the%2520therapeutic%2520response%2520in%2520major%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1987%26volume%3D7%26spage%3D24S%26epage%3D35S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. Q.</span><span> </span><span class="NLM_article-title">Effects of 5-HT<sub>1A</sub> antagonists on fluoxetine-induced changes in extracullular serotonin concentrations in rat frontal cortex</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2FS0014-2999%2897%2901580-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=1998&pages=41-46&author=L.+A.+Dawsonauthor=H.+Q.+Nguyen&title=Effects+of+5-HT1A+antagonists+on+fluoxetine-induced+changes+in+extracullular+serotonin+concentrations+in+rat+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901580-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901580-X%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DNguyen%26aufirst%3DH.%2BQ.%26atitle%3DEffects%2520of%25205-HT1A%2520antagonists%2520on%2520fluoxetine-induced%2520changes%2520in%2520extracullular%2520serotonin%2520concentrations%2520in%2520rat%2520frontal%2520cortex%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D314%26spage%3D41%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1177%2F026988110201600205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=12095073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=145-152&author=L.+A.+Dawsonauthor=J.+Q.+Nguyenauthor=D.+L.+Smithauthor=L.+E.+Schechter&title=Effect+of+chronic+fluoxetine+and+WAY-100635+treatment+on+serotonergic+neurotransmission+in+the+frontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex</span></div><div class="casAuthors">Dawson, L. A.; Nguyen, H. Q.; Smith, D. L.; Schechter, L. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-152</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Clin. augmentation strategies have shown that some improvement in antidepressant efficacy can be achieved by combining the β-adrenergic/serotonin (5-HT)1A/1B receptor antagonist (±)pindolol with a selective serotonin reuptake inhibitor (SSRI).  This has lead to the hypothesis that a combination of a 5-HT1A receptor antagonist with an SSRI will lead to a faster onset of antidepressant action.  Although there is a significant accumulation of acute preclin. data supporting this rationale, until recently, there have been no investigations examg. the chronic effects of combining an SSRI with a 5-HT1A receptor antagonist.  Here, we detd. the chronic effects of fluoxetine (10 mg/kg o.d.), administered in combination with the selective 5-HT1A receptor antagonist WAY-100635 (1 mg/kg b.i.d.), on serotonergic neurotransmission in the frontal cortex using in-vivo microdialysis.  Following chronic administration of fluoxetine ± WAY-100635, functional changes in serotonergic neurotransmission, as well as 5-HT1A autoreceptors, were assessed by administering fluoxetine or (±) 8-hydroxy-2-(di-n-propylamino)tetralin [(±) 8-OH-DPAT] 24 h after the last chronic dose.  Chronic administration of WAY-100635 alone produced no detectable change in the functional status of the 5-HT1A receptor.  However, fluoxetine alone produced a time-dependent adaptation in serotonergic transmission such that fluoxetine (acutely administered on day 15) was able to produce a two-fold increase in extracellular 5-HT levels but the decrease in response to 8-OH-DPAT was completely attenuated.  These data indicate that the fluoxetine-induced adaptation was mediated by desensitization of the 5-HT1A receptor.  WAY-100635 given chronically in combination with fluoxetine blocked the SSRI-induced desensitization of the 5-HT1A receptor.  Furthermore, chronic treatment with this combination produced no tolerance in terms of its ability to acutely increase forebrain 5-HT levels.  These data suggest that augmentation of an SSRI by combined pharmacotherapy with a 5-HT1A antagonist would be effective upon prolonged exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg1tnS2Y2n_7Vg90H21EOLACvtfcHk0lgIhbMCctrC4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVejtr8%253D&md5=e9cfcafe0b61b568853ee5118f07f736</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F026988110201600205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110201600205%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DNguyen%26aufirst%3DJ.%2BQ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DEffect%2520of%2520chronic%2520fluoxetine%2520and%2520WAY-100635%2520treatment%2520on%2520serotonergic%2520neurotransmission%2520in%2520the%2520frontal%2520cortex%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2002%26volume%3D16%26spage%3D145%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Czachura, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span> </span><span class="NLM_article-title">Effect of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat</span> <span class="citation_source-journal">Naunyn-Schmiedeberg’s Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1007%2Fs002100000290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=10997729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Wjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2000&pages=266-275&author=J.+F.+Czachuraauthor=K.+Rasmussen&title=Effect+of+acute+and+chronic+administration+of+fluoxetine+on+the+activity+of+serotonergic+neurons+in+the+dorsal+raphe+nucleus+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat</span></div><div class="casAuthors">Czachura, Janet F.; Rasmussen, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">266-275</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The gradual recovery of activity of serotonergic neurons following an initial inhibition has been hypothesized to play an important role in the delayed onset of efficacy of selective serotonin reuptake inhibitors.  This study explored the clin. relevance of this hypothesis by examg. the effects of different doses and routes of administration of fluoxetine on the recovery of activity of serotonergic neurons over the course of a 21-day exposure.  Single-unit, extracellular recordings of serotonergic neurons were made in the dorsal raphe nucleus of anesthetized male rats.  Acute i.v., s.c. and i.p. administration of fluoxetine inhibited the activity of serotonergic neurons.  With chronic administration of fluoxetine, at clin. relevant doses, the activity of serotonergic neurons gradually recovered to baseline levels over the course of 14-21 days.  The dose of fluoxetine (5, 10 or 20 mg/kg per day) did not make a significant difference in the time course of the recovery of activity of serotonergic neurons.  A significant, non-parallel shift in the dose-response curve of serotonergic neurons to the serotonin-1A (5-HT1A) agonist 8-OH-DPAT occurred over the 21 days of treatment with fluoxetine, indicating a desensitization of the 5-HT1A receptor during this period.  The recovery of firing did not correlate with either plasma or cerebrospinal fluid levels of fluoxetine or norfluoxetine.  These results indicate that, similar to the effects of dose on the speed of onset of the clin. effects of SSRIs, increasing the dose of fluoxetine does not hasten the recovery of firing of serotonergic neurons during chronic administration.  These results support the hypothesis that desensitization of the 5-HT1A receptor and consequent recovery of firing of 5-HT cells in the dorsal raphe nucleus plays a role in the delayed therapeutic onset of fluoxetine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVUJuqOMV8B7Vg90H21EOLACvtfcHk0lgIhbMCctrC4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Wjurk%253D&md5=5d643f9f1a152872c4650b8c6f9148f8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs002100000290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000290%26sid%3Dliteratum%253Aachs%26aulast%3DCzachura%26aufirst%3DJ.%2BF.%26aulast%3DRasmussen%26aufirst%3DK.%26atitle%3DEffect%2520of%2520acute%2520and%2520chronic%2520administration%2520of%2520fluoxetine%2520on%2520the%2520activity%2520of%2520serotonergic%2520neurons%2520in%2520the%2520dorsal%2520raphe%2520nucleus%2520of%2520the%2520rat%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D362%26spage%3D266%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. R.</span><span> </span><span class="NLM_article-title">Onset of the effects of the 5-HT1A antagonist, WAY100635, alone and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat</span> <span class="citation_source-journal">Pharmacol. Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1999&pages=333-338&author=J.+F.+Cryanauthor=C.+McGrathauthor=B.+E.+Leonardauthor=T.+R.+Norman&title=Onset+of+the+effects+of+the+5-HT1A+antagonist%2C+WAY100635%2C+alone+and+in+combination+with+paroxetine%2C+on+olfactory+bulbectomy+and+8-OH-DPAT-induced+changes+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DMcGrath%26aufirst%3DC.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26aulast%3DNorman%26aufirst%3DT.%2BR.%26atitle%3DOnset%2520of%2520the%2520effects%2520of%2520the%25205-HT1A%2520antagonist%252C%2520WAY100635%252C%2520alone%2520and%2520in%2520combination%2520with%2520paroxetine%252C%2520on%2520olfactory%2520bulbectomy%2520and%25208-OH-DPAT-induced%2520changes%2520in%2520the%2520rat%26jtitle%3DPharmacol.%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D63%26spage%3D333%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Woods, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornfelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbett, R.</span><span> </span><span class="NLM_article-title">Selective serotonin reuptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1993&pages=195-198&author=A.+Woodsauthor=C.+Smithauthor=M.+Szewczakauthor=R.+W.+Dunnauthor=M.+Cornfeltauthor=R.+Corbett&title=Selective+serotonin+reuptake+inhibitors+decrease+schedule-induced+polydipsia+in+rats%3A+a+potential+model+for+obsessive+compulsive+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoods%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DSzewczak%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DR.%2BW.%26aulast%3DCornfelt%26aufirst%3DM.%26aulast%3DCorbett%26aufirst%3DR.%26atitle%3DSelective%2520serotonin%2520reuptake%2520inhibitors%2520decrease%2520schedule-induced%2520polydipsia%2520in%2520rats%253A%2520a%2520potential%2520model%2520for%2520obsessive%2520compulsive%2520disorder%26jtitle%3DPsychopharmacology%26date%3D1993%26volume%3D112%26spage%3D195%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvi, A.</span><span> </span><span class="NLM_article-title">Acceleration of onset of action in schedule-induced polydipsia: combination of SSRI and 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptor antagonists</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2004&pages=69-75&author=S.+Hoggauthor=A.+Dalvi&title=Acceleration+of+onset+of+action+in+schedule-induced+polydipsia%3A+combination+of+SSRI+and+5-HT1A+and+5-HT1B+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DDalvi%26aufirst%3DA.%26atitle%3DAcceleration%2520of%2520onset%2520of%2520action%2520in%2520schedule-induced%2520polydipsia%253A%2520combination%2520of%2520SSRI%2520and%25205-HT1A%2520and%25205-HT1B%2520receptor%2520antagonists%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2004%26volume%3D77%26spage%3D69%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kelly, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrynn, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">The olfactory bulbectomy rat model of depression—an update</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1016%2FS0163-7258%2897%2900004-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=9352586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK2sXmsFCgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1997&pages=299-315&author=J.+P.+Kellyauthor=A.+S.+Wrynnauthor=B.+E.+Leonard&title=The+olfactory+bulbectomy+rat+model+of+depression%E2%80%94an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The olfactory bulbectomized rat as a model of depression: an update</span></div><div class="casAuthors">Kelly, J. P.; Wrynn, A. S.; Leonard, B. E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">299-316</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 161 refs.  The olfactory bulbectomized (OB) rat has been proposed as an animal model of depression.  The following behavioral changes have been obsd. following bilateral olfactory bulbectomy: hyperactivity in an enclosed arena, such as the open-field; enhanced nocturnal hyperactivity in a 24-h home cage activity monitor; deficits in memory, as shown by passive avoidance behavior and in the Morris maze and the 8-arm radial maze; increased open arm entries in the elevated plus-maze; and changes in food motivated and conditioned taste aversion behavior.  Alterations in the noradrenergic, serotonergic, cholinergic, γ-aminobutyric acid (GAB)ergic and glutamatergic neurotransmitter systems are also assocd. with olfactory bulbectomy.  The variety of immune changes following olfactory bulbectomy includes reduced neutrophil phagocytosis, lymphocyte mitogenesis, lymphocyte no. and neg. acute phase proteins, increased leukocyte adhesiveness/aggregation, monocyte phagocytosis, neutrophil no. and pos. acute phase proteins.  An enhanced nocturnal secretion of corticosterone is obsd. in OB rats, which is normally suppressed by dexamethasone.  The most commonly employed behavioral indicator of antidepressant activity is attenuation of the OB-related hyperactivity in the open-field.  However, many of the other behavioral, neurotransmitter and immune changes have been shown to be attenuated by chronic (but not acute) antidepressant treatment.  Tricyclic antidepressants (amitriptyline, desipramine), atypical agents (mianserin), selective serotonin reuptake inhibitors (paroxetine, sertraline, fluvoxamine), reversible inhibitors of monoamine oxidase A (moclobemide), as well as putative antidepressants such as 5-hydroxytryptamine1A agonists (zalospirone, ipsapirone), noncompetitive N-methyl-D-aspartate antagonists (MK-801) and triazolobenzodiazepines (alprazolam, adinazolam), have demonstrated antidepressant-like activity in this model.  As many of the changes exhibited by the OB rat are qual. similar to those obsd. in depressed patients, it may be concluded that the OB rat is a model of depression and not just a means whereby putative antidepressants may be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoApMQoaubNgbVg90H21EOLACvtfcHk0ljKEbsfBp6QPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsFCgsL4%253D&md5=233bae5852dd681d966f0ee301738c13</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2897%2900004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252897%252900004-1%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BP.%26aulast%3DWrynn%26aufirst%3DA.%2BS.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DThe%2520olfactory%2520bulbectomy%2520rat%2520model%2520of%2520depression%25E2%2580%2594an%2520update%26jtitle%3DPharmacol.%2520Ther.%26date%3D1997%26volume%3D74%26spage%3D299%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Landen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikkson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agren, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahlen, T.</span><span> </span><span class="NLM_article-title">Effects of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1097%2F00004714-199906000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=10350034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=268-271&author=M.+Landenauthor=E.+Erikksonauthor=H.+Agrenauthor=T.+Fahlen&title=Effects+of+buspirone+on+sexual+dysfunction+in+depressed+patients+treated+with+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors</span></div><div class="casAuthors">Landen, Mikael; Eriksson, Elias; Agren, Hans; Fahlen, Tom</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-271</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">To evaluate the possible influence of buspirone on sexual dysfunction in depressed patients treated with a selective serotonin reuptake inhibitor (SSRI; citalopram or paroxetine), data were analyzed from a placebo-controlled trial designed to explore the efficacy of buspirone as add-on treatment for patients not responding to an SSRI alone.  All the patients met the criteria for a major depressive episode according to DSM-IV and had received citalopram or paroxetine during a min. of 4 wk without responding to the treatment.  Buspirone (20-60 mg/day) or placebo was added to the SSRI for 4 wk; the mean daily dose of buspirone at endpoint was 48.5 mg/day.  Before starting medication with buspirone or placebo, 40% (47 of 117 patients) reported at least one kind of sexual dysfunction (decreased libido, ejaculatory dysfunction, orgasmic dysfunction).  During the 4 wk of treatment, approx. 58% of the subjects treated with buspirone reported an improvement with respect to sexual function; in the placebo group, the response rate was 30%.  The difference between placebo and active drug treatment was more pronounced in women than in men.  The response was obvious during the 1st week, with no further improvement during the course of the study.  It is suggested that the effect of buspirone on sexual dysfunction is a result of a reversal of SSRI-induced sexual side effects rather than of an antidepressant effect of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZbJOWG8AQ4rVg90H21EOLACvtfcHk0ljKEbsfBp6QPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ant7Y%253D&md5=2dfff4a62cec531824046f7500819000</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2F00004714-199906000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-199906000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DLanden%26aufirst%3DM.%26aulast%3DErikkson%26aufirst%3DE.%26aulast%3DAgren%26aufirst%3DH.%26aulast%3DFahlen%26aufirst%3DT.%26atitle%3DEffects%2520of%2520buspirone%2520on%2520sexual%2520dysfunction%2520in%2520depressed%2520patients%2520treated%2520with%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D1999%26volume%3D19%26spage%3D268%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Norden, M. J.</span><span> </span><span class="NLM_article-title">Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Depression</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1002%2Fdepr.3050020208" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1994&pages=109-112&author=M.+J.+Norden&title=Buspirone+treatment+of+sexual+dysfunction+associated+with+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fdepr.3050020208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdepr.3050020208%26sid%3Dliteratum%253Aachs%26aulast%3DNorden%26aufirst%3DM.%2BJ.%26atitle%3DBuspirone%2520treatment%2520of%2520sexual%2520dysfunction%2520associated%2520with%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DDepression%26date%3D1994%26volume%3D2%26spage%3D109%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Baldwin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithers, A.</span><span> </span><span class="NLM_article-title">Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1177%2F0269881107078490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=17715211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1emtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=55-63&author=D.+Baldwinauthor=J.+Hutchinsonauthor=K.+Donaldsonauthor=B.+Shawauthor=A.+Smithers&title=Selective+serotonin+re-uptake+inhibitor+treatment-emergent+sexual+dysfunction%3A+randomized+double-blind+placebo-controlled+parallel-group+fixed-dose+study+of+a+potential+adjuvant+compound"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670</span></div><div class="casAuthors">Baldwin, David; Hutchison, John; Donaldson, Kirsteen; Shaw, Bob; Smithers, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Sexual dysfunction is common during acute and continuation treatment of depressed patients with selective serotonin (5-hydroxytryptamine, 5-HT) re-uptake inhibitors (SSRIs), but there is no consensus on clin. management.  Compds. with 5-HT1A agonist properties have been proposed as adjuvant agents in patients continuing with SSRIs.  Randomized double-blind placebo-controlled parallel-group fixed-dose 4-wk treatment study.  Previously depressed male or female patients in symptomatic remission receiving stable doses of fluoxetine or paroxetine but experiencing treatment-emergent sexual dysfunction were randomised to double-blind treatment with placebo or VML-670 (a 5-HT1A and 5-HT1D agonist).  Sexual dysfunction was assessed by the Arizona Sexual Experiences Scale (ASEX).  Two-hundred and eighty-eight patients (204 women, 84 men; mean age 44.2 years) received VML-670 (n = 149; 107 women, 42 men) or placebo (n = 139; 97 women, 42 men).  In the intention-to-treat, last-observation carried forward anal. (n = 282), proportionately more patients became free of sexual dysfunction with VML-670 (34.3% vs. 27.9% with placebo) but this difference was not statistically significant.  Male patients treated with VML-670 showed a significantly greater (p = 0.01) improvement in ability to achieve and maintain penile erection (a secondary outcome measure).  A similar proportion of patients reported on-treatment, treatment-emergent adverse events with VML-670 (71.1%) and placebo (68.3%), and a similar proportion experienced at least one treatment-related adverse event (36.9% vs. 35.3%).  Double-blind treatment with VML-670 offered no significant advantage over placebo on the primary outcome measure in the overall sample.  Further studies may be warranted in larger groups of male patients with sexual dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPDYgF8UnulrVg90H21EOLACvtfcHk0ljy7M6HqpmVvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1emtrc%253D&md5=9b8b7c7002f1c2997717ec145e51ed8b</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1177%2F0269881107078490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881107078490%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DD.%26aulast%3DHutchinson%26aufirst%3DJ.%26aulast%3DDonaldson%26aufirst%3DK.%26aulast%3DShaw%26aufirst%3DB.%26aulast%3DSmithers%26aufirst%3DA.%26atitle%3DSelective%2520serotonin%2520re-uptake%2520inhibitor%2520treatment-emergent%2520sexual%2520dysfunction%253A%2520randomized%2520double-blind%2520placebo-controlled%2520parallel-group%2520fixed-dose%2520study%2520of%2520a%2520potential%2520adjuvant%2520compound%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2008%26volume%3D22%26spage%3D55%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">A novel approach for predicting antidepressant-induced sexual dysfunction in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2008&pages=459-467&author=S.+J.+Sukoff-Rizzoauthor=L.+E.+Schechterauthor=S.+Rosenzweig-Lipson&title=A+novel+approach+for+predicting+antidepressant-induced+sexual+dysfunction+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DA%2520novel%2520approach%2520for%2520predicting%2520antidepressant-induced%2520sexual%2520dysfunction%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D195%26spage%3D459%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulicicchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats</span> <span class="citation_source-journal">J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1017%2FS1461145709000406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=1045-1053&author=S.+J.+Sukoff-Rizzoauthor=C.+Pulicicchioauthor=J.+E.+Malbergauthor=T.+H.+Andreeauthor=G.+P.+Stackauthor=Z.+A.+Hughesauthor=L.+E.+Schechterauthor=S.+Rosenzweig-Lipson&title=5-HT1A+receptor+antagonism+reverses+and+prevents+fluoxetine-induced+sexual+dysfunction+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1A receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats</span></div><div class="casAuthors">Sukoff Rizzo, Stacey J.; Pulicicchio, Claudine; Malberg, Jessica E.; Andree, Terrance H.; Stack, Gary P.; Hughes, Zoe A.; Schechter, Lee E.; Rosenzweig-Lipson, Sharon</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1045-1053</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Sexual dysfunction assocd. with antidepressant treatment continues to be a major compliance issue for antidepressant therapies. 5-HT1A antagonists have been suggested as beneficial adjunctive treatment in respect of antidepressant efficacy; however, the effects of 5-HT1A antagonism on antidepressant-induced side-effects has not been fully examd.  The present study was conducted to evaluate the ability of acute or chronic treatment with 5-HT1A antagonists to alter chronic fluoxetine-induced impairments in sexual function.  Chronic 14-d treatment with fluoxetine resulted in a marked redn. in the no. of non-contact penile erections in sexually experienced male rats, relative to vehicle-treated controls.  Acute administration of the 5-HT1A antagonist WAY-101405 resulted in a complete reversal of chronic fluoxetine-induced deficits on non-contact penile erections at doses that did not significantly alter baselines.  Chronic co-administration of the 5-HT1A antagonists WAY-100635 or WAY-101405 with fluoxetine prevented fluoxetine-induced deficits in non-contact penile erections in sexually experienced male rats.  Moreover, withdrawal of WAY-100635 from co-treatment with chonic fluoxetine, resulted in a time-dependent reinstatement of chronic fluoxetine-induced deficits in non-contact penile erections.  Addnl., chronic administration of SSA-426, a mol. with dual activity as both a SSRI and 5-HT1A antagonist, did not produce deficits in non-contact penile erections at doses demonstrated to have antidepressant-like activity in the olfactory bulbectomy model.  Taken together, these data suggest that 5-HT1A antagonist treatment may have utility for the management of SSRI-induced sexual dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0jkpTIMFXhrVg90H21EOLACvtfcHk0ljy7M6HqpmVvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWiurnL&md5=103c7ed40454ca39883ae32165bc5499</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1017%2FS1461145709000406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145709000406%26sid%3Dliteratum%253Aachs%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DStack%26aufirst%3DG.%2BP.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3D5-HT1A%2520receptor%2520antagonism%2520reverses%2520and%2520prevents%2520fluoxetine-induced%2520sexual%2520dysfunction%2520in%2520rats%26jtitle%3DJ.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D12%26spage%3D1045%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wen, H.; Goolcharran, C.; Ghosh, K.; Nagi, A.</span><span> </span><span class="NLM_article-title">Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-HT<sub>1A</sub> receptor having enhanced intestinal dissolution</span>. Patent WO 2008101139, <span class="NLM_month">8</span>/<span class="NLM_day">21</span>/<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=H.+Wen&author=C.+Goolcharran&author=K.+Ghosh&author=A.+Nagi&title=Sustained-release+tablet+formulations+of+piperazine-piperidine+antagonists+and+agonists+of+the+5-HT1A+receptor+having+enhanced+intestinal+dissolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DH.%26atitle%3DSustained-release%2520tablet%2520formulations%2520of%2520piperazine-piperidine%2520antagonists%2520and%2520agonists%2520of%2520the%25205-HT1A%2520receptor%2520having%2520enhanced%2520intestinal%2520dissolution%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ku, M. S.; Dulin, W. A.; Lin, Y. A.</span><span> </span><span class="NLM_article-title">Controlled-release formulation of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution</span>. Patent WO 2008067399, <span class="NLM_month">6</span>/<span class="NLM_day">6</span>/<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+S.+Ku&author=W.+A.+Dulin&author=Y.+A.+Lin&title=Controlled-release+formulation+of+piperazine-piperidine+antagonists+and+agonists+of+the+5-HT1A+receptor+having+enhanced+intestinal+dissolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKu%26aufirst%3DM.%2BS.%26atitle%3DControlled-release%2520formulation%2520of%2520piperazine-piperidine%2520antagonists%2520and%2520agonists%2520of%2520the%25205-HT1A%2520receptor%2520having%2520enhanced%2520intestinal%2520dissolution%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Cottet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlosser, M.</span><span> </span><span class="NLM_article-title">Recommendable routes to trifluoro-substituted pyridine- and quinolinecarboxylic acids</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">1559</span><span class="NLM_x">–</span> <span class="NLM_lpage">1568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=1559-1568&author=F.+Cottetauthor=M.+Marullauthor=O.+Lefebvreauthor=M.+Schlosser&title=Recommendable+routes+to+trifluoro-substituted+pyridine-+and+quinolinecarboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCottet%26aufirst%3DF.%26aulast%3DMarull%26aufirst%3DM.%26aulast%3DLefebvre%26aufirst%3DO.%26aulast%3DSchlosser%26aufirst%3DM.%26atitle%3DRecommendable%2520routes%2520to%2520trifluoro-substituted%2520pyridine-%2520and%2520quinolinecarboxylic%2520acids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2003%26spage%3D1559%26epage%3D1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Comery, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martone, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achmies, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchinson, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">Acute g-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">8898</span><span class="NLM_x">–</span> <span class="NLM_lpage">8902</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm1000908&amp;key=10.1523%2FJNEUROSCI.2693-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm1000908&amp;key=16192379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm1000908&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=8898-8902&author=T.+A.+Comeryauthor=R.+L.+Martoneauthor=S.+Achmiesauthor=K.+P.+Atchinsonauthor=G.+Diamantidisauthor=X.+Gongauthor=H.+Zhouauthor=A.+F.+Kreftauthor=M.+N.+Pangalosauthor=J.+Sonnenberg-Reinesauthor=J.+S.+Jacobsenauthor=K.+L.+Marquis&title=Acute+g-secretase+inhibition+improves+contextual+fear+conditioning+in+the+Tg2576+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Acute γ-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease</span></div><div class="casAuthors">Comery, Thomas A.; Martone, Robert L.; Aschmies, Suzan; Atchison, Kevin P.; Diamantidis, George; Gong, Xiaohai; Zhou, Hua; Kreft, Anthony F.; Pangalos, Menelas N.; Sonnenberg-Reines, June; Jacobsen, J. Steven; Marquis, Karen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">8898-8902</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Transgenic mice (Tg2576) overexpressing the Swedish mutation of the human amyloid precursor protein display biochem., pathol., and behavioral markers consistent with many aspects of Alzheimer's disease, including impaired hippocampal function.  Impaired, hippocampal-dependent, contextual fear conditioning (CFC) is obsd. in mice as young as 20 wk of age.  This impairment can be attenuated after treatment before training with the phosphodiesterase-4 inhibitor rolipram (0.1 mg/kg, i.p.).  A rolipram-assocd. improvement is also obsd. in the littermate controls, suggesting that the effect of rolipram is independent of β-amyloid.  Acute treatment before training (but not after training or before testing) with the γ-secretase inhibitor (GSI) N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine tert-Bu ester (DAPT), at a dose that reduces brain concns. of β-amyloid (100 mg/kg), attenuates the impairment in 20- to 65-wk-old Tg2576 mice.  Importantly, DAPT had no effect on performance of control littermates.  These data are supportive of a role of β-amyloid in the impairment of CFC in Tg2576 mice.  Furthermore, they suggest that acute treatment with GSI may provide improved cognitive functioning as well as disease-modifying effects in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXYk2LoMtDdrVg90H21EOLACvtfcHk0ljqX_I438SEqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7rE&md5=fbfc0b5caefdde799667072b5683799a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2693-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2693-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DComery%26aufirst%3DT.%2BA.%26aulast%3DMartone%26aufirst%3DR.%2BL.%26aulast%3DAchmies%26aufirst%3DS.%26aulast%3DAtchinson%26aufirst%3DK.%2BP.%26aulast%3DDiamantidis%26aufirst%3DG.%26aulast%3DGong%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKreft%26aufirst%3DA.%2BF.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DAcute%2520g-secretase%2520inhibition%2520improves%2520contextual%2520fear%2520conditioning%2520in%2520the%2520Tg2576%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D8898%26epage%3D8902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff-Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunlop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span> </span><span class="NLM_article-title">Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2008&pages=159-170&author=S+Rosenzweig-Lipsonauthor=A.+Sabbauthor=G.+Stackauthor=P.+Mitchelauthor=I.+Luckiauthor=J.+E.+Malbergauthor=S.+Grauerauthor=J.+Brennanauthor=J.+F.+Cryanauthor=S.+J.+Sukoff-Rizzoauthor=J.+Dunlopauthor=J.+E.+Barrettauthor=K.+L.+Marquis&title=Antidepressant-like+effects+of+the+novel%2C+selective%2C+5-HT2C+receptor+agonist+WAY-163909+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS%26aulast%3DSabb%26aufirst%3DA.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMitchel%26aufirst%3DP.%26aulast%3DLucki%26aufirst%3DI.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DCryan%26aufirst%3DJ.%2BF.%26aulast%3DSukoff-Rizzo%26aufirst%3DS.%2BJ.%26aulast%3DDunlop%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26atitle%3DAntidepressant-like%2520effects%2520of%2520the%2520novel%252C%2520selective%252C%25205-HT2C%2520receptor%2520agonist%2520WAY-163909%2520in%2520rodents%26jtitle%3DPsychopharmacology%26date%3D2008%26volume%3D192%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-ref53_1"><span><span class="NLM_contrib-group">Childers, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huryn, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potestio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Benzodioxanylpiperazine Derivatives as Potent Serotonin 5-HT<sub>1A</sub> Antagonists: The Discovery of Lecozotan</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3467</span><span class="NLM_x">–</span> <span class="NLM_lpage">3470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049493z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3467-3470&author=W.+E.+Childersauthor=M.+A.+Abou-Gharbiaauthor=M.+G.+Kellyauthor=T.+H.+Andreeauthor=B.+L.+Harrisonauthor=D.+M.+Hoauthor=G.+Hornbyauthor=D.+M.+Hurynauthor=L.+Potestioauthor=S.+J.+Rosenzweig-Lipsonauthor=J.+Schmidauthor=D.+L.+Smithauthor=S.+J.+Sukoffauthor=G.+Zhangauthor=L.+E.+Schechter&title=Synthesis+and+Biological+Evaluation+of+Benzodioxanylpiperazine+Derivatives+as+Potent+Serotonin+5-HT1A+Antagonists%3A+The+Discovery+of+Lecozotan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref53_1&amp;dbid=16384&amp;doi=10.1021%2Fjm049493z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049493z%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHo%26aufirst%3DD.%2BM.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DHuryn%26aufirst%3DD.%2BM.%26aulast%3DPotestio%26aufirst%3DL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%2BJ.%26aulast%3DSchmid%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Benzodioxanylpiperazine%2520Derivatives%2520as%2520Potent%2520Serotonin%25205-HT1A%2520Antagonists%253A%2520The%2520Discovery%2520of%2520Lecozotan%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3467%26epage%3D3470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i109"><a href="/doi/suppl/10.1021/jm1000908">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20322"></div></div></div></div></div><hr /></hr><p class="last">Detailed experimental protocols for the pharmacology assays and a graph depicting the effect of compound <b>10b</b> on fluoxetine-induced sexual dysfunction. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1000908/suppl_file/jm1000908_si_001.pdf">jm1000908_si_001.pdf (194.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1000908&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-10%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm1000908%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1000908" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679980906e0e3d5a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
